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psExecutive Summary
Background
•	 The EU GMO (genetically modified organisms) legislation provides for monitoring (ex	post assessment) 
and reporting on the socio-economic implications of the deliberate release and placing on the market 
of GMOs. 
•	 At the request of the Environment Council in December 2008, the Commission gathered available 
data from the Member States on the socio-economic implications of the cultivation of GMOs 
and published a report in 2011. In view of the quantitative and qualitative heterogeneity of the 
information provided, the Commission recommended in the report that, in order to gain a better 
understanding of these impacts in the specific EU context, a methodological framework should 
be built up to define the precise socio-economic indicators to be monitored and to establish 
appropriate rules for data collection. 
The Workshop
•	 The Institute for Prospective Technological Research (IPTS) of the Commission’s Joint Research 
Centre (JRC) was requested to review for policy makers the main findings of scientists who are active 
worldwide in the field of socio-economic assessment (SEA). In order to fulfil this task, an “International 
workshop on socio-economic impacts of genetically modified crops” was co-organised by the JRC-
IPTS and FAO (Food and Agriculture Organization of the United Nations) in November 2011. 
•	 The workshop brought together leading experts in the field to present their research results to experts 
from the Member States and to discuss experiences and the further development of SEA. The coverage 
of the workshop was worldwide and structured into seven sessions ranging from farm level to 
consumer impacts. 
The Socio-Economic Impacts on Farmers
•	 Large-scale planting of GM crops started in 1996. In 2010 148 million hectares (10% of the world 
cropped area) in 29 countries were already covered by GM crops, half of them grown in developed 
countries and the other half in developing countries. However, the diversity of GM plants is still very 
low in terms of the crops and traits accessible to farmers. Four crops represent virtually the whole 
biotech area.
•	 The herbicide tolerant (HT) soybean (covering 50% of the world’s GM area) has been very quickly 
adopted in those countries where it is available to farmers (100% of soy in Argentina is GM and 
93% in the USA). In both countries, adoption had small and generally insignificant yield effects. 
Incremental profits for farmers are small, but larger in South America than in North America, reflecting 
differences in Intellectual Property Rights schemes. 
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•	 In both regions the extremely fast adoption rate is generally associated with the significant ease of 
use, efficiency, and flexibility that HT soybeans confer for weed control. In Argentina, HT soybeans 
also enable double cropping i.e. soybeans planted as a second crop after wheat. As for the USA, a 
recent study conducted in the Midwest shows that the adoption of GM soybeans tends to reduce the 
rate of use of all types of variable inputs (capital, labour, energy, chemicals and other materials) and 
generates in the mid-term a benefit-cost ratio of about 3.6.
•	 Insect Resistant (Bt) maize (31% of the global GM area) is cultivated in the highest number of countries 
(16; six of which are in the EU). In the USA, the adoption of GM maize has reached 86% of the total 
maize area (when considering Bt maize, HT maize and stacks together). In this country, cultivation of 
GM crops is associated with a small but significant increase in yield and with a reduction in the use 
of insecticides. In Midwestern US states, the output effects of the adoption of GM maize varieties are 
shown to be insignificant but the rate of use of all input groups (capital, labour, energy, chemicals and 
other materials) tended to decline, leading to a benefit-cost ratio of roughly 5.2.
•	 Bt maize is the only GM crop grown in the EU in significant amounts (mainly in Spain). Detailed 
surveys in Spain report gains for farmers of +195 EUR/ha/year mainly due to the increase in yield and 
reduced insecticide use.
•	 Bt cotton is the most studied GM crop in socio-economic terms. India is the first country in the world 
in terms of area of Bt cotton, followed by China and by the USA. In India, it amounts to 90% of the 
total cotton area, and growers are mainly smallholders. Bt cotton strongly reduces insecticide use and 
increases yields, as farmers were not entirely efficient at controlling pests before the adoption of GM 
cotton. The positive effects of Bt cotton cultivation have also been observed in many other countries 
worldwide, and related literature is abundant. The benefits in tropical countries are greater than in 
temperate countries because of the higher pest pressure.
•	 The sustainability of the benefits over time will depend on the adoption of “best agricultural 
practices”, either for conventional or GM crops, in particular to prevent the advent of any kind of 
resistance on weed or pests that will make technology fail. The issue of environmental impacts of GM 
crops and how to introduce externalities into economic analyses is under debate.
•	 A number of methodological issues are associated with the impact assessment of GM crops at farm 
level, especially in developing countries where researchers must collect data in personal interviews 
with farmers due to the lack of reliable sources and where random sampling may not be feasible. 
During the first decade of published studies, the most commonly applied methodologies were partial 
budgets and econometric models of farm production, in which researchers tested hypotheses related 
to the yield advantages, labour and pesticide savings associated with adoption.
•	 Data quality was a major limitation of early studies, where samples were typically small, field 
observation periods were brief, and estimates of key parameters were often based on farmers’ recall. 
Perhaps the most critical concern has been self-selection bias, i.e. the fact that farmers adopting 
the GM technology may also be the most efficient, or those with greater endowments and better 
access to markets or information. Additionally, the decision to grow a GM crop may be endogenous, 
and explained by other factors which are unobservable or not integrated into the model (like the 
pest pressure for instance). These methodological issues can be addressed by using advanced 
econometrical techniques.
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•	 The cultivation of GM crops in a global market has effects upstream and downstream of the farming 
sector. GM seed suppliers profit by selling seeds, while users of the GM products (feed/food industry, 
the biofuel sector and textile industry) benefit from less expensive and/or better quality of raw 
materials. Consumers gain from lower commodity prices and sometimes increased quality attributes. 
As for the potential losers, manufactures of competitive inputs (insecticides, agrochemicals) lose 
market share and non-adopting farmers have a competitive disadvantage.
•	 Economic models have been developed to estimate the global economic welfare creation of GM 
cultivation and the distribution of its benefits among stakeholders. The data presented in the workshop 
show that HT soybeans generate 3 billion USD per year, distributed between the consumers/
processors (50%), the adopting farmers (28%) and the innovating biotechnology sector (22%).
•	 Yet examples of economic research on welfare distribution are not many. Evidence suggests that 
institutional factors influence this distribution. Case studies covering different GM crops and countries 
indicate that the biotechnology sector captures 30% to 60% of the created benefits in developed 
countries. In countries with a lower degree of patent protection however, farmers capture 80%-90% 
of the benefits. Farmers in developing countries may experience a multiplicative effect on benefits: 
a farmer adopting GM crops expects higher yields and will therefore be attracted to buy underused 
inputs such as fertilizers, eventually resulting in even higher yield benefits.
•	 Spill-over of yield benefits and cost reductions are also important in the global markets as they 
influence prices, even for countries not cultivating GM crops but importing them. Models estimate 
that world food price increases would be significantly higher in the absence of GM cultivation, by 
10% to 30% depending on the crop and the underlying assumptions. This price effect benefits all 
consumers globally through trade.
•	 In recent years a geographic shift of farmers’ benefits was observed from the initial situation where 
benefits were concentrated in the USA, Canada and Argentina to a situation where small farmers in 
a variety of developing countries are obtaining more benefits from the technology. As a secondary 
effect, a shift in R&D investment in biotechnology to developing countries has been observed recently. 
Multinationals are opening research centres in countries where the crops will be grown. The creation 
of technology-related jobs has important multiplier effects on the local economies.
•	 The shift in benefits from the agro-chemical industry and conventional seed producers to the 
biotechnology industry also translates to a shift in R&D between these sectors. It is not clear whether 
this shift leads to a concentration in the agricultural input sector as the traditional players have 
activities in both conventional and GM markets.
Economics of Segregation/Coexistence of GM and non-GM Supply Chain
•	 The cultivation and marketing of GM crops is regulated in most countries and different public policies 
govern the segregation and coexistence between GM and conventional food and feed supply chains. 
In some countries market actors complement these regulations with private standards. For example, 
the EU-based food industry and retailers are hesitant to accept GM products and are willing to accept 
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higher costs to avoid mandatory GM labelling while most of the EU feed industry accepts GM raw 
materials, relying solely on the legal thresholds for labelling.
•	 Segregation and coexistence policies result in additional costs but may also generate consumer 
benefits (consumer choice, creation of niche markets for non-GM labelled products etc). Until now, 
empirical studies mostly assessed the costs for farmers and their downstream supply chains in many 
parts of the world.
•	 At the farm level, EU Member States apply coexistence policies for GM and non-GM farming, 
consisting of a set of ex	 ante regulations and ex	 post liabilities. So far, in all EU Member States’ 
regulations, it is the GM farmer who should take the measures (usually administrative measures or 
technical measures such as isolation distances) and who bears the liability.
•	 The costs and feasibility of coexistence depend to a large extent on the threshold set for adventitious 
presence of GM crops in non-GM production. Beside the legal threshold for labelling (0.9%), some 
private operators in the EU (retailers or organic industry) demand higher private standards (0.1%). 
Farmers can minimize coexistence costs by cooperating and spatially aggregating the production of 
GM and non-GM crops (e.g. “Production zones” in Portugal).
•	 The general policy of European food industry and retailers to avoid GM raw materials can be achieved 
by sourcing ingredients from certified non-GM markets (at higher costs) and separating GM and non-
GM ingredients in their processing facilities. Case studies show that the type and complexity of the 
supply chain to a great extent influence the segregation costs. The total additional costs of coexistence 
and product segregation systems can rise to almost 13% of production turnover for non-GM rapeseed 
oil while they represent only 0.6% in the case of a frozen pizza producer. These results show that the 
costs of coexistence and the feasibility in the supply chain should be considered on a case-by-case 
basis. Very little empirical information on these costs is available and often constitutes proprietary 
business data which makes it a challenging subject for research.
•	 The perceived demand of European consumers for non-GM food has created new niche markets for 
the food industry. In Germany, the government introduced a new “GM free” label and “GM free” 
logo (in 2008 and 2009) which has been managed by a stakeholder organisation since 2010. Since 
the launch of the GM free label there has been a steady growth in participants. Non-GM production 
incurs higher costs that have to be compensated in the market. Economic analyses showed that 
German farmers get a small price premium from the scheme to cover their extra costs (some 3-4% of 
the price for producers of milk from cows fed with non-GM feed).
•	 Food/feed ingredients are highly traded commodities and Europe is a top importer for maize, 
soybeans and soybean meal. To serve the non-GM grain markets worldwide (mainly Japan and 
the EU), grain traders use different types of spatial and temporal separation measures. However, 
some bottlenecks exist, e.g. the low number of ports used to ship the commodities from all over 
America or the production of certified seeds. Adventitious presence of non-approved GM crops in 
the non-GM supply chain did result in trade distortions and higher costs for European importers 
and processors. Indeed, the world prices for non-GM segregated grains have significantly 
increased in the past years.
11
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•	 The 2000 Cartagena Protocol on Biosafety (CPB) - part of the UN Convention of Biological Diversity 
– stipulates in Article 26.1 that for decisions on GMO imports, countries may consider SEAs of the 
impact of GMOs on the conservation and sustainable use of biodiversity, especially with regard to the 
value of biological diversity to indigenous and local communities. When implementing the PCB in 
the national legislation, many countries have gone beyond the contents of Article 26.1 by introducing 
other considerations, such as social, ethical or philosophical aspects.
•	 When a country includes a SEA in the GMO biosafety regulatory process it has to decide if the 
SEA should be voluntary or mandatory, if it should be carried out for approval (ex	ante) and/or for 
post-release monitoring (ex	post) and which methodology should be applied. For ex	ante studies the 
choice of methods is limited and they necessarily will be based on projections and assumptions.
•	 As for potential implications of the introduction of SEAs in the regulatory process, SEAs will provide 
more and better information about the technological impact for the decision making process and may 
help to avoid the adoption of inefficient technologies. However, the regulatory compliance costs will 
increase, regulatory delays are possible and, if standards are not clear, the system might even become 
unworkable. The experts participating in the workshop argued that the inclusion of a robust SEA, 
in addition to strict science-based safety assessments, could make regulatory decision-making on 
cultivation more objective and transparent.
•	 Comparison of current approaches to the inclusion of SEAs in the GMO regulatory process in 
Argentina, Brazil and China shows significant differences. In Argentina, SEA is mandatory and 
comprises the ex	 ante assessment of economic impacts on trade and competitiveness. Brazil has 
introduced a non-mandatory SEA with an open scope and it is decided on a case-by-case basis if it is 
used. In China, the SEA is currently not included in the guidelines and regulations.
•	 Since the late 1990s, approvals of GM crops in Argentina have taken into account the state of play 
in other countries especially in the EU (“mirror policy”) and also more recently in China and India. 
Decisions on the authorisation of cultivation of GM crops are made on the basis of three independent 
expert opinions: an environmental risk evaluation, a food and feed safety assessment and an analysis 
of the potential impacts on Argentina’s international trade. The third expert analysis evaluates the 
stage of approval for production, consumption and import in the main importing countries and the 
competiveness of Argentina as an exporter for the crop, taking into account the situation of the import 
markets and other exporters.
Economic Compensation, Liability Issues and Institutional Framework Influencing 
Adoption of GM Crops
•	 Even with well-designed policies and regulations, unwanted harmful consequences of GMO 
cultivation can affect others’ assets (e.g. through adventitious admixture in the agricultural supply 
chain) and, in order to compensate the victims, liability problems have to be solved. There are 
different mechanisms in place to deal with liability issues, regulation (liability/tort law) and market 
place liability.
12
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•	 In Europe, regulation is the common approach with tort law being a cornerstone. However, in spite 
of common fundamental values, tort law requirements vary substantially throughout Europe, leading 
to variations in the way potential claims would be handled and resolved. Moreover, tort law overlaps 
with other regulations such as good agricultural practice, coexistence rules and national policies.
•	 Insurance schemes can be introduced, in order to distribute the burden of liability for farmers 
cultivating GM crops between those contributing through the payment of premiums. Compensation 
funds established with contributions from farmers cultivating GMO crops and/or from government 
revenue could substitute where insurance schemes are absent. Indeed, compensation funds do exist 
in Denmark and Portugal, the latter being private and the former government-supported. All these 
schemes are theoretical and their actual applicability is unknown since there is no record of practical 
experiences or court cases in Europe.
•	 In the USA and Canada, coexistence or segregation of GM crops and non-GM crops is not specifically 
regulated. Therefore, civil liability applies in the context of GM crop cultivation and liability issues 
are solved between private parties (marketplace liability). In the event of admixture, the product 
development company may be held responsible and obliged to pay compensation.
•	 Two cases from the USA illustrate situations where traces of unapproved GMOs were found in non-
GM products. StarLink maize was detected in food products despite only being approved for feed use 
and, in the ensuing court case, plaintiffs who could prove that their crop, product or market had been 
negatively impacted by StarLink maize joined a class action lawsuit. In the other case, traces of LL601 
rice (which was not yet authorised for marketing in the USA or in Europe) were found in US exports 
to the EU. The US rice industry lost the EU market for years after this incident and the biotechnology 
company recently offered USD 750 million in compensation to concerned rice producers.
•	 Institutional and political factors influencing the adoption and profitability of GM crops were 
discussed on the basis of studies from South Africa. The South African Government views 
biotechnology as a strategic industry to support economic growth and created an environment 
facilitating science-based and balanced considerations and regulation of GM crop cultivation which 
led to fast adoption of GM crop cultivation. The Makhathini Flats Bt cotton experience illustrates 
the importance of institutional factors in the adoption of GM crops by smallholder farmers. After 
the swift adoption of Bt cotton cultivation under favourable institutional conditions (institutional 
arrangement with one geographically isolated cotton gin supplying credit and extension services to 
contract farmers), the cotton cultivation system collapsed after institutional failure exacerbated by 
droughts and floods. 
Consumers’ Attitudes and Direct/Indirect Impacts on Consumers
•	 Many researchers have set out studies to measure the preference of consumers regarding GM or non-
GM food products (estimated by the Willingness To Pay - WTP). Two main types of methodologies to 
elicit consumers’ valuation of non-GM products can be distinguished: stated or revealed preference. In 
the case of the first method, consumers’ WTP is elicited in a hypothetical framework, for instance with 
questions about purchase intentions. This method is generally easier to implement, as it allows quick 
collection of data at low cost (which is specifically relevant in developing countries), although it usually 
leads to overvaluation of WTP (“hypothetical bias”). The second method, namely “revealed preference” 
13
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auctions are especially useful in situations where no market for the assessed GM food products exists.
•	 A recent meta-analysis of studies confirmed the common assumption that consumers in developed 
countries have a preference for non-GM food, especially in Europe. A second assumption, namely 
that consumers in developing countries are more inclined to buy GM food than in industrial countries 
was questioned by experts who suggested that hypothetical bias (in these countries most studies rely 
on stated preference methods) may have led to an overvaluation of the preferences of consumers.
•	 A recent two-year study in the EU (ConsumerChoice, funded by EU Framework Programme for 
Research) evaluated consumers’ WTP for non-GM products in real purchasing situations. Two general 
conclusions could be drawn. Firstly, the actual purchase behaviour of consumers regarding GM food 
products does not correspond to their stated attitude when questioned on the subject; and secondly, 
when GM food products are available on the shelves, consumers are generally willing to buy them. 
By and large, the level of opposition to GM food rises with the higher income and better education of 
consumers.
•	 Although the current GM crops (first generation) were not designed to provide health benefits, studies 
provide evidence that concentrations of certain mycotoxins are significantly lower in Bt maize than in 
its conventional isogenic line (linked to reduced insect damage). These mycotoxins can cause adverse 
health effects in humans. Therefore, consumers, especially in developing countries where mycotoxin 
contamination is higher, could benefit from the adoption of Bt maize.
Looking Forward: New Crops in the Pipeline and Possible Economic and Social Impacts 
•	 The global pipeline for GM crops is active and expanding: up to 124 GM events are expected to 
be commercially available by 2015, compared to some 40 GM events released so far. Although 
existing crops (soy, canola, maize, cotton) and traits (HT, Bt) will still be dominant in 2015 there will 
be a slight but significant diversification in terms of genetically modified species, but also in terms 
of traits. Different agronomic traits (e.g. resistance to viruses, improved resistance to diseases and 
tolerance to abiotic stresses such as drought or high salinity) are expected to increase in importance, 
as will ‘second-generation’ crops which will specifically address the needs of consumers, through, for 
instance, improved fatty acid profile or higher content in beta carotene.
•	 The coming years will see the emergence of technology providers from Asia as a major source of GM 
events. This region will be especially active, putting on the market the first GM rice varieties, even if 
the release of some of the GM rice events in the pipeline a few years ago has been delayed or even 
cancelled. Most of the rice events close to commercialization are insect resistant varieties, in addition 
to the biofortified rice called Golden Rice. Nevertheless, in Asia the dynamic of the research pipeline 
seems unaffected by the uncertainties of governments.
•	 In the case of Golden Rice, an event genetically modified to express genes that lead to the 
accumulation of beta carotene in the rice grain, the development is already quite advanced, and 
a regulatory dossier could be delivered to the authority in the Philippines by 2013. Indeed, among 
Asian countries, the Philippines and Indonesia might be the ones releasing the first commercial GM 
rice in the next years.
14
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•	 Improvement in crop quality may generate nutritional or health benefits for consumers, and thus may change 
their attitude toward GM crops. Therefore, the new traits incorporated by the GM crops in the pipeline would 
require new evaluation methods and new socio-economic indicators to assess their impact (e.g. to compare 
the cost effectiveness of the use of these crops with alternative public health measures).
•	 Actually, some ex	ante assessments of the impacts of new GM crops are already available. In the 
case of Golden Rice, recent studies estimated the reduction in morbidity and mortality potentially 
generated by the introduction of this crop. Results show a significant beneficial health impact, at a 
lower cost when compared with alternative public measures. Ex	ante studies for Bt rice conducted in 
China estimated a huge internal gain for rice production, even when considering the potential loss of 
export markets.
•	 For Europe, developing ex	ante impact assessments is a priority due to the limited number of GM crops 
that are available to be studied ex	post. Examples of successfully applied methodologies are studies 
predicting the level of adoption and the economic impacts of the introduction of GM maize designed to 
control the Western Corn Rootworm, a pest that arrived in Central Europe in the 1990s. Bio-economic 
simulations of this kind should be extended to the main GM crops in the regulatory pipeline.
15
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ps1 Introduction
Techniques of genetic modification based 
on recombinant DNA (Deoxyribonucleic acid) 
have been used in plant breeding since the 1980s 
and the first crops produced by GM technologies 
reached commercial cultivation in the mid-
1990s. In many countries the existing legislation 
was not regarded as sufficient to regulate GMOs 
and so new legislation on GMOs was introduced 
in the 1980s and 1990s. It generally provides for 
an authorisation process for experimental and 
commercial release, import and marketing and 
use of these new crops including comprehensive 
risk assessments (environmental and food and 
feed safety).
In more recent years studies on the socio-
economic impact of policies were introduced 
as an additional support tool for policy makers 
in decisions in many policy fields. While 
environmental and health risk assessment is 
usually an integral and mandatory step in the 
regulatory process, the carrying out of a socio-
economic assessment (SEA) is rather facultative in 
the authorisation process or is used (ex	post) to 
monitor the impact of approved technologies.
The EU GMO legislation provides for ex	post 
assessment of the socio-economic implications 
of deliberate release and placing on the market 
of GMOs. Under Directive 2001/18/EC1 the 
Commission is required to submit a report on 
the implementation of the Directive including an 
assessment on the abovementioned subject. At 
a meeting in December 2008, the Environment 
Council called to mind the Directive’s 
requirement to submit a specific report on the 
implementation of the Directive 2001/18/EC and 
1 Directive 2001/18/EC of the European Parliament and of 
the Council of 12 March 2001 on the deliberate release 
into the environment of genetically modified organisms 
and repealing Council Directive 90/220/EEC OJ L 106, 
17.4.2001, p. 1–39
invited Member States to collect and exchange 
relevant information on the implications of the 
placing on the market of GMOs2.
Considering a SEA (ex	 ante) in the 
authorisation process for GMO cultivation 
appears to be a possible approach. Regulation 
(EC) No 1829/2003 asks the Commission to take 
into account, for the decisions on applications 
for the authorisation of GMOs, the opinion 
of the European Food Safety Authority (EFSA), 
relevant provisions of the Community law and 
“other legitimate factors relevant to the matter 
in consideration”. The possible consideration 
of socio-economic factors in the authorisation 
of GMOs for cultivation was also stressed by 
Member States in several Environmental and 
Agricultural Councils3.
Methodology for environmental and 
health risk assessments is well-developed and 
implemented in the regulatory process of GMOs, 
whereas studies on the socio-economic impact 
of the cultivation are carried out mainly by 
academia. However, a recent review4 revealed 
that even academic research does not cover all 
relevant sectors equally (most of the studies focus 
on the farm level, with fewer studies on the other 
sectors such as seed, food, feed and consumer) 
and that methodology has to be developed 
2 Working paper to the Commission report on 
socio-economic implications of GMO cultivation 
(SANCO/10715/2011): http://ec.europa.eu/food/food/
biotechnology/reports_studies/docs/swp_socio_economic_
report_GMO_en.pdf
3 Environment Council of 2 March 2009, Agriculture 
Council of 23 March 2009 and Environment Council of 
 25 June 2009.
4 Report from the Commission to the European Parliament 
and the Council on socio-economic implications of GMO 
cultivation on the basis of Member States contributions, as 
requested by the Conclusions of the Environment Council 
of December 2008 (SANCO/10715/2011 Rev.5): http://
ec.europa.eu/food/food/biotechnology/reports_studies/
docs/socio_economic_report_GMO_en.pdf
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on further. Currently the global area sown with GM 
varieties is over 148 million hectares5, although 
only some 100,000 ha of GM crops (mainly Bt 
maize) are cultivated in the EU. Consequently, 
most studies (especially ex	 post	 studies) were 
carried out in countries outside the EU.
In the European Union (EU), the European 
Commission (EC) recently initiated activities 
to build up a methodological framework 
for socio-economic impact assessments, to 
define the precise socio-economic indicators 
to be monitored and to establish appropriate 
rules for data collection. The main purpose 
of this report is to provide the proceedings 
of an international workshop on the socio-
economic impacts of genetically modified 
(GM) crops co-organised by the JRC-IPTS 
and the Food and Agriculture Organization 
of the United Nations (FAO) as a first step in 
technical discussions between the Member 
States and the Commission. However, it also 
provides information on the background and 
prospects for future development.
5 James, C. Global Status of Commercialized Biotech/
GM Crops: 2010. ISAAA Brief 42. http://www.isaaa.
org/resources/publications/briefs/42/default.asp. 
International	 Service	 for	 the	 Acquisition	 of	 Agri-
Biotech	Applications,	Ithaca,	NY (2010).
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This JRC Scientific and Policy Report provides 
proceedings of the “International workshop on 
socio-economic impacts of genetically modified 
(GM) crops” which was co-organised by the JRC-
IPTS and the FAO in Seville on 23-24 November 
2011.
The JRC-IPTS has been requested to review 
for policy makers the main findings of scientists 
active in this field worldwide in co-operation 
with the FAO. The objective of this workshop, 
which was directed at socio-economic experts 
from the competent authorities of the EU Member 
States and staff from the EC, was to start technical 
discussions between the Member States and the 
Commission to define the factors and indicators 
necessary to properly capture the impacts of 
GMOs in the EU.
Chapter 3 provides background information 
on the Commission report on the socio-economic 
implications of the cultivation of GMOs and 
current changes to Directive 2001/18/EC which 
will give more flexibility and responsibility to 
Member States concerning decisions on the 
cultivation of GMOs in their territory. Additionally 
it reports on a Commission conference on the 
socio-economic impacts of cultivation of GMOs 
which was organised in October 2011 and it 
provides an overview of activities of the JRC-IPTS 
and the FAO in the field. Chapter 4 is dedicated 
to the “International workshop on socio-
economic impacts of GMO crops” (November 
2011). It summarises the main topics presented 
and the discussions from each of the sessions and 
discusses the prospects of further research.
The list of the workshop participants and the 
agenda of the workshop are included in Annex 1 
and Annex 2 respectively. Annex 3 contains short 
papers on the presentations given during the 
workshop provided by the authors.
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3.1 Commission report on the socio-
economic implications of the 
cultivation of GMOs, 20116
In December 2008, the Environment 
Council invited the Commission and Member 
States to provide a report on the socio-economic 
implications of the deliberate release and placing 
on the market of GMOs. The Commission 
launched a consultation of the Member States on 
the socio-economic impact of GMO cultivation 
via an indicative questionnaire which focused on 
issues such as economic and social implications, 
agronomic sustainability and environmental 
impacts. Alternatively, Member States could send 
their contributions in other formats.
Data submitted by the Member States 
originated from a wide range of sources, 
from peer-reviewed studies to assumptions of 
individuals. Inputs from different stakeholders 
had been synthesised by a competent national 
authority, or an unabridged set of answers from 
different stakeholders was transmitted directly to 
the Commission.
The report, which was finalised in 2011, 
provides a short summary of the main elements of 
the Member States’ contributions. Non-exhaustive 
compilations of the individual contributions 
of the Member States are in the Commission’s 
working paper accompanying the report. All the 
received contributions are available in full on the 
website of the Commission7.
6 Report from the Commission to the European Parliament 
and the Council on socio-economic implications of GMO 
cultivation on the basis of Member States contributions, as 
requested by the Conclusions of the Environment Council 
of December 2008 (SANCO/10715/2011 Rev.5): http://
ec.europa.eu/food/food/biotechnology/reports_studies/
docs/socio_economic_report_GMO_en.pdf
7 http://ec.europa.eu/food/food/biotechnology/reports_
studies/contributions_en.htm
Complementary to the results of the 
consultation with Member States, the report also 
includes a review of the international scientific 
literature on the economic and social dimension 
of GMO cultivation. The references are listed 
in the working paper accompanying the report. 
Additionally the report provides a short discussion 
of the most relevant research projects under the 
sixth Framework Programmes for Research:
•	 Results	and	perspectives	on	the	coexistence	
and traceability of GM and non GM supply 
chains (CO-EXTRA – 2005-2009)8
•	 Sustainable	 introduction	 of	 GM	 crops	 to	
European agriculture (SIGMEA 2004-2007)9
•	 Do	 Europeans	 buy	 GMO	 food?	
(CONSUMERCHOICE – 2006-2008)10
Overall, the report concludes that GMO 
cultivation in Europe is limited to rather small 
agricultural areas in a few of the Member States. 
Seven Member States have past or present 
experience in cultivating Bt maize MON 810. 
Romania cultivated herbicide tolerant (HT) 
soybeans before joining the EU and the cultivation 
of the GM potato Amflora has been started in 
three Member States. Consequently, relevant 
information from ex	post studies is limited.
Additionally, statistically relevant data on 
the socio-economic impacts of GMO cultivation 
8 Results and perspectives on the coexistence and 
traceability of GM and non GM supply chains (CO-EXTRA 
– 2005-2009) http://www.coextra.eu/
9 Sustainable introduction of GM crops to European 
agriculture (SIGMEA 2004-2007): http://sigmea.group.
shef.ac.uk/
10	 Do	 Europeans	 buy	 GMO	 food?	 (CONSUMERCHOICE	
– 2006-2008): http://www.kcl.ac.uk/medicine/research/
divisions/dns/projects/consumerchoice/downloadfiles/
Chapter01.pdf
20
3 
B
ac
kg
ro
un
d 
In
fo
rm
at
io
n
in Europe (and also outside Europe) are mainly 
available at farm level. The socio-economic 
impacts of GMO cultivation in Europe across 
the food chain and the society as a whole are 
often not analysed in an objective manner. On 
this basis the Commission considered a targeted 
analysis of specific topics as inappropriate.
The Commission recommends that a robust 
set of factors should be defined to capture ex	ante 
and ex	post socio-economic consequences over 
the whole food chain, from seed production to 
consumers. A methodological framework should 
be built up to define the precise socio-economic 
indicators to be monitored and to establish 
appropriate rules for data collection.
3.2 A more flexible approach for GMO 
cultivation under the existing GMO 
legislation in the EU
In July 2010 the Commission proposed a 
package of two series of measures aiming to 
provide more possibilities for Member States to 
decide on GMO cultivation.
The first element of this package was 
the adoption on 10 July 2010 of a new 
Recommendation on guidelines for the 
development of national coexistence measures11, 
replacing a previous Recommendation from 
200312. The new Recommendation provides a 
more flexible interpretation of Article 26a of 
Directive 2001/18/EC which allows Member 
States to adopt measures to avoid the unintended 
presence of GMOs in other crops. Indeed 
the new Recommendation recognises that 
the potential loss of income for producers of 
particular products, such as organic products, 
11 Commission Recommendation on guidelines for the 
development of national strategies to avoid the unintended 
presence of GMOs in conventional and organic crops OJ 
C 200, 13.07.2010, p. 1-5
12 Commission Recommendation on guidelines for the 
development of national strategies and best practices to 
ensure the co-existence of genetically modified crops with 
conventional and organic farming OJ L189, 29.7.2003, p. 36
is not necessarily limited to the exceeding of 
the labelling threshold set at 0.9% in the EU 
legislation. In certain cases, and depending on 
market demand and on the respective provisions 
of national legislation (e.g. some Member 
States have developed national standards of 
‘GM-free’ labelling), the presence of traces of 
GMOs in particular food crops – even at a level 
below 0.9% – may cause economic harm to 
operators who would wish to market them as 
not containing GMOs. In those cases, Member 
States would be able to define measures going 
beyond the provisions of Directive 2001/18/EC, 
e.g. measures that aim to reach levels of GMO 
presence in other crops lower than 0.9%.
The second element of this package is a 
legislative proposal to the European Parliament 
(EP) and to the Council aiming to increase 
the possibility for Member States to restrict or 
prohibit the cultivation of authorised GMOs in 
their territory. This proposal which takes the form 
of the inclusion of a new Article 26b in Directive 
2001/18/EC13 will allow Member States to invoke 
grounds which are not related to the existence of 
adverse effects to health or environment to restrict 
or prohibit GMO cultivation. The legislative 
proposal is currently being discussed by the EP 
(EP first reading report adopted on 5 July 2011) 
and the Council of Ministers.
3.3 Commission conference on the 
socio-economic impacts of the 
cultivation of GMOs (Brussels, 
October 2011)
As a follow-up to the publication of the 
report on the socio-economic impacts of GMO 
cultivation (see chapter 3.1), the Commission 
organised a one-day public conference on the 
matter in Brussels on 18 October 2011. The 
13 Directive 2001/18/EC of the European Parliament and of 
the Council of 12 March 2001 on the deliberate release 
into the environment of genetically modified organisms 
and repealing Council Directive 90/220/EEC. OJ L 106, 
17.4.2001, p. 1–39
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psaim of the conference was to explore in further 
detail the findings of the report, and offer the 
possibility to Member States, third countries and 
stakeholders to comment and expose their own 
views and experience.
The agenda, the presentations and live 
recording of the conference are provided on the 
EC website:
http://scic.ec.europa.eu/str/index.php?sessio
nno=d37124c4c79f357cb02c655671a432fa
h t t p : / / e c . e u r o p a . e u / f o o d / f o o d /
biotechnology/docs/gmo_agenda18102011_
en.pdf
This conference was part of a series of 
public debates related to GMOs organised by the 
Commission in order to engage science, policy 
and society in a constructive dialogue on this 
highly complex and challenging issue. A first 
event was organised in March 2011 on GMO 
risk assessment and management, which was 
attended by around 250 participants.
3.4 Research at JRC-IPTS in the field 
of socio-economic impacts of the 
cultivation of GMOs in the EU
The Institute for Prospective Technological 
Studies (IPTS) of the Joint Research Centre (JRC) 
has been involved in research on the socio-
economic impact of certain traits of GM crops 
since 2004, which began with a review on 
the economic impact of dominant GM crops 
worldwide14.
An ex	 post study at farm level on the 
adoption and performance of Bt maize based on 
a survey of farmers in three provinces of Spain 
14 Gómez-Barbero, M., & Rodríguez-Cerezo, E. (2006). 
Economic Impact of Dominant GM Crops Worldwide: 
a review. Technical Report Series. JRC Technical Report, 
EUR 22547 EN, European Commission, Joint Research 
Centre, 2006
was carried out in 2005 and the data evaluated in 
the following years15, 16, 17. A further ex	post study 
on Bt maize in three countries in the EU and pilot 
ex	ante studies on HT rape seed, HT sugar beet 
and HT maize were carried out in 2009-2010. 
The data of the ex	post study are currently being 
evaluated.
In parallel, the IPTS started to work in the 
field of coexistence. In the framework of the 
Coexistence Bureau, which was established at the 
IPTS in 2007, a best practice document for the 
coexistence of GM crops with conventional and 
organic farming18 was elaborated in cooperation 
with experts from the Member States. A further 
publication discusses distances needed to limit 
cross-fertilization between GM and conventional 
maize in Europe19. In the coming years, the IPTS 
will carry out a study on the costs of coexistence 
measures in the framework of the project “Practical 
implementation of coexistence in Europe” (PRICE) 
under the seventh Framework Programme.
3.5 FAO research in the field of socio-
economic impacts of the cultivation 
of GMOs in developing countries
The FAO’s overall mandate is to support 
Governments of Members in achieving 
food security. The FAO’s mandate regarding 
15 Gómez-Barbero, M., Berbel, J., Rodríguez-Cerezo, 
E. Adoption and performance of the first GM crop 
introduced in EU agriculture: Bt maize in Spain. Technical 
Report. JRC Technical Report, EUR 22778 EN, European 
Commission, Joint Research Centre, 2008
16 Gómez-Barbero, M., Berbel, J., Rodríguez-Cerezo, E. Bt 
corn in Spain – the performance of the EU’s first GM crop, 
Correspondence, Nature Biotechnology 26, 384-386 (2008).
17 Areal, F.J., Riesgo, L. and Rodrigez-Cerezo, E. Attitudes 
of European farmers towards GM crops adoption. Plant 
Biotechnology Journal (in press).
18 Czarnak-Klos, M., Rodríguez-Cerezo, E. European 
Coexistence Bureau (ECoB): Best Practice 
Document for coexistence of genetically modified 
crops with conventional and organic farming: 
1. Maize crop production. JRC Scientific and Technical 
Reports, EUR 24509, European Commission, Joint 
Research Centre, 2010
19 Riesgo, L., Areal, F.J., Sanvido, O., Rodríguez-Cerezo, E. 
Distances needed to limit cross-fertilization between GM 
and conventional maize in Europe. Nature Biotechnology, 
28, 780-782 (2010)
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agricultural biotechnologies cuts across the 
Organization’s global goals of providing support 
to Member Governments in producing sufficient 
safe and nutritious food; ensuring people have 
the income and means to access food through 
sustainable livelihoods; and managing natural 
resources sustainably.
The FAO undertakes four types of activities 
in relation to agricultural biotechnologies:
•	 The	 FAO	 provides	 Members	 with	 legal	
and technical advice on areas such as the 
development of national biotechnology 
strategies and the development of biosafety 
frameworks.20
•	 It	assists	Members	with	capacity	development	
in various aspects of agricultural 
biotechnologies, often in collaboration 
with a range of partners, including other 
UN agencies and the research centres of 
the Consultative Group on International 
Agricultural Research (CGIAR).
•	 The	FAO	serves	as	a	meeting	place	for	nations,	
facilitates the development of international 
standards and helps frame international 
conventions and agreements, as well as 
hosting major conferences, technical meetings 
and expert consultations.20 For example, 
the FAO hosts the Secretariats of several 
intergovernmental bodies/treaties dealing with 
some biotechnology-related issues.21
•	 In	 recent	 years	 the	 FAO	 has	 been	 at	 the	
forefront of providing high-quality, up-to-
date, balanced science-based information 
about agricultural biotechnologies to its 
Member countries. In particular, the FAO 
has been active in publishing science-
based, peer-reviewed analyses of the socio-
economic impacts of transgenic crops in 
developing countries.22, 23, 24, 25, 26
20 FAO. 2011. Biotechnologies for agricultural development: 
Proceedings of the FAO international technical conference 
on ‘Agricultural biotechnologies in developing countries: 
Options and opportunities in crops, forestry, livestock, 
fisheries and agro-industry to face the challenges of food 
insecurity and climate change’ (ABDC-10). http://www.
fao.org/docrep/014/i2300e/i2300e00.htm. 
21 For example, FAO has assisted countries such as 
Bangladesh, Paraguay, Sri Lanka and Swaziland to develop 
their national biotechnology policies and strategies.
22 The Commission on Genetic Resources for Food and 
Agriculture, the International Plant Protection Convention, 
the International Treaty on Plant Genetic Resources for 
Food and Agriculture and the Joint FAO/WHO Codex 
Alimentarius Commission.
23 Raney, T. and I. Matuschke. 2011. Genetically modified 
crops in developing countries, in Carter, C., G. Moschini 
and I. Sheldon, eds. Genetically Modified Food and 
Global Welfare. UK: Emerald. 
24 Raney, T. and Pingali, P. 2007. Sowing a Gene Revolution. 
Scientific American. September 2007. 29 (3):104-111.
25 Evenson, R. and Raney, T. (eds.) 2007. The Political 
Economy of GM Foods. An Elgar Reference Collection. 
Cheltenham, UK and Northampton, MA, US: Edgar Elgar 
Publishing.
26 Raney, T. 2006. Economic impact of transgenic crops in 
developing countries. Current Opinion in Biotechnology. 
Vol. 17, Issue 2, pp 1-5.
27 FAO. 2004. Agricultural biotechnology: Meeting the needs 
of	the	poor?	The	State	of	Food	and	Agriculture,	2003-04.	
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Global status of GM crop adoption and review of 
impacts on developing world’s farmers
Matin Qaim, Universität Göttingen, Germany
Adoption and impacts at farm level in the USA Wallace Huffman, Iowa State University, USA
The case of Bt maize in Europe Emilio Rodriguez Cerezo, European Commission, JRC-IPTS, Spain
Challenges in measuring the economic impacts of 
biotech crops on farms in developing agriculture
Melinda Smale, Michigan State University, USA
4 The Workshop
An international workshop took place on 
23-34 November 2011 in Seville, Spain which 
was directed at socio-economic experts from the 
competent authorities of the EU Member States 
and staff from the EC (see chapter 2).
This workshop brought together leading 
experts in the field to present the results of their 
research and to discuss experiences and possible 
further development. Additionally presentations and 
discussions on how socio-economic considerations 
can be (and are currently) used by some countries in 
decision making and authorisation of GMOs were 
included. The coverage was worldwide and ranged 
from farm level to consumer impacts. The high 
percentage of invited speakers based in countries 
outside the EU reflects the limited EU experience in 
the cultivation of GM crops.
Chapters 4.1 to 4.7 summarise the main 
topics presented and the discussions from each 
of the sessions and discusses the prospects for 
further research. The list of participants and the 
agenda are included in Annexes 1 and 2 of this 
report. Annex 3 includes short papers for all 
presentations.
4.1 Session 1: Adoption of GM crop varieties and socio-economic impacts on farmers
Presentations:
Main topics presented:
Global adoption of GM crops and socio-
economic impact
The main objective of this session was 
to provide the most recent research findings 
related to the adoption rate and the socio-
economic impacts of GM crops at farm level, 
both in developing and in industrialized 
countries. Also, the methodological difficulties 
of measuring socio-economic impacts at farm 
level, notably in developing countries, were 
discussed.
Although controversy persists, farmers 
worldwide are increasingly adopting GM crops. 
The first GM varieties were commercially 
released in the USA in 1996, and in 2010 148 
million hectares in 29 countries were covered by 
GM crops, an area that represents approximately 
10% of the world cropped area. This dramatic 
expansion makes GM crops one of the fastest 
adopted technologies in the history of agriculture.
As for geographical distribution, the USA 
is still leading and represents 45% of the global 
GM area, and together with Canada (6% of the 
global GM area) they account for almost the 
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since among the countries of the European Union 
only Spain cultivates GM maize on a significant 
(but still relatively small) scale. But countries in 
the developing world now represent almost half 
of the global GM area, notably Brazil (17%), 
Argentina (16%), India (6%) and China (2.5%).
Despite the increasing cultivation of GM 
crops worldwide, the diversity of GM plants is 
still very low, in terms of crops and traits. Four 
crops represent virtually the whole biotech area. 
The first of them, namely the Herbicide Tolerant 
(HT) soybean, accounts for half of the global 
GM area, mostly in Northern and Southern 
America. Maize is second, and covers 31% of 
the global GM area. GM traits introduced in 
maize are either HT, Insect Resistant (IR or Bt 
for Bacillus	thuringiensis, a soil bacterium whose 
genes conferring a resistance to insects were 
inserted into the maize DNA), or stacked, i.e. 
a combination of the two previous traits. GM 
cotton (HT, BT or stacked), grown mainly in 
India, China, South Africa and in the USA, covers 
14% of the global biotech area, whereas HT 
canola is grown on 5% of the global biotech area, 
primarily in North American countries. The other 
GM crops commercially released so far (such as 
alfalfa, sugar beet, papaya, potato, squash, sweet 
pepper), are still confined to a few countries and 
to very small areas.
The HT soybean has been very quickly 
and extensively adopted in countries where it 
is available to farmers. Almost 100% of soy in 
Argentina and 93% in the USA is HT. In both 
countries, adoption is associated with small and 
generally insignificant yield effects, and in the 
USA with no significant change in the use of 
agricultural chemicals. In South America, there 
have been some increases in herbicide use, 
since herbicides are being substituted for tillage. 
However, the herbicides used in HT soybeans 
(primarily glyphosate but also some glufosinate) 
are generally less toxic than those used on 
conventional soybeans. Profits associated with 
the adoption of HT soybeans for farmers are 
generally small, but larger in South America 
than in North America, reflecting differences in 
Intellectual Property Rights schemes. While in the 
USA the cost reductions for farmers (herbicide 
cost and operation cost) are essentially offset 
by the technology fee charged by the seed 
companies, in South America the latter is much 
lower due to the institutional environment and to 
the re-use of farm seed.
However, in both regions farmers have found 
the managerial benefits of HT soybeans to be 
significant, and the extremely fast adoption rate 
is generally better explained by the considerable 
ease of use, efficiency and flexibility that HT 
soybeans confer for weed control than by direct 
economic considerations. The technology is 
time-saving for farmers, and also has agronomic 
advantages: it reduces the risk of an unsuccessful 
weeding and facilitates soil conservation 
techniques, such as no-till practices. In Argentina, 
it also enables double cropping i.e. soybeans 
planted as a second crop after wheat, thus using 
available farmland more efficiently (and reducing 
further area expansion). This is one of the main 
reasons behind the large increase in production 
of soybeans from South America.
However, recent empirical evidence shows 
that in Argentina the average profit gain through 
HT soybean adoption was about 23 USD per 
hectare. As for the USA, a recent study conducted 
in the Midwest shows that the adoption of GM 
soybeans tends to reduce the rate of use of all 
types of variable inputs (capital, labour, energy, 
chemicals and other materials) and generates in 
the mid-term a benefit-cost ratio of about 3.6.
There are a number of questions related to 
the spread of HT soybeans all around the world, 
since more than 77% of the global soybean area 
is GM. HT soybeans imply a reduction in the 
toxicity of the herbicides used, in tillage and 
probably in greenhouse gases (GHG), but may 
also promote soy monoculture and favour the 
outbreak of weed resistance. By consequence, 
best practices concerning the crop and 
technology rotation may be required in the future 
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production. Additionally, this technology may 
not meet the needs of small-scale farmers, since 
they often weed manually and thus do not apply 
herbicides.
GM maize is the GM plant cultivated 
in the largest number of countries (16; six of 
which are in the EU). At the global level, GM 
maize represents slightly more than a quarter 
of the total area covered by maize. In the USA, 
its adoption started slowly but represents 86% 
of the total maize area (when considering Bt 
maize, HT maize and stacks together). In this 
country, cultivation of GM (when compared to 
conventional maize) is associated with a small but 
significant increase in yield, which is higher for 
stacked varieties, and with a reduction in the use 
of insecticides. In Midwestern US States, output 
effects of the adoption of GM maize varieties are 
shown to be insignificant but the rate of use of all 
input groups (capital, labour, energy, chemicals 
and other materials) tended to decline, leading to 
a benefit-cost ratio of roughly 52, which supports 
future increased intensity of use of GM maize.
Bt maize is the only GM crop grown in 
the EU in significant amounts, and 90% of that 
production takes place in Spain. Detailed surveys 
conduced in 2005 and in 2009 report that 
Spanish farmers cultivating Bt maize experience 
no significant changes in costs, the reduction 
in insecticide costs being offset by the higher 
price for Bt maize seed. However, Bt farmers do 
observe a substantial increase in yield, by 11.4% 
on average in 2009, resulting in a gain in partial 
gross margin of 195 EUR/ha/year.
In circumstances where insect pests were not 
effectively controlled by chemicals prior to the 
adoption of Bt corn, the main effect of switching 
to Bt will be a reduction in crop damage and 
thus a raise in yield. This may be the common 
situation in developing countries, where the use 
of insecticides was restrained by the availability 
of suitable products or by technical, financial or 
institutional constraints. Effective yield-increasing 
effects of Bt maize in the order of 11% (South 
Africa) or even 34% (Philippines) have been 
observed, resulting in a profit increase of 42 
USD/ha and 53 USD/ha, respectively.
Bt cotton is by far the most commonly 
studied GM crop in socio-economic terms, 
probably because it has been adopted by 
a large number of small-scale farmers in 
developing countries and thus raises issues of 
rural development, poverty or dependence, in 
addition to the more common environmental 
concerns associated with GM crops. India is the 
first country in the world in terms of area of Bt 
cotton, followed by China and the USA. In India, 
90% of the whole cotton area is Bt, and there are 
more than 6 million smallholder farmers growing 
it, with an average cotton area of 1.5 ha each. 
Though different studies vary somewhat in terms 
of the concrete effects observed, most of them 
find positive agronomic and economic effects 
for Bt cotton farmers. The common feature is that 
the cultivation of Bt cotton strongly reduces the 
use of insecticide (by 65% in China and 41% in 
India) and increases yields (by 24% in China and 
37% in India), as farmers were not fully effective 
in controlling pests before the adoption of GM 
cotton. Although the cost of the Bt cotton seed is 
higher (for instance, +166% in India), Bt cotton 
farmers make an important additional profit, 
between 135 USD per ha (in India) and 470 USD 
per ha (in China).
Also indirect benefits of the Bt technology 
were found. In India, a study conducted at village 
level concludes that the positive spillover of Bt 
cotton cultivation for the local economy (in terms 
of additional household income) was almost 
comparable to the direct benefits for farmers. For 
the country as a whole, this would imply a direct 
economic gain of 1.3 billion USD, which rises 
to 2.3 billion if the indirect effects for the rural 
economy are added. Additionally, health benefits 
have been reported. An 80% reduction in the 
number of farmer acute poisoning events was 
found following the adoption of Bt cotton. These 
strong positive effects of Bt cotton cultivation have 
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been observed in many countries worldwide, the 
benefits in tropical countries being usually more 
important because of higher pest pressure.
Methodological challenges
A number of methodological issues are 
associated with the socio-economic assessment 
of GM crops at farm level, especially in 
developing countries, where researchers typically 
cannot rely on agricultural census data or 
samples representative of the whole country to 
generate information. Researchers must collect 
data in personal interviews with farmers using 
specially designed surveys which are costly and 
challenging to implement because of logistical 
considerations. Random sampling may not be 
feasible because of the political sensitivity of GM 
crops and the unwillingness of community leaders 
and individual farmers to respond to questions. 
During the first decade of published studies, 
the most commonly applied methodologies 
were partial budgets and econometric models 
of farm production, in which researchers tested 
hypotheses related to the yield advantages, labour 
and pesticide savings associated with adoption.
As a recent survey conducted in the 
Midwestern states of the USA shows, fitting a 
production function may also aid identification 
of impacts on each input type separately, as it 
allows the modeller to relate outputs to inputs 
and technology econometrically. When data for 
prices of inputs and outputs are available, the 
estimation of output supply and input demand 
equations provides useful information about the 
technology effects. 
Data quality was a major limitation of early 
studies, where samples were typically small, field 
observation periods were brief, and estimates 
of key parameters were often based on farmers’ 
recall. With respect to partial budgeting, early 
studies often suffered conceptual limitations, 
such as measurement of gross rather than net 
margins, and not considering land and labour 
costs. Some of the most advanced studies treat 
risk and uncertainty using stochastic budgeting. 
Perhaps the most critical concern has been self-
selection bias, i.e. the fact that farmers adopting 
the GM technology may also be the most 
efficient, or those with greater endowments and 
better access to markets or information. More 
recent studies have addressed self-selection bias 
in various ways.
Under some circumstances, the variability in 
the Bt gene expression may also be challenging. 
It is notably the case in developing countries, 
like China or India, where the high number of 
commercial varieties available for Bt cotton, 
combined with the existence of a black market 
and counterfeiting of seeds, may lead to a 
high variation in the efficiency of Bt cotton 
in controlling pests. As this information is not 
easily available, it is therefore also difficult 
to include it into an econometric model. 
Additionally, the decision to grow a GM crop 
may be endogenous, and explained by other 
factors which are unobservable or not integrated 
into the model (like pest pressure for instance). 
These methodological issues can be addressed by 
using advanced econometrical techniques (that 
correct the endogeneity problem by, for instance, 
introducing an instrumental variable), as recent 
surveys have done. 
Discussion:
It was noted that the general public does 
not usually understand the difference in quality 
of publications. Laypersons are generally not 
able to distinguish between partisan reports and 
scientific peer-reviewed studies, which indeed 
they are hardly aware of. Therefore, contradicting 
studies from different origins and with opposing 
results usually lead to confusion.
The sustainability of the benefits over time 
was also questioned, and it will depend on the 
adoption of the “best agricultural practices”, 
either for producers of conventional or GM 
crops, in particular to prevent the advent of 
resistance to weeds or pests that will make the 
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Welfare creation and distribution Carl Pray, Rutgers University, New Brunswick, USA
Impacts on global productivity and world food prices David Zilberman, University of California, Berkeley, USA
technology fail. Until now, few cases of weed or 
insect resistance have been reported. The issue of 
the environmental impacts of GM crops and how 
to introduce externalities in economic analyses is 
under debate, as well as the way to consider the 
impacts of GM crops on biodiversity.
Experts stressed the importance of conducting 
more robust studies. However, they also agreed 
that the overall conclusions presented so far 
remain valid even taking into account the need 
for improved methodologies to highlight some of 
the pending, more subtle issues. It was noted that 
the most important step in the development of a 
study is the design of the sample, which has to 
address potential selection biases.
It was stated that experts in the EU will face 
similar challenges as in developing countries 
when approaching farmers in the context of 
a study. In some areas, because of the limited 
number of non-adopters and the high sensitivity 
of the issue it will be very difficult to target a 
representative sample of adopters and non-
adopters. On the other hand, an expert from the 
USA noted that such kinds of socio-economic 
assessments are now conducted less frequently, 
probably because of the decreasing interest 
of journals in publishing these studies and the 
difficulty to find non-adopters (for comparison) in 
areas with a very high adoption rate.
Prospects:
Participants all agreed that more independent, 
ex	post farm studies on the impacts of GM crops 
are necessary in order to move forward the 
scientific knowledge in the field of the socio-
economic assessment of GM plants. These studies 
need to rely on surveys at farm level, in order 
to capture the real-life effects of GM crops on 
farmers’ practices, and to take into consideration 
the consequences for the agricultural production 
system as a whole (and not only the yield or 
the cost-reduction effects for instance, but also 
labour effects and flexibility of work). Further 
research will also have to cover more crops, traits 
and countries than in the previous studies, relying 
on advanced methodologies in terms of sampling 
and data analysis.
4.2 Session 2: Aggregated and global impacts of GM technology in agriculture.
Presentations:
Main topics presented:
Potential beneficiaries and losers - globally
The main objective of this session was 
to give an overview of the effects of GM crops 
outside the farm gate. Cultivation of GM crops 
takes place in a global market which gives rise 
to effects both upstream and downstream of the 
farming sector. The affected actors can be divided 
into two groups, the winners and the losers.
The potential beneficiaries along the supply 
chain include the seed and biotechnology 
industry, through higher seed sales, and farmers 
through increased income and, in some cases, 
improved health status. The different downstream 
users of agricultural outputs such as the food 
industry, the feed industry, the livestock industry 
and the textile industry increase profits by buying 
higher value agricultural products at a lower cost. 
Finally consumers benefit from lower prices for 
food and fibre and reap the benefits from biofuels. 
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As for the potential losers, manufactures of 
competitive inputs (insecticides, agrochemicals) 
lose market shares and non-adopting farmers 
have a competitive disadvantage which may lead 
to losses. The latter can either be conventional 
farmers not adopting the technology who face 
lower output prices or producers who lose 
markets because of admixture of GM crops (see 
session 3 of coexistence).
Although all these effects are known 
qualitatively, few studies assess these effects 
in an integrated quantitative way. The majority 
only focus on specific aspects of the problem, 
evaluating the impacts for certain stakeholders or 
certain markets.
Economic models have been developed to 
estimate the global economic welfare creation 
of GM cultivation and the distribution of its 
benefits among stakeholders. The HT soybean 
is one of the crops being researched and has 
been estimated to create benefits of around 3 
billion USD globally each year. According to 
the results of model calculations, 50% of this 
amount accrues to processors and consumers 
while farmers capture about 28%. The remaining 
22% seem to be extracted by the innovating 
biotechnology sector. Disaggregated data 
evidence suggests that institutional factors 
influence this distribution among stakeholders 
to a great extent. In developed countries, where 
strong intellectual property rights exist, the share 
of the benefits of the biotechnology sector is 
significantly higher than in developing countries. 
In the case of the cultivation of soybeans in the 
USA, the biotechnology sector is able to extract 
57% of the arising benefits. 
Case studies covering different GM crops 
and countries indicate that the biotechnology 
sector captures 30% to 60% of the generated 
benefits in developed countries. In countries with 
a lower degree of patent protection however, 
farmers secure 80%-90% of the benefits, leading 
to higher domestic benefits from the technology. 
Moreover, farmers in developing countries face a 
higher potential pay-off from GM technology due 
to several reasons. Pest pressure is often greater in 
developing countries and the pests are often not 
adequately controlled in conventional farming. 
Hence the introduction of a GM crop diminishing 
pest damages may result in high yield benefits. 
Furthermore, a multiplicative effect on benefits 
may occur: a farmer adopting GM crops expects 
higher yields and will therefore be attracted 
to buy underused inputs such as fertilizers, 
eventually resulting in even higher yield benefits. 
A recent study spanning 1996-2008 and 8 crops 
confirms these assumptions, estimating a yield 
increase in cotton, maize and soybeans following 
the adoption of GM crops that is significantly 
higher in developing countries. The higher 
economic and agronomic productivity of GM 
crops may also have affected global land use and 
carbon sequestration, but the extent of this effect 
is currently only supported by a few studies.
Yield benefits and cost reductions are also 
important in the global markets as spill-over 
effects influence prices, even for countries not 
cultivating GM crops but importing them. For 
instance, the EU does not allow production of HT 
soybeans but in 2009 Europe imported, primarily 
for animal feed, 23 million tons of soy meal 
and 12.6 million tons of soybeans from South 
America and the USA, mostly HT soybeans.
The price effects of GM crop adoption 
are substantial, having a direct impact on food 
security and availability. Models estimate that 
the increases in world food prices would have 
been significantly higher in the absence of GM 
cultivation, by 10% to 30% depending on the 
crop and the underlying assumptions. These price 
increases would have been especially devastating 
during the food commodity price peak in 2008. 
This price effect benefits all consumers globally 
through trade. Of particular significance is the 
increase in supply of soybeans due to the use 
of herbicide tolerant varieties that were able 
to meet the growing demand for meat in Asia 
during the last decade. Studies also estimate that 
if GM varieties had been adopted in Africa and 
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countered some of the price increases associated 
with the introduction of biofuel.
The benefits captured by direct customers 
differ depending on the trait and the geographic 
area. For cotton, benefits ultimately accrue 
to consumers through reduced textile prices, 
estimated at around 1%. For maize in the EU, 
USA, Brazil and Argentina the food, feed and 
biofuel industry are the primary customers who 
transfer the price reduction to consumers. In 
the case of maize in Africa and Central America 
price reductions are beneficial to all consumers 
as it is the staple grain for millions of consumers. 
However, very limited studies are available on 
the aggregated impact of the technology on the 
consumer side and its distribution to the different 
groups of consumers.
Global and sectorial shifts of benefits over time
The combination of institutional and 
environmental effects led to a geographic shift 
of farmer benefits from the initial situation where 
benefits were concentrated in the USA, Canada 
and Argentina to a situation where small farmers 
in a variety of developing countries obtain more 
benefits from the technology. Farmers’ benefits 
from insect resistant maize are still highest in the 
USA, but most of the benefits from HT soybeans 
are obtained by farmers in Argentina and Brazil 
and the benefits from IR cotton mainly accrue to 
farmers in China and India.
This shift in benefits may have important 
secondary effects in the long term. One effect 
that has recently been observed is a shift in 
R&D investment in biotechnology to developing 
countries following the rapid growth in sales. 
The technology fees give biotech companies 
money to invest in local research and the rapid 
growth in the market for GM holds the promise 
of greater profits in the future. In the last ten years 
Monsanto has invested in major biotech research 
facilities in Brazil, India and China. DuPont has 
invested in basic biotechnology laboratories in 
China and India. In addition there have been 
major investments in biotechnology research by 
multinationals based in the developing world 
such as Advanta (India) and Pannar (South Africa), 
and by national firms particularly in India, and 
the governments of China, Brazil and India. 
These programs are developing technology for 
the needs of the developing world – GM white 
maize in South Africa and hundreds of hybrids of 
Bt cotton to suit local agricultural conditions in 
India have already been developed by the private 
sector. DuPont, Bayer Agrosciences and other 
key biotech companies have major rice research 
programs for Asia which were virtually non-
existent 20 years ago. In India alone private seed 
R&D grew 18 times between 1995 and 2008. 
This creation of high technology jobs is expected 
to have important multipliers on local economies.
Moreover, the shift in benefits from the 
agro-chemical industry and conventional 
seed producers to the biotechnology industry 
translates to a shift in R&D between these sectors. 
The effects of this shift are still unclear. One of the 
concerns often raised is whether this shift leads to 
concentration in a seed sector and a decreased 
interest in conventional breeding.
Discussion:
The issue of concentration in the seed sector 
was raised. The experts reiterated the opinion that 
this issue is difficult to assess and the concentration 
is highly dependent on the specific context. 
Generally, the high cost of approval seems to 
make it impossible for small companies to engage 
in the GM regulatory process, possibly leading to 
concentration in the sector and IP rights presumably 
contribute to this development. However, in the 
USA no extra concentration in the seed sector has 
been found since the introduction of GM crops 
for maize, and concentration increased for soy but 
decreased for cotton, and the concentration for 
the supply of gene events recently decreased. In 
developing countries (Brazil, India and China) the 
possible increase in concentration is counteracted 
both through small private companies or (para-) 
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statal investment. In order to fully understand the 
effect of GM regulation on the concentration in the 
seed sector it is essential to separate it from other 
factors such as the impact of IP rights.
Since some speakers mentioned benefits of 
GM crops for small scale farmers, a question on 
the definition of small scale farming was raised. 
Participants agreed that this is a context-specific 
definition. It was noted that the mere size of the farm 
was not decisive but that other factors, such as the 
access to resources and markets, were important. 
GM cultivation as such is regarded as scale neutral 
as both large and small farms can profit.
Finally the importance of GM cultivation 
for food security was stressed by one of the 
experts. Adoption of GM cultivation in additional 
countries (such as in the EU and Africa) could 
increase agricultural productivity. However, 
although at first glance consumers would profit 
from decreased world prices concern was 
raised that the adoption of GM cultivation in 
the EU could lower the export opportunities for 
developing countries. The expert replied that 
this issue has not yet been studied in depth and 
is therefore difficult to assess as it is strongly 
dependent on assumptions about future approval 
of crops in different areas of the world. He noted 
that food demand is expected to increase in the 
coming decades, presumably leaving export 
markets for developing countries intact.
Prospects:
The session stressed the need for more studies 
assessing the impact of GM crops on a global 
scale and in a global market. Most of the present 
studies focus on a specific aspect and fail to 
capture spill-over effects. A first step would be to 
broaden the scope of the crops and assess different 
crops at the same time, as substitution may occur. 
Even more interesting for policymakers would be 
a more in-depth insight into the effects on global 
consumers and on those sectors in the economy 
that might be losing out from the introduction of 
GM technologies. Finally, more attention should 
be given to irreversible long-term effects such 
as the impact on climate change and the shift in 
R&D investment. Only by incorporating these 
secondary effects can a full understanding of the 
impact of GM crops on society be obtained.
Main topics presented:
The main objective of this session was 
to discuss the feasibility and costs of different 
Case studies of supply chain analysis and segregation 
costs in the EU 
Klaus Menrad and Andreas Gabriel, University Weihenstephan, 
Straubing, Germany
Coexistence of GM and non-GM supply chains in the 
EU: policy framework and  economic aspects 
Justus Wesseler, Technical University Munich, Germany
EU coexistence policies may shape future adoption of 
GM technology by EU farmers
Francisco Areal, Laura Riesgo* and Emilio Rodriguez Cerezo 
European Commission, JRC-IPTS
Managing GM free label Christoph Zimmer, VLOG, Berlin, Germany
The global agricultural supply chain: feasibility, costs 
and opportunities of coexistence of GM and non-GM 
commodities 
Nicholas Kalaitzandonakes, Univ. Missouri, USA
4.3 Session 3: Economics of segregation/coexistence of supply chain.
Presentations:
coexistence and segregation systems, be 
they regulatory or market-driven. This topic 
is particularly important for the EU given its 
regulatory framework.
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The cultivation and marketing of GM 
crops is regulated in most countries. Freedom 
of choice for both consumers and farmers 
is one of the major arguments used for 
justifying additional regulations. Different 
public policies govern the segregation and 
coexistence between GM and conventional 
food and feed supply chains. In some countries 
market actors complement these regulations 
with private standards which require even 
stricter segregation rules than required by the 
respective governments. For example, the EU-
based food industry and retailers are hesitant to 
accept GM products and are willing to accept 
higher costs to avoid mandatory GM labelling, 
while most of the EU feed industry accepts 
GM raw materials, relying solely on the legal 
thresholds for labelling.
Segregation costs
Segregation and coexistence policies 
result in additional costs but may also generate 
consumer benefits (consumer choice, creation of 
niche markets for non-GM labelled products etc). 
Until now, empirical studies mostly assessed the 
costs for farmers and their downstream supply 
chains in many parts of the world.
At the farm level, EU Member States apply 
coexistence policies for GM and non-GM 
farming, consisting of a set of ex	ante regulations 
and ex	 post liabilities. The EU has decided that 
the GM farmer should take the measures (usually 
administrative measures or technical measures 
such as isolation distances) and bear the liability.
This arrangement increases the cost of 
adoption of GM crops. Moreover, research 
shows that these regulations have a tendency 
to discriminate against small farmers (unable 
to implement isolation distances) and may also 
have a regional and landscape effect on adoption 
through the so-called domino effect.
The costs and feasibility of coexistence 
depend, to a large extent, on the threshold set 
for adventitious presence of GM crops in non-
GM production. Beside the legal threshold for 
labelling (0.9%), some private operators in the 
EU (retailers or organic industry) demand higher 
private standards (0.1%), making coexistence 
even more expensive or even infeasible. Farmers 
can minimize coexistence costs by cooperating 
and spatially aggregating the production of GM 
and non-GM crops (e.g. “Production zones” 
in Portugal). However, to allow for this, the 
ex	 ante regulations have to be flexible. Rigid 
regulations hamper GM adoption, as shown 
both theoretically and econometrically in six EU 
member states.
The general policy of European food 
industry and retailers to avoid GM raw materials 
can be achieved by sourcing ingredients from 
certified non-GM markets (at higher costs) and 
separating GM and non-GM ingredients in their 
processing facilities. Separation can be achieved 
through different approaches. A first solution is to 
separate GM and non-GM crops spatially through 
separated production facilities or by splitting 
up production lines in one facility. Alternatively 
temporal separation can be applied, e.g. by 
producing first the non-GM line followed by the 
GM line. This implies allowing enough time for 
cleaning the facility in between batches.
Costs are connected to both approaches. 
Case studies show that the type and complexity 
of the supply chain to a great extent influence 
the segregation costs. The total additional costs 
of coexistence and product segregation systems 
can rise to almost 13% of production turnover for 
non-GM rapeseed oil in Germany. In case of non-
GM sugar production the additional costs amount 
to 2%-5% and in the case of non-GM wheat 
starch production to 8%-13%. When comparing 
supply chains in different countries, different 
cost structures can be found because of special 
legal frameworks and company (infra)structure. 
Therefore, variable additional costs for non-
GM rapeseed oil were estimated for Denmark 
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(8.3% of turnover), Switzerland (5.3%) or Poland 
(3.6%). In the case of highly processed goods 
the share of segregation costs in the turnover 
tends to be lower. For a frozen pizza producer 
the coexistence costs represent only 0.6% of the 
turnover of a reference company. The case studies 
reveal that the ability of food processors, in terms 
of infrastructure and resources endowment, to 
deliver both GM and non-GM commodities in 
parallel determines the feasibility of coexistence. 
The conversion to parallel production will be 
difficult to manage, especially for companies 
with smaller facilities. Only a few European 
companies have the opportunity for specialization 
and supplying the market with GM and non-GM 
food products if the demand situation changes. 
These results show that the costs of coexistence 
and the feasibility in the supply chain should be 
considered on a case-by-case basis. Very little 
empirical information on these costs is available 
and often constitutes proprietary business data 
which makes it a challenging subject for research. 
The perceived demand of European 
consumers for non-GM food has created new 
niche markets for the food industry. In Germany, 
the government introduced a new “Ohne 
Gentechnik” (Without Genetically Engineering) 
law (initially for meat and milk products) which 
specifies requirements that products have to 
fulfil in order to be labelled GM free. In 2009 
the Federal Ministry of Food, Agriculture and 
Consumer Protection introduced a GM free logo 
which is now managed by the stakeholders, by 
VLOG (Verband Lebensmittel ohne Gentechnik) 
which was founded in 2010. Since the launch of 
the GM free label there has been a steady growth 
in participants. According to a representative of 
VLOG, the goal of the label is ambitious with a 
market penetration of 80% in the egg market by 
2012 and over 50% in the milk market by 2014. 
Non-GM production incurs higher costs that have 
to be compensated in the market, but it also faces 
increased uncertainty, as the risk of contamination 
and price volatility is higher in non-GM input 
markets. Economic analyses showed that German 
farmers get a small price premium from the 
scheme to cover their extra costs (some 3-4% 
of the price for producers of milk from cows 
fed with “non-GM” feed). For food processors, 
the label adds a perceived quality attribute 
which allows a price premium and potentially 
an increased turnover. No cost-benefit analysis 
of the scheme is available for the food industry. 
It is interesting to note that the German scheme 
allows “GM free” labelling of products for which 
a GM counterpart does not exist (i.e. apples). 
This could be considered as disinformation and 
just a market opportunity. Overall these types of 
private labelling and schemes have not yet been 
comprehensively studied.
Implications on international trade
Food/feed ingredients are highly traded 
commodities and Europe is a top importer for 
maize, soybeans and soybean meal. Over 80% 
and 90% of traded maize and soybeans (including 
soy meal) respectively originates from countries 
that grow GM maize and soybeans. To serve the 
non-GM grain markets worldwide (mainly Japan 
and the EU), grain traders use different types 
of spatial and temporal separation measures. 
However, some bottlenecks exist, e.g. the low 
number of ports used to ship the commodities 
from all over America or the certified seeds. The 
major determinant of the costs is the level set for 
the threshold for GM traces in the non-GM end 
product. For the moment the market reveals price 
premiums that cover the incremental costs for the 
entire supply chain.
Adventitious presence of non-approved 
GM crops in the non-GM supply chain did 
result in trade distortions and higher costs for 
European importers and processors. Indeed, the 
world prices for non-GM segregated grains have 
significantly increased in recent years.
Discussion:
There was notable interest in the presented 
case study on the German GM free label. A similar 
scheme seems to exist in Finland and Austria, and 
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psFrance is also about to introduce a GM free label. 
The French participant stated that their national 
scheme excludes GM free claims for products where 
no GM counterpart exists. MS’ experts questioned 
the involvement of the German government in 
the scheme. The expert indicated support from 
the government on two levels. The government 
initially aided the association through a subsidy for 
communication measures (webpage). Furthermore, 
the German government is responsible for testing 
and monitoring the compliance with the regulation 
of GM free labelling.
The question of how production areas 
outside the EU manage farm-level coexistence 
in the absence of regulations was raised. In 
Brazil non-GM soy is grown in particular regions 
and hence spatial clustering is inherent. It was 
suggested that institutional factors, such as the 
regional demand for GMO crops by traders 
and the presence of ports, gave rise to this 
development. Until 2004 the premiums received 
for non-GM soy were obtained by the traders, 
and since 2011 there is also a premium for the 
farmer. In the USA farms are very large and have 
no problem implementing isolation distances and 
border rows to manage coexistence if necessary.
The existence of a price premium for non-GM 
crops in the market could encourage countries 
aiming to penetrate this market. Brazil tried this 
in the past but was not able to attain a significant 
premium and hence changed to GM production. 
Some African countries however have an incentive 
to stay non-GM as exports are very sectoral and 
only aimed at the European market.
Finally the question was raised as to why 
thresholds differ between countries as it has been 
proven to be a main driver of the coexistence 
costs. The conclusion was that it is often more a 
political choice than a rational decision.
Prospects:
At the farm level there is a need for a 
better understanding of the impact of different 
coexistence regulations on the adoption 
and the diffusion of GM technology. This 
information is important for the design of 
efficient coexistence measures. From the other 
side of the spectrum it is important to get an 
insight into the working of non-GM markets. 
The demand in these markets and the resulting 
price premium will determine how the food/
feed industry will react and how segregation in 
the supply chain will be achieved, from farm 
to fork. An integrated model with endogenous 
price mechanisms could be a way to achieve 
these goals.
Socio economic considerations of GM crops in the 
context of the Cartagena Protocol of Biosafety- CBD
José Falck-Zepeda, IFPRI, Washington, USA
Socioeconomic assessment - a requirement for 
authorisation for cultivation of GM crops in Argentina
Carmen Vicién, University of Buenos Aires, Argentina
4.4 Session 4: Socio economic impacts of GM crops: examples of use in decision-
making.
Presentations:
Main topics presented:
Session 4 reviewed the implications of 
the use of a socio-economic assessment (SEA) 
of GM crops in regulatory decision making 
systems. An international example, SEA in 
the framework of the Cartagena Protocol of 
Biosafety (CPB), and a national example, SEA 
as an integral part of the GM regulatory process 
in Argentina, were presented.
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The Cartagena Protocol on Biosafety (CPB)
The 2000 Cartagena Protocol on Biosafety 
(CPB) - part of the UN Convention of 
Biological Diversity – initially focused mainly 
on assessment procedures for environmental 
safety and transboundary movements of living 
GMOs and was later expanded to include 
food/feed safety and cultivation decisions for 
commercialization. Article 26.1 of the CPB 
stipulates that for decisions on GMO imports, 
countries may consider SEAs of the impact of 
GMOs on the conservation and sustainable use 
of biodiversity, especially with regard to the 
value of biological diversity to indigenous and 
local communities. When implementing the 
CPB in national legislation, many countries have 
gone beyond the contents of Article 26.1 by 
introducing other considerations, such as social, 
ethical or philosophical aspects.
When a country includes a SEA in the GMO 
biosafety regulatory process it has to decide if 
the SEA should be voluntary or mandatory, if 
it should be carried out for approval (ex ante) 
and/or for post-release monitoring (ex post) 
and which methodology should be applied. 
For ex ante studies the choice of methods is 
limited and they will necessarily be based on 
projections and assumptions. Furthermore, 
countries will need to decide on the scope of 
the SEA (narrow interpretation of Article 26.1 of 
the CPB or broader set of assessments) and who 
will be the body responsible for conducting the 
SEA (e.g. government or third party experts). 
Finally, they will need to specify the decision 
making rules and standards to be used in the 
process.
Comparison of the current approaches to 
include SEAs in the GMO regulatory process in 
Argentina, Brazil and China shows significant 
differences. In Argentina, a SEA is mandatory and 
comprises the ex ante assessment of economic 
impacts on trade and competitiveness. Brazil 
has introduced a non-mandatory SEA with an 
open scope and it is decided on a case-by-case 
basis whether it is to be used (after the biosafety 
assessment is completed and only if specific issues 
are identified). In both countries government experts 
are responsible for carrying out the assessment. 
In China, a SEA is currently not included in the 
guidelines and regulations, it may be conducted by 
third party experts and the scope is not defined.
As for potential implications of the 
introduction of SEAs in the regulatory process, 
SEAs will provide more and better information 
about the technological impact for the decision 
making process and may help to avoid the 
adoption of inefficient technologies. However, 
the regulatory compliance costs will increase, 
regulatory delays are possible and, if standards 
are not clear, the system might even become 
unworkable. Study results show that the 
increased costs of compliance may not be as 
relevant in affecting net benefits to society as the 
regulatory delays.
Argentina - Socioeconomic assessment as part of 
the GM regulatory process
By the end of the 1990s, Argentina had 
implemented a mandatory SEA as an integral 
part of the approval procedure for GM crops. The 
aim of the SEA is to avoid barriers to Argentina’s 
international trade. Decisions on the authorisation 
of cultivation of GM crops are made by the 
Secretary of Agriculture, Livestock and Fisheries 
on the basis of three independent expert opinions 
(an environmental risk evaluation, a food and 
feed safety assessment and an analysis of the 
potential impacts on Argentina’s international 
trade), although they are not binding.
The applicant for the authorisation for 
release of a GM crop for commercialization has 
to submit, amongst other things, information on 
the stage of approval of the event in the main 
markets. As a first step in the procedure, experts 
from the Directorate on Agricultural Markets 
draft a preliminary report which evaluates the 
stage of approval for production, consumption 
and import in the main importing countries and 
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for the crop, taking into account the situation of 
the import markets and other exporters. Potential 
benefits for farmers, consumers, other actors 
in the food and feed chain and, if applicable, 
impacts on the agro-ecosystems are also taken 
into account.
Stakeholders are informed of the conclusions 
of the report in a meeting and their comments are 
taken into account for the final expert opinion 
which is submitted to the Secretary.
Unlike the assessments of the environmental 
risk and food safety, which are the basis for the 
technical decision on the authorisation, the 
SEA is the basis for political decisions. From the 
very beginning, Argentina’s decisions reflected 
the state of play in the EU (so-called “mirror 
policy”). In the last few years, and especially in 
the framework on decisions on soybean events, 
approvals in China and India were also taken 
into account. More recently, decisions made in 
Brazil (as a main competitor) were followed too, 
although still informally.
A special feature of the SEA is that its 
conclusions change over time (in contrast 
to the conclusions of the environmental risk 
and food safety assessments). An initially 
unfavourable opinion becomes favourable 
once trade restrictions are removed (the event 
has been approved in the importing country). 
In this way the SEA delays the final decision, 
usually by a year or two, as the authorisation 
process in Argentina (without the additional 
step of a SEA) is generally faster than in the 
importing countries.
 
Discussion:
Complementary to the presentations on 
SEAs in the framework of the CPB and the GM 
regulatory system in Argentina, experts from The 
Netherlands and France presented the efforts of 
their countries in the field. In The Netherlands, 
experts evaluated literature results on the 
sustainability of GMO cultivation (compared with 
conventional crops) applying selected indicators. 
The study serves to provide information to the 
Dutch Parliament and, as a follow-up, a workshop 
is planned for the beginning of 2012. In France, 
it was decided to introduce a second chamber 
in the High Council for Biotechnolgy (HCB). 
In addition to the existing scientific committee 
(responsible for the biosafety assessment), a 
socioeconomic committee was established. The 
task of this socioeconomic committee is to deliver 
opinions directed at the French government (non-
binding) on specific issues.
The experts discussed the trade-off between 
the benefits of the introduction of a SEA into the 
approval procedure of a new technology (e.g. 
GM crops) and its potential negative impacts 
for innovation. The experts participating in the 
workshop argued that the inclusion of a robust 
SEA, in addition to strict science-based safety 
assessments, could make regulatory decision-
making on cultivation more objective and 
transparent. The EC has made a legislative 
proposal to the EP and to the Council with the 
aim of increasing the possibility for the Member 
States to restrict or prohibit the cultivation of 
authorised GMOs in their territory based on 
grounds other than adverse effects to health or 
environment (see chapter 3.2).
Prospects and conclusions:
Session 4 provided useful information 
on decisions which have to be taken when 
introducing SEAs into the GMO regulatory 
system (e.g. voluntary vs. mandatory SEAs, ex	
ante vs. ex	post assessment, scope of the SEA). 
However, the chosen approach will depend on 
the context (e.g. a SEA focusing on trade barriers 
is only relevant for an exporting country such as 
Argentina) and has to be developed on a case-
by-case basis, choosing a suitable methodology 
(see sessions 1-3). Useful information could be 
obtained by assessing the regulatory process 
in different countries from the cost/benefit 
perspective.
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4.5 Session 5: Economic compensation, liability issues and institutional framework 
influencing adoption of GM crops
Presentations: 
Liability, compensation, redress in case of admixture: 
legal issues
Bernhard A. Koch, University of Innsbruck, Austria
Innovation and liability in biotechnology 
transnational and comparative perspectives
Stuart J. Smyth, University of Saskatchewan, Canada, 
Institutional/political factors that influence adoption 
and profitability of GM crops in South Africa
Marnus Gouse, University of Pretoria, South Africa
Main topics presented:
Session 5 was dedicated to the legal 
implications of the mixture of GM and non-GM 
crops and policy and the institutional framework 
influencing the adoption of GM crops.
Liability in biotechnology - Europe
Even with well-designed policies and 
regulations, unwanted harmful consequences of 
GMO cultivation can affect others’ assets (e.g. 
through adventitious admixture in the agricultural 
supply chain) and, in order to compensate the 
victims, liability problems have to be solved. 
There are different mechanisms in place to deal 
with liability issues, regulation (liability/tort law) 
and market place liability.
In Europe, regulation is the common 
approach with tort law being a cornerstone. 
However, in spite of common fundamental 
values, tort law requirements vary substantially 
throughout Europe, leading to variations in the 
way potential claims would be handled and 
resolved. Even the notion of “damage” differs 
from country to country. Not all jurisdictions 
are prepared to compensate so-called “pure 
economic loss”, such as the loss of value of 
a crop/product if, due to the presence of GM 
traces, it commands lower prices or cannot be 
marketed at all. The sort of loss recognized, the 
thresholds for compensating farm losses, the 
likelihood of causation which has to be proven 
and the required standard of care differ from 
country to country. Moreover, tort law overlaps 
with other regulations such as good agricultural 
practice, coexistence rules and national policies.
Insurance schemes can be introduced in 
order to distribute the burden of liability for 
farmers cultivating GM crops between those 
contributing through the payment of premiums. 
Insurers may handle claims more efficiently than 
courts. However, due to a lack of data for risk 
assessment and the remaining uncertainties in tort 
law, insurers are still reluctant to offer products.
Compensation funds established with 
contributions from farmers cultivating GMO crops 
and/or from government revenue could substitute 
where insurance schemes are absent. However, 
these funds would face the same problems as 
insurers, such as unpredictable developments 
and difficulties in calculating the risk.
Some EU Member States have already set up 
compensation funds, e.g. Denmark and Portugal. 
In Denmark farmers pay a statutory fee per hectare 
cultivated with GM crops, and the State serves as 
a short-time financier when losses exceed the 
limits of the fund. The fund only covers economic 
loss resulting from actual GMO presence in 
non-GM crops (e.g. not from environmental 
damage). However, in the absence of GM crop 
cultivation the relevance of the scheme is of a 
purely theoretical nature. Portuguese farmers pay 
EUR 4 per packet of seeds (“seed tax”), the state 
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accidental economic loss resulting from actual 
GMO presence in non-GM crops.
Liability in biotechnology – North America
In the USA and Canada, coexistence or 
segregation of GM crops and non-GM crops is 
not specifically regulated. Therefore, civil liability 
applies in the context of GM crop cultivation and 
liability issues are solved between private parties 
(marketplace liability). In the event of admixture, 
the product development company may be held 
responsible and obliged to pay compensation.
Three court cases were presented in 
the workshop. Two court cases in the USA 
concerned the commingling of unapproved 
GMOs with commercial agricultural crops. 
StarLink maize had received a so-called 
“split approval” for feed use (but was not yet 
approved for food uses) and was supposed to 
be controlled through an identity preservation 
system. Despite this, StarLink maize was 
detected in food products in 2000 and in the 
ensuing court case, plaintiffs who could prove 
that their crop, product or market had been 
negatively impacted by StarLink maize, joined 
a class action lawsuit. The developer settled 
out of court by providing USD 110 million in 
compensation.
In 2006, trace amounts of an unapproved 
GM rice event (LL601 rice) were found in US 
exports to the EU. More than 1,000 lawsuits 
were launched against the biotech company 
developing the event. The US rice industry lost 
the EU market for years after this incident and 
the biotechnology company recently offered 
USD 750 million in compensation to the rice 
producers concerned.
In Canada, the Saskatchewan Organic 
Directorate (SOD) launched a lawsuit in 2001 
claiming that organic farmers had suffered fiscal 
damage from the commercialisation of GM canola, 
however the lawsuit was rejected by the court.
Institutional and political factors – South Africa
Factors which influence the adoption and 
profitability of GM crops, such as institutional 
and political factors, were discussed on the 
basis of studies from South Africa. The situation 
in South Africa is characterised by a dualistic 
agricultural sector. On the one side, large-scale 
farmers produce the bulk of crops and ensure 
employment and, to a large degree, national 
food security, but receive no direct support from 
the government. On the other side, previously 
disadvantaged small-scale farmers, the vast 
majority of whom are subsistence farmers, receive 
government support to develop infrastructure, 
skills and markets. Therefore, the South African 
government has to meet the challenge to develop 
policies which support both groups of farmers.
Three examples of how institutional and 
political factors influence adoption of GM crops 
were discussed: building on a strong scientific 
history, South Africa implemented their GMO Act 
(1997) in 1999, constituting a biosafety regulatory 
authority. The South African Government views 
biotechnology as a strategic industry to support 
economic growth. The regulatory authority and 
the Government-funded Public Understanding 
of Biotechnology program have created an 
environment facilitating science-based and 
balanced considerations and regulation of GM 
crop cultivation.
The Makhathini Flats Bt cotton experience 
illustrates the importance of institutional factors in 
the adoption of GM crops by smallholder farmers. 
Bt cotton was introduced in 1997 in this region 
and by 2001 90% of the cotton farmers cultivated 
Bt cotton. Though adopting farmers benefitted 
substantially from higher yields and savings on 
insecticides the rapid adoption rate was largely 
down to the institutional arrangement with one 
geographically isolated cotton gin supplying 
credit and extension services to contract farmers. 
However, due to institutional failure (ginnery 
competition and low prices) exacerbated by 
droughts and floods the cotton cultivation system 
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collapsed in 2002. This example showed that 
GM crops, like conventional crops, cannot be 
produced profitably and sustainably without 
functioning markets and institutional support.
As a third example, the limited adoption 
of GM maize by smallholder maize farmers 
was contrasted with the high level of adoption 
by large-scale commercial farmers. Production 
and marketing-side limiting factors caused by 
institutional and political reasons, as well as 
maize production motivations, were discussed 
and shown to influence farmers’ GM maize 
adoption decisions.
Discussion:
Experts noted that the two court cases in 
the USA involved non-approved events and 
therefore the outcome was not relevant for the 
question of how courts would decide in the case 
of adventitious presence of approved GMOs in 
crops from organic or conventional farming and 
asked if such examples already exist. Participants 
were aware of cases where organic farmers 
in Europe (Spain) claimed damages from GM 
cultivation. As these cases were (presumably) 
all settled out of court no information on the 
outcomes is publicly known.
Participants in the workshop showed 
interest in how compensation funds (e.g. in 
Denmark and Portugal) would function in 
practice. The actual applicability is unknown 
since there is no record of practical experiences 
or relevant court cases in Europe. Due to 
the small number of producers of GM crops 
in Europe the collected funds might not be 
sufficient to pay compensation for liability cases 
unless the State (as in the case of Denmark) or 
the seed producer (as in the case of Portugal) 
steps in. The uncertainty created by liability 
problems and the “compensation fund” may 
prevent farmers from adopting GM crops. 
However, experts did not come to an agreement 
concerning the importance of these factors for 
farmers’ decisions.
It was noted by experts that further 
private mechanisms exist (in addition to what 
was mentioned in presentations) to deal with 
liability issues. Contractual arrangements 
between biotech companies and farmers 
may include compensation schemes for the 
adventitious presence of GMOs in other 
crops. Additionally, companies frequently 
find pragmatic solutions for liability issues 
(out of court) in order to secure their market 
share. Strong players in the supply chain (e.g. 
supermarket chains) may receive compensation 
on the basis of their market power (and 
independent of court cases).
Concerning the presented case studies from 
South Africa, it was noted by an expert that the 
situation in South Africa is characteristic of all 
sub-Saharan countries. Policy and institutional 
factors, such as a functioning seed supply system 
or stability in the availability of credits, are 
crucial to enable farmers in this region to adopt 
technologies such as GM crops. This presumably 
also applies to other countries (e.g. India and 
China) and studies should be carried out. With 
regard to the situation in the EU, experts stressed 
the importance of policy approaches which allow 
science-based decisions in order not to hamper 
innovation.
Prospects:
Experts agreed that institutional and 
policy approaches and liability issues are 
important factors for reaching decisions on 
the adoption of GM cultivation and that 
detrimental developments can hamper 
innovation. Comprehensive studies on liability 
approaches exist for Europe and North America 
whereas currently little is known on the actual 
impact of liability issues on farmers’ decisions 
concerning GM crop adoption. Moreover, as 
long as no case is brought to court the extent 
of the compensations remains hypothetical. 
Information gaps could be closed by including 
liability issues as a parameter to be evaluated 
in farm-level, sector-level and coexistence 
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Reviewing science behind consumer attitudes, 
willingness to pay
Matty Demont, African Rice Centre, Saint Louis, Senegal
Transgenic crops in the context of global health Felicia Wu, University of Pittsburgh, USA
Consumer reactions/choice (findings of the project 
CONSUMERCHOICE)
Vivian Moses, King’s College, London, UK
studies (see sessions 1-3). A methodology 
for the evaluation of the impact of policy and 
institutional factors on adoption and profitability 
of GM crops has been developed. It would be 
of interest to also conduct such studies in other 
developing (e.g. India and China) and developed 
countries (e.g. Europe) where respective data are 
currently missing. 
4.6 Session 6: Research on consumers attitudes and direct/indirect impacts of GM 
crops on consumers including health
Presentations:
Main topics presented:
Session 6 addresses the issue of consumer 
attitudes towards GM crops, which is of 
significant importance for the adoption of GM 
crops: even when GM crops perform better than 
conventional crops, they will not be cultivated 
if consumers are not willing to buy them. One 
presentation reviewed the theory behind studies 
on consumer choice and a second presentation 
gave more empirical insights into this issue. 
In addition, a third presentation dealt with the 
health benefits associated with GM crops.
Measuring the preference of consumers
Many researchers have set out studies 
to measure the preference of consumers 
regarding GM or non-GM food products 
(estimated by the Willingness To Pay - WTP), 
and several reviews of these studies are 
available. Two main types of methodologies 
to elicit consumers’ valuation of GM products 
can be distinguished, depending on whether 
the valuation process is hypothetical or not. In 
the case of the first method (such as contingent 
valuation), the preferences of consumers are 
stated, i.e. they are elicited in a hypothetical 
framework, for instance with questions about 
purchase intentions. This method is generally 
easier to implement than the non-hypothetical 
one, as it allows quick collection of data at 
low cost (which is specifically relevant in 
developing countries). However, experience 
showed that when consumers are asked 
(theoretically) how much they are willing 
to pay for non-GM food products, they 
generally state higher prices than in real (or 
experimental) purchase situations. This so-
called ’hypothetical bias’ may lead to a 2.6 
times over valuation of WTP for non-GM food, 
according to a 2005 estimate.
The second method, namely “revealed 
preference”, was developed amongst other 
reasons in order to overcome drawbacks 
associated with the stated preference method. 
Its main purpose is to elicit consumers’ WTP 
for non-GM products by positioning them 
in real purchasing situations. For instance, 
in experimental auctions, participants are 
encouraged to bid for real products with 
real money, within a set of rules that provide 
incentives to faithfully reveal the valuation of 
consumers for GM or non-GM products for sale. 
Experimental auctions are especially useful in 
situations where no market for the assessed GM 
food products exists. 
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Results of studies on consumer preference for 
GM / non-GM food products
Two main findings emerge from the growing 
body of literature on consumers’ attitudes towards 
GM food products: (1) consumers in developed 
countries have a preference for non-GM food, 
especially in Europe, whereas (2) in developing 
countries (e.g. China) they are more inclined to 
buy GM food than in industrial countries, even 
leading in some cases to a price premium for 
these products. The first finding was confirmed 
by a recent meta-analysis. However, the second 
one was questioned by experts who suggested 
that hypothetical bias (in these countries most 
studies tend to rely on hypothetical methods and 
purchase intention questions rather than on real 
life situations) may have led to an overvaluation 
of the preferences of consumers.
A recent two-year study in the EU 
(ConsumerChoice, funded by EU Framework 
Programme for Research) evaluated whether 
the actual purchase behaviour of consumers 
corresponds to the answers they gave when asked 
whether they would or would not buy GM food 
products. In the main survey, conducted in Spain, 
The Netherlands, the Czech Republic, Poland 
and the UK, all products purchased by a panel of 
consumers in selected supermarkets where GM 
cooking oil and other products were available 
during a given period of time were recorded 
through barcode scanning. Eventually, the data 
collected were compared with the statements 
of the very same (albeit anonymous) consumers 
regarding their willingness to buy GM food 
products. Additional surveys studied the purchase 
behaviour concerning the selection of “GM-
free” milk in Germany, and of the awareness 
and choices made by Polish citizens living in 
the US and by UK residents who had travelled 
to North America, where GM food products 
are widespread but unlabelled. Eventually, the 
researchers surveyed which GM products were 
available for purchase, and whether they remain 
in stores over time, assuming that shelf space is 
very valuable and shops do not continue to stock 
products which do not sell. Yet GM products have 
remained on offer for years in those five countries 
listed above.
Depending on the circumstances (type of 
survey, sample of consumers) and the European 
country, the results of this study varied but 
not greatly. Two general conclusions could be 
drawn. Firstly, the actual purchase behaviour of 
consumers regarding GM food products does not 
correspond to their stated attitude when asked 
on the subject; and secondly, when GM food 
products are available on the shelves, consumers 
are generally willing to buy them. 
Potential health benefits for consumers of GM crops
Consumers usually do not associate 
consumption of GM products with health benefits. 
However, studies show some evidence that first 
generation GM crops may provide health benefits, 
even if this was not breeders’ intention.
Currently cultivated GM crops may increase 
labour productivity and therefore either slacken 
the constraints of workforces in regions where 
it is scarce (e.g. in areas where HIV is highly 
prevalent) or allow workers to engage in other food 
production activities that will help diversify their 
diet. Secondly, producers may also benefit from the 
reduced amount of insecticides spread on the fields 
(in the case of IR crops), or from the lower toxicity 
of herbicides used (in the case of HT crops).
There is also an important but often 
unrecognized health benefit for consumers 
associated with Bt crops. Multiple field studies have 
shown that concentrations of certain mycotoxins 
are significantly lower in Bt maize than in its 
conventional isoline. As the crystal (Cry) proteins that 
are synthesised by the plant thanks to the insertion of 
the Bt gene result in reduced insect damage, there is 
also a reduction in the levels of toxin-producing fungi 
colonizing the maize ears. These mycotoxins can 
cause adverse health effects in humans. Therefore, 
their reduction results in improved health outcomes, 
and consumers, especially in developing countries 
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of conducive climate and/or less stringent food 
safety regulation and enforcement), could benefit 
from the adoption of Bt maize.
Discussion:
During the discussion participants raised 
methodological issues on how to obtain 
representative samples, focusing on shoppers rather 
than on consumers in general. Some biases can 
be overcome by using econometrical methods; 
however, experts noted that wherever GM foods are 
available for sale, better results would be obtained 
by performing surveys directly in the marketplace. 
But the latter also have some limitations and 
therefore it might be useful to carry out experimental 
studies to elicit consumer preferences.
Participants also wondered why according to 
poll surveys consumers reject GM food products, 
whereas studies show that consumers do buy them 
when they are available on the shelves. While some 
experts stated that providing more information to 
consumers would increase their understanding 
regarding safety and GM technology, and thus 
their acceptance of GM food, others argued that 
they would expect the government to provide an 
environment allowing all stakeholders to operate 
in the market. Participants stated that consumers 
are not a homogenous group, with some of them 
rejecting GM food products, others being neutral 
and the remainder being interested in buying 
GM food. Generally, the level of opposition to 
GM food rises with the higher income and better 
education of consumers.
Prospects and conclusions:
As for the socio-economic assessment of 
GM crops at farm level, experts have to focus 
on the choice of a suitable methodology and 
address methodological limitations when studying 
consumers’ preferences concerning GM or non-GM 
food and WTP. Study design is especially challenging 
in countries such as EU Member States where few 
food products labelled as GM are available. In 
the absence of GM food products, surveys on the 
marketplace (ex	post) are not possible. In this case, in 
order to avoid hypothetical bias, preference should 
be given to methods where consumers have to 
make real purchase decisions (such as experimental 
auctions for instance) over methods where 
preferences of consumers are only stated.
Global pipeline of GM crops by 2015 Emilio Rodriguez Cerezo, European Commission, JRC-IPTS, Spain
Predicting “ex ante” the economic impact of a new 
GM crop: the case of CRW-resistant maize in Europe
Koen Dillen, European Commission, JRC-IPTS, Spain
Closing talk: the future of GM rice and the possible 
social and economic impacts  in Asia
Gerard Barry, International Rice Research Institute, Philippines
4.7 Session 7: Looking forward: New GM crops in the pipeline and their possible 
economic and social impacts
Presentations:
Main topics presented:
The final session reviewed new GM crops 
which are expected to be released in the coming 
years and the implications for socio-economic 
impact assessments.
The pipeline of GM crops with a special focus 
on Asia
The global pipeline for GM crops is active 
and is expanding: up to 124 GM events are 
expected to be commercially available by 2015, 
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compared to some 40 GM events released so 
far. Currently, the four major GM crops (maize, 
soybeans, cotton and rapeseed) represent around 
80% of the total number of commercialized GM 
events, whereas by 2015 this figure will fall to 
around 60%. New varieties for some of the most 
important crops for global agriculture, such as 
rice (no GM rice is yet commercially used) or 
potatoes, will eventually be included in the list 
of available GM varieties. Also for “smaller” 
(but no less relevant) crops, such as tomato, 
eggplant, papaya, alfalfa, or cabbage, new 
genetically engineered varieties are expected 
to be available by 2015. Thus, there will be a 
slight but significant diversification in terms of 
genetically modified species, but also in terms 
of traits. Even if the two main existing ones 
(herbicide tolerance and insect resistance) will 
still dominate by 2015, other agronomic traits are 
also expected. These traits (some new) include 
resistance to viruses, improved resistance to 
diseases and tolerance to abiotic stresses (such 
as drought or high salinity). The first ‘second 
generation’ GM crops are also expected to be 
commercially available by 2015. These crops 
will specifically address the needs of consumers 
through, for instance, improved fatty acid profile 
or higher content in beta carotene. Some crops 
with events designed to meet the needs of the 
industrial sector (including the biofuel industry) 
will also be available.
Major changes are expected in the years 
to come concerning the region of origin of GM 
events. Indeed, while in 2008 three out of four 
commercialized GM events were still developed 
by North American or European companies, 
the coming years will see the emergence of 
technology providers from Asia as a major source 
of GM events. This region will be especially 
active by putting on the market the first GM rice 
varieties, even if the release of some of the GM 
rice events in the pipeline a few years ago has 
been delayed or even cancelled. Most of the 
rice events close to commercialization are insect 
resistant varieties, in addition to the biofortified 
rice called Golden Rice.
However, both in India and China, 
governments do not consistently support the 
release of GM rice and other GM food crops. In 
China, concerns about possible low consumer 
acceptance of GM food and recently tightened 
controls on Chinese rice exports to the EU appear 
to have slowed down the approval process for GM 
rice. In India, various new regulations regarding 
biotechnology are waiting to be promulgated. 
Nevertheless, in both countries the dynamic of 
the research pipeline seems unaffected by the 
uncertainties of governments. Recently, a Bt 
rice event (Bt63) received a biosafety certificate 
from the Chinese regulatory agency, but variety 
registration is still delayed. Numerous field trials 
are conducted in China for crops with different 
traits, including insect resistance, herbicide 
tolerance, drought and salt tolerance, nitrogen 
use efficiency, and grain quality, many of them 
developed by public national centres.
In India, the central government continues to 
authorise new field trials, but they are subject to 
the final approval of the local state governments. 
Nevertheless, late stages of regulatory trials for 
a Bt rice developed by a private company have 
recently been conducted, and other trials are 
following. In the case of Golden Rice, an event 
genetically modified to express genes that lead 
to the accumulation of beta carotene in the rice 
grain – beta carotene is a precursor of vitamin 
A – the development is already quite advanced, 
and a regulatory dossier could be delivered to 
the authority in the Philippines by 2013. Indeed, 
among Asian countries, the Philippines and 
Indonesia might be the ones releasing the first 
commercial GM rice in the next years.
New GM events and implications for socio-
economic impact assessment
The new traits incorporated by the GM 
crops in the pipeline would require new socio-
economic indicators to assess their impact. 
Improvement in crop quality may generate 
nutritional or health benefits for consumers, and 
thus may change their attitude toward GM crops. 
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indictors are required to measure the direct 
nutritional or health effects of these crops with 
new traits for nutritional improvement, and to 
compare the cost effectiveness of the use of these 
crops with alternative public health measures.
Actually, some ex	 ante assessments of 
the impacts of new GM crops are already 
available. In the case of Golden Rice, recent 
studies estimated (using a Disability Adjusted 
Life Years [DALY] indicator) the reduction in 
morbidity and mortality potentially generated 
by the introduction of this crop. Results show a 
significant beneficial health impact, at a lower 
cost when compared with alternative public 
measures. Ex	 ante studies for Bt rice conducted 
in China estimated huge internal gains for rice 
production, even when considering the potential 
loss of export markets.
In the case of the European Union, a 
recent ex	 ante study simulated the level of 
adoption and the economic impacts of the 
introduction of a GM maize designed to 
control the Western Corn Rootworm, a pest 
that arrived in Central Europe in the 1990s. 
This trait is available in the USA but not yet 
in the European Union. Different options for 
crop protection were compared (crop rotation, 
chemical protection or GM maize), and the 
high heterogeneity within farmers in the region 
was taken into account in the model. The bio-
economic simulations predict that in Hungary, 
for 69% of the farmers in a land constraint 
situation, the crop rotation option will ensure 
a higher income than GM maize, whereas 78% 
of maize monoculture farmers would be better 
off relying on GM maize than on insecticide 
applications. Results from other Central 
European countries indicate that, in general 
terms, the introduction of this new GM maize 
in Central Europe would significantly reduce 
the quantity of soil insecticides used, and offer 
a better protection against the economic loss 
due to Western Corn Rootworm by increasing 
the available crop protection toolbox.
Discussion:
Experts discussed the accuracy of 
the commercial pipeline of GMOs. Big 
discrepancies were noted in the past between 
the announced and actual dates of release 
for certain GM events. However, it was also 
noted that, in some cases, new GM crops 
had been available in a shorter time than 
expected. In sum, commercial pipelines 
are not very reliable when dealing with 
longer term, and should instead be focused 
on events in the later stages of R&D. But 
with time, experts expect an increase in the 
probability of developed events eventually 
being commercially released, as more public 
or public-related actors, who have a more 
accurate view of the needs of the market, will 
be involved in the research funding.
The experts also discussed the impact of 
the evolution of world agricultural markets on 
the development and trade of GM crops, with a 
special reference to the recent ’food crisis’, i.e. 
the 2007-08 rise in food prices. It was noted that 
in some Asian countries, such as Bangladesh, 
the increase in food prices concentrated the 
consumption of the poorest households on rice, 
dramatically reducing their dietary diversification. 
Therefore this situation reduced the intake of 
higher nutrient foods, exacerbating micronutrient 
deficiency troubles, especially among women, and 
thus made the biofortified crops more relevant. 
Additionally, in sub-Saharan Africa, the so-called 
food crisis or some acute drought conditions have 
made a number of poor countries more tolerant 
of importing GM white maize and incorporating 
it into their food system. This might eventually 
change attitudes there towards GM crops.
Prospects:
This session brought back to mind the 
fact that the pipeline for GM events is really 
active and that the number of crops and traits 
developed with the help of biotechnology will 
strongly increase in the coming years. Experts 
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huge, even if it may still take some time to get 
very new traits on the market. As some of the 
new GM events will show other characteristics 
beyond just agronomic benefits, new indicators 
for socio-economic assessment will be required. 
As a consequence, there will be a need for new 
surveys and data collection.
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Introduction
The global area under genetically modified (GM) crops grew from 1.7 million ha in 1996 to 148 
million ha in 2010. Today, over 15 million farmers worldwide grow GM crops in 29 countries, including 19 
developing countries (James 2010). This rapid spread has been accompanied by an intense public debate. 
While some see great potential in GM crops to raise agricultural productivity and contribute to sustainable 
development, others emphasize the potential environmental, health, and social risks. Especially with 
respect to developing countries, there are concerns that smallholder farmers would not be able to benefit. 
While emotional public controversies continue, there is a growing body of literature providing empirical 
evidence on impacts of GM crops in different countries. Here, we present an overview of global GM crop 
adoption, and review recent impact studies with a focus on the developing world.
Global status of GM crop adoption
The commercial adoption of GM crops began in the mid-1990s. Since then, the technology has spread 
rapidly around the world. In 2010, GM crops were already grown on 148 million ha in 29 countries. The 
countries with the biggest GM crop area shares are the US (45%), Brazil (17%), Argentina (15%), India 
(6%), Canada (6%), and China (2.5%) (James 2010). Among the countries of the European Union (EU) 
only Spain grows GM crops on a significant scale. In other EU countries, GM crop areas are negligible, 
largely due to public acceptance problems.
In spite of the widespread international use of GM crops, the portfolio of commercialized crop-
trait combinations is still quite limited. Up till now, only a few first-generation GM crops have been 
commercialized. The dominant technology is herbicide tolerance (HT) in soybeans, which made up 
50% of the global GM crop area in 2010. HT soybeans are mostly grown in the US, Argentina, Brazil, 
and other South American countries. GM maize is the second-most dominant crop, covering 31% of the 
global GM area in 2010. It involves HT and insect resistance, partly as separate and partly also as stacked 
technologies. Insect resistance is based on different genes from Bacillus	thuringiensis (Bt). HT and stacked 
HT/Bt maize is cultivated primarily in North and South America and in South Africa; Bt maize is also 
grown in a number of other countries, including Spain and the Philippines.
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Other GM crops with significant area shares include cotton and canola. Bt cotton is particularly 
relevant in developing countries. In 2010, India had the largest Bt cotton area with 9.4 million ha, 
followed by China with 3.5 million ha. South Africa, Argentina, Mexico, and a few other countries use this 
technology as well. In the US, Bt and HT cotton are employed, partly as stacked technologies. HT canola 
is mostly grown in Canada and the US. There are also a few other GM crops that have been approved in 
individual countries, so far only covering relatively small areas. Those include HT alfalfa and sugarbeet as 
well as virus-resistant papaya, among others.
Impacts of HT crops
HT adopting farmers benefit in terms of lower herbicide expenditures. Total herbicide quantities 
applied were reduced in some situations, but not in others. In Argentina, herbicide quantities were even 
increased significantly. This is largely due to the fact that herbicide sprays were substituted for tillage. The 
share of soybean farmers using no-till has increased significantly since the introduction of HT technology. 
In terms of yields, there is no significant difference between HT and conventional crops in most cases. 
Only in some regions, where certain weeds were difficult to control with selective herbicides, the adoption 
of HT and the switch to broad spectrum herbicides resulted in better weed control and higher crop yields.
Overall, HT technology reduces the cost of production through lower expenditures for herbicides, 
labor, machinery, and fuel. Yet, the innovating companies charge a technology fee on seeds, which 
varies between crops and countries. Several studies for HT crops in the US and Canada showed that the 
fee was in a similar magnitude as the cost reduction in agricultural production, so that profit effects for 
farmers were small. In South American countries, the average profit effects are larger, because – due to 
weaker intellectual property rights (IPRs) – the technology fee charged on seeds is lower. In Argentina, the 
average profit gain through HT soybean adoption is in a magnitude of USD 23 per ha. The technology is 
so attractive for farmers that HT is now used on 100% of the Argentine soybean area. In Brazil and other 
South American countries, adoption rates have also increased rapidly (Qaim 2009).
Impacts of Bt crops
If insect pests are effectively controlled through chemical pesticides, the main effect of switching to Bt 
crops will be a reduction in insecticide use, as the genetic resistance mechanism substitutes for chemical 
control agents. However, there are also situations where insect pests are not effectively controlled by 
chemical means, due to the unavailability of suitable insecticides or other technical, financial, or 
institutional constraints. In those situations, Bt can help reduce crop damage and thus increase effective 
yields. Table 1 shows that both insecticide-reducing and yield-increasing effects of Bt crops can be 
observed internationally.
Profit effects of Bt technologies are also shown in Table 1. In spite of higher prices for seeds, Bt 
adopting farmers benefit financially. Yet the absolute gains differ remarkably. On average, they are higher 
for Bt cotton than for Bt maize, and they are also higher in developing than in developed countries. The 
latter is due to higher pest pressure in the tropics and weaker IPR protection in developing countries.
Especially in China, India, and South Africa, Bt cotton is often grown by small-scale farmers with 
land areas of less than 5 ha. In South Africa, many smallholders grow Bt white maize as their staple food. 
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Country Insecticide reduction (%) Increase in effective yield (%) Increase in profit (US$/ha)
Bt cotton
Argentina 47 33 23
Australia 48 0 66
China 65 24 470
India 41 37 135
Mexico 77 9 295
South Africa 33 22 91
USA 36 10 58
Bt maize
Argentina 0 9 20
Philippines 5 34 53
South Africa 10 11 42
Spain 63 6 70
USA 8 5 12
Several studies show that Bt technology advantages for small-scale farmers are in a similar magnitude 
as for larger-scale producers, in some cases even higher (Qaim 2009). In a study for Bt cotton in India, 
Subramanian and Qaim (2010) revealed sizeable employment-generating and poverty-reducing effects 
in the small farm sector, while Kouser and Qaim (2011) showed significant health benefits due to lower 
exposure to toxic pesticides.
Sustainability of effects
Like any new technology, GM crops tend to impact on ecosystem dynamics. Thus, system adaptation 
processes may potentially influence technological effectiveness over time. For instance, pest populations 
may develop resistance to GM pest control mechanisms. In certain locations where HT crops are used 
extensively, resistance to broad-spectrum herbicides such as glyphosate has been observed in some weed 
species. Resistance management can be improved through proper crop and technology rotations. For Bt 
crops, insect pest species may develop resistance. Furthermore, non-Bt target insects (secondary pests) 
may gain in importance. If this were to happen, the benefits of Bt crops would decrease over time, which 
could create social problems especially in the small farm sector.
Recent research in India has analyzed the sustainability of Bt cotton impacts based on panel survey 
data (Krishna and Qaim 2011). Strikingly, Table 2 shows that the beneficial effects of Bt did not decrease 
but increase over time. Obviously, Bt resistance development and secondary pest outbreaks are not yet 
problems of practical relevance in India. While long-term effects are still uncertain, these results mitigate 
the concern that GM crops would soon become ineffective in smallholder environments.
54
A
nn
ex
 3
: P
ap
er
s
References
James, C. (2010). Global Status of Commercialized Biotech/GM Crops: 2010. ISAAA Brief 42, International 
Service for the Acquisition of Agri-biotech Applications, Ithaca, NY.
Kathage,	J.,	M.	Qaim	(2011).	Are	the	Economic	Benefits	of	Bt	Cotton	Sustainable?	Evidence	from	Indian	
Panel Data. CRC-PEG	Discussion	Paper	80, University of Goettingen.
Kouser, S., M. Qaim (2011). Impact of Bt Cotton on Pesticide Poisoning in Smallholder Agriculture: A 
Panel Data Analysis. Ecological	Economics 70, 2105-2113.
Krishna, V.V., M. Qaim (2011). Bt Cotton and Sustainability of Pesticide Reductions in India. Agricultural	
Systems (forthcoming).
Qaim, M. (2009). The Economics of Genetically Modified Crops. Annual	Review	of	Resource	Economics 
1, 665-693.
Subramanian, A., M. Qaim (2010). The Impact of Bt Cotton on Poor Households in Rural India. Journal of 
Development	Studies 46, 295-311.
Table 2. Treatment effects of Bt cotton in India (per ha of Bt compared to conventional cotton)
Insecticide use
(kg of active ingredients)
Cotton yield (kg)
Incidence of farmer 
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effects	panel	regressions	with	representative	survey	data	collected	between	2002	and	2008	in	four	waves	and	in	four	states	of	central	
and	southern	India.	Appropriate	control	variables	were	included.	***	Coefficient	estimate	is	statistically	significant	at	the	1%	level.
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The GM field crop revolution started in the USA in 1996 as the first GM-corn, soybean and cotton 
varieties became available to farmers. Soybean, corn, and cotton varieties became available with 
genetically engineered herbicide tolerance (HT), and cotton and corn varieties became available that 
were engineered for insect resistance (IR) (Fernandez-Cornejo and McBride 2000, NRC 2010). Second 
generation GM traits of herbicide tolerance and insect resistance became available by 2000 for cotton, 
and for corn shortly thereafter. Third generation GM corn varieties became available to some farmers 
in 2010, and Monsanto has an eight transgene variety—three genes for above ground insect resistance, 
three for below ground insect resistance, and two for herbicide tolerance. IR varieties provide a biological 
alternative to chemical insecticide applications and provide a reduced pesticide load on the environment 
and lower risks to human health (NRC 2010). HT soybean, corn, and cotton provide more effective weed 
control than with earlier herbicides. The key herbicide in this process is Roundup, which is environmentally 
and human health friendly relative to earlier chemical herbicides used for weed control (NRC 2010). In 
contrast, GM-wheat varieties are not available to farmers. The primary reason is the negative image that 
GM wheat has in the export market.
The objective of this paper is to review the adoption rates for GM field crops in the USA and examine 
their impacts on production decisions of farmers in US Midwestern states, which is the leading area in the 
USA for corn and soybean production and adoption of GM corn and soybean varieties. The impact GM 
corn and soybean varieties on farmers’ production decisions are examined with the aid of an aggregate 
profit function and the associated input demand and output supply functions, which are fitted to data for 
eight Midwestern State over 1960-2004. This methodology uses prices of farm outputs (corn, soybean, 
wheat and livestock) and inputs (capital services, labor, farm energy, agricultural chemicals and other 
materials) and quasi-fixed factors, including technology indicators for GM seed adoption, to explain 
farmers’ decision on the quantity of outputs to produce and inputs to use. Findings include the following 
technology effects: A higher GM-soybean and corn adoption rate reduces the demand for all inputs and 
biases input decisions toward farm chemicals. The shadow value, or increase in profit, from increasing 
the GM soybean and corn adoption rates is significantly larger than the marginal cost, supporting farmers’ 
decisions to adopt these GM corn and soybean varieties and future high adoption rates of these crops.
GM Field-Crop Introduction and Adoption
In the mid-90s, the science of biotechnology was applied by private seed companies to develop 
new methods for controlling pests. A recent NRC report (NRC 2010) summarizes the generally favorable 
environmental effects of these GM crop varieties. When plants are genetically engineered to be herbicide 
tolerant (HT), e.g., Roundup	Ready, they survive the application of the herbicide Roundup with minimal 
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harm. When farmers plant GM-soybean varieties, this technology replaces more expensive, less effective 
and more toxic herbicides and hand weeding. Also, farmers have a significant window of opportunity 
for applying the herbicide and obtaining effective control of weeds (Fernandez-Cornejo 2008). However, 
when US farmers purchase GM soybeans (cotton and canola), they must sign an agreement with the seed 
company waving their right to save GM seed for their own use or for sale. HT corn has many of the same 
advantages, although corn is more competitive against weeds than soybeans, and the herbicide Atrazine 
can be used on non-GM corn to control broadleaf weeds. However, Atrazine use has contaminated ground 
water in the Midwest, and consumption of this polluted water can cause health problems.
The grand goal of plant bioengineering, however, was to create biological insect resistance (IR) in 
plants. For example, one major pest experienced by Midwestern farmers is the European corn borer, which 
damages stocks and makes the corn plant subject to lodging. Bacillus thuringiensis (Bt) is a bacteria that 
occurs naturally in the soil. Several advantages exist for Bt corn varieties. First, the level of toxin expressed 
can be very high, thus delivering a lethal dosage to target insects. Second, the corn plant produces the 
toxin throughout its life and the toxin is distributed relatively uniformly throughout all plant parts. Hence, 
Bt provides season-long protection against target insects, but has no significant effect on other insects.1  
Third, the toxin expression can be modulated by using tissue-specific promoters, and GM resistance 
replaces the use of synthetic pesticides in an attempt to kill target insects. Fourth, the Bt toxin expressed 
in the corn plants is not toxic to humans or animals. Although the early Bt corn varieties were resistant to 
the European corn borer, they were also somewhat protective against the corn earworm, the southwestern 
corn borer and to a lesser extent the cornstalk borer (Fernandez-Cornejo and McBride 2000). Later, Bt-
corn varieties carried resistance to corn rootworms, which are a pest that reduces and weakens the root 
structure of corn plants. New evidence shows that farmers planting non-GM corn hybrids are major 
beneficiaries from other farmers planting Bt-corn hybrids because area-wide moth counts have been 
steadily declining as the Bt-corn adoption rate in an area increases. However, some evidence of resistance 
to GM rootworm control is surfacing.
The first successful GM field-crop varieties were planted in 1996, accounting for 7 percent of the 
soybean acreage, 4 percent of the corn acreage and for 17 percent of the cotton acreage. Although 
Bt-cotton adoption got off to a fast start in 1996, the HT-cotton adoption rate surpassed the Bt-cotton 
adoption rate by 1998, reflecting the fact that weeds are a persistent problem in cotton, and HT-cotton has 
experienced higher adoption rates than Bt-cotton through 2010. Although the US adoption rate for HT-
soybean varieties was initially lower than for Bt-cotton, HT-soybean varieties have experienced very rapid 
adoption rates over 1997-2007, except for a brief setback over 1999-2000, when new uncertainties about 
the future market for GM crops in Europe surfaced. However, in 2004, GM soybeans accounted for 85 
percent of planted acres in 2004 and 93 percent acres in 2010. The adoption of HT- and IR-corn varieties 
started more slowly. The GM adoption rate for HT corn declined a little over 1998-2000, and the Bt corn 
adoption rate declined significantly over 1999-2000, deviating from trend by more than 10 percentage 
points. After 2000, the IR- and HT-corn adoption rates increased slowly until the mid-2000s when the 
pace peaked up. In 2004, 47 percent of US corn acreage were planted to varieties with one or more input 
traits. By 2010, this adoption rate had reached 86 percent. In the eight Midwestern US states that are the 
focus of the empirical analysis of production effects of GM field crops, the adoption rates mirrored those 
at the US level.
1 Bt produces spores that form the crystal protein insecticide δ-endotoxins. The protein toxin is active against species of the order 
Lepidoptera, Diptera, Coleoptera, Hymenoptra and nematodes. When these insects ingest toxin laden crystals, chemicals in their 
digestive track activate the toxin. It inserts into the insect’s gut cell-membrane and dissolves it and eventually causes death of the insect.
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The responsiveness of farms to (expected) prices of outputs and inputs is an important dimension of 
the structure of Midwestern farm production (see Schuring et al. 2011 for more details). All own-price 
elasticities are negative for inputs and positive for outputs, except for livestock. The negative own-price 
effect for livestock may arise as farmers respond to an increase in livestock prices by marketing animals 
at lighter weights or building breeding-stock inventories. Among the outputs, the own-price elasticity of 
supply for wheat is largest, 0.79, for corn is moderate, 0.33, and for soybeans is smallest, 0.12. Hence, the 
elasticity of supply of major crops produced in Midwestern production is substantial. Among inputs, the 
own-price elasticity of demand for farm chemicals is largest, -0.71, and followed by farm energy, -0.38 
and “other materials, -0.27. The other (variable) inputs have somewhat smaller own-price elasticities; 
-0.09 for farm capital services and -0.04 for farm labor.
Farmers’ adoption of GM corn and soybean varieties affects other production decisions. An increase in 
the adoption rate for GM soybean and corn varieties reduces the demand for all variable inputs. However, 
a weak tendency for GM soybean adoption to increase the supply of soybeans and wheat occurs but it 
reduces the supply of corn and livestock. A higher GM-corn adoption rate tends to reduce all outputs, but 
its largest impact is on the supply of wheat and livestock.
Farmers’ adoption of GM soybean and corn varieties has been profitable. An increase in the adoption rate 
for GM-soybean varieties by one percentage point has a shadow-value payoff of about $2.7 million per year in 
the average Midwestern state (in 1996 prices). This compares with an estimated technology fee for switching 
one percentage point of the soybean acres over 1996 to 2004 from non-GM to GM soybeans of $757,000. 
Ignoring any short term discounting, this translates into a benefit-cost ratio of about 3.6. An increase in the 
adoption rate for GM-corn varieties by one percentage point has a shadow-value payoff of $26.8 million (1996 
prices) per year in an average Midwestern state (in 1996 prices). This compares with an estimated technology 
fee cost for switching one percentage point of corn acres over 1996 to 2004 from non-GM to GM corn varieties 
of $515,000. This translates into a benefit-cost ratio of about 52. These benefit-cost comparisons are quite large 
and support continued higher use of GM corn and soybean varieties in the US Midwest.
Farmers in the US have experienced a high payoff to adopting GM corn and soybean varieties, and 
the new crops have been environmentally friendly but a small amount of resistance by target pests has 
surfaced. This is expected because of the evolving nature of target pest.
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European Commission, JRC-IPTS, Seville, Spain
Emilio.Rodriguez-Cerezo@ec.europa.eu
1. Introduction
Insect resistant (Bt) maize in the European Union (EU) reached 91,193 ha in 2010 (James, 2011) 
which represented 2.28% of the total grain maize area in the EU-15 and 1.71% of the total grain maize 
area in the EU-25. Only six countries of the EU planted Bt maize for commercial use. These countries in 
descending order of hectarage were Spain, the Czech Republic, Portugal, Romania, Poland and Slovakia. 
Spain had the largest hectarage of Bt maize in the EU with 74.26% of the total Bt maize area in the 
EU in 2010. The adoption rate of Bt maize in Spain has been stable around 21% since 2007 (MARM, 
2010). Most Bt maize is used in animal feed and currently all compound feed sold in Spain is labelled as 
genetically modified (GM) with the exception of organic feed (Brookes et al., 2005). However, as in other 
EU countries a specific new market for non-GM compound feed may emerge also in Spain (Brookes et al., 
2005).
2. Materials and Methods
In order to evaluate the economic performance of Bt maize relatively to conventional maize in Spain 
a survey amongst maize farmers was conducted between June and July 2010. A total of 180 farmers 
were interviewed by phone including 119 farmers growing conventional maize and 61 farmers growing 
Bt maize. The questionnaire included questions on farm characteristics in 2009 such as crop hectarage, 
yields, prices or production costs as well as farmer’s socio-demographic questions.
This paper has a double objective. First, the profitability of Bt maize when compared to its conventional 
counterpart is analysed after 12 years of experience growing Bt maize in Spain. Secondly, this paper 
establishes the limits of the higher profitability of Bt maize relatively to conventional maize. These limits 
are based on different scenarios that have an effect on inputs’ costs and prices of harvested maize.
Economic performance of Bt maize when compared with its conventional counterpart can be 
evaluated through the difference in gross margin between both crops.
1 Currently at Department of Economics, Pablo de Olavide University, Spain
2 Currently at Economic and Social Sciences Division, University of Reading, U.K.
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3. Results
Results show incomes are 11.55% higher for Bt maize farmers than for conventional maize farmers, 
showing that Bt maize continues to perform economically better than conventional maize in Spain after 
12 years of cultivation. Previous studies showed similar results at earlier stages of Bt maize adoption in 
Spain (Gómez-Barbero et al., 2008).
A profitability analysis of Bt maize was conducted by examining the thresholds at which the crop 
start to be profitable. Given the baseline scenario in 2009, different variables were modified to analyse 
the profitability of Bt maize when compared with its conventional counterpart under different situations. 
Scenarios where Bt maize price decrease and conventional maize price increase were considered. Results 
from the profitability analysis show that slight changes in Bt and conventional maize prices imply a great 
fall in the probability of Bt gross margin being greater than conventional gross margin.
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Introduction
Debates about transgenic crop varieties have often polarized public discussions about the potential 
of biotechnology to meet the needs of smallholder farmers, particularly in developing country agriculture. 
Governments need objective assessments, but such information is not easy to generate.
The ideology of the debate over biotech crops seasons not only the interpretation of the findings but 
also, in some cases, the methods selected for analysis. The methods used to assess impacts also suffer, as 
do any scientific methods, from limitations.
Growing transgenic varieties, like other new crop varieties, has social and economic consequences 
for small-scale farmers and their communities. Unlike other new crop varieties, however, transgenic crop 
varieties have raised ethical concerns that have not been raised before.
Thus, particular challenges are faced by researchers seeking to assess the impacts of biotech crops 
on farm households in developing agriculture. This presentation reviews the methods used by applied 
economics to measure impacts on farms, focusing on the first decade since their introduction (1997-2007). 
Advances from more recent work are also highlighted, and reference is made to a recently published 
meta-analysis by Finger et al. (2011).
Scope
We began with a systematic review of all literature published in English, French and Spanish, 
combining databases available on line, web-bibliographies related to biotechnology, references cited in 
published articles and direct communication with economists working on the research questions. Only 
peer-reviewed articles with a stated economics method, conducted in developing agriculture, were 
selected. After examining their content, a total of 321 articles met our criteria as of August 30, 2011. 
They are grouped by major economics research question, which corresponds roughly to the sectors of the 
economy (farmer, consumer, industry, trade), in Table 1. 
Of the papers using primary data analysis, about half examine impacts on farmers (127). Studies of 
consumer acceptance and industry impacts are next in numbers (47,48). Analyses of international trade 
follow (33). The ratio of review articles to primary analyses appears to be high. There are several articles on 
the costs of regulation, biodiversity, and biosafety. The total numbers seem to have declined in recent years. 
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Methods Applied to Measure Impacts on Farmers
Smale et al. (2010) analysed the methods used to measure impacts on farmers through 2007, spanning 
the first decade since the introduction of biotech crops in developing agriculture. The most common 
approaches employed were partial budgets, followed by farm production and input use models. A small 
subset of articles used variety choice models based on revealed or stated preferences, value chain analysis, 
or mathematical programming. Only the partial budgets and econometric models are discussed here.
Most articles were based on analysis of Bt cotton, followed by Bt maize, and a few articles on HT 
soybeans and a small collection of articles on other crops (papaya, banana, rice, sweet potato, potato, 
eggplant).
Partial	budgeting
Partial budgeting is the simplest approach used by agricultural economists to test hypotheses 
concerning the effects of Bt crops on yield losses from pests, insecticide use costs, labour use costs, and 
profits. The major limitations associated with this approach reside with the data used to construct them. 
Data sources are generally farm surveys, trial data, or company data. Some authors use several sources 
at a time. Trial data does not represent farm conditions well. Company data sources may be construed as 
potentially biased.
Constructing a sampling frame for farm surveys of biotech crops can be particularly costly and difficult 
due to lack of information and political sensitivities. Many of the first generation of studies are based on 
very small samples, reflecting the fact that they were implemented in the early phases of adoption. They 
also exhibit a placement bias, since initially, promotional programs were often initiated with a unique 
group of farmers—either because more efficient, or they were targeted for other reasons. This type of bias 
is often recognized by the authors themselves.
Conceptual limitations include the fact that most margins presented in early studies are gross, 
rather than net, and do not consider land or labor costs. A whole-farm perspective would provide 
Table 1. Number of articles examining the economic impact of biotech crops in developing agriculture 
(through mid-2011)
 Pre- 2005 2006 2007 2008 2009 2010 2011 Total
Farmers 51 18 10 21 17 5 5 127
Consumers 14 13 4 9 4 2 1 47
Industry 17 6 6 13 5 1 0 48
Trade 17 6 4 2 2 2 1 34
Review findings 17 5 0 3 5 3 0 33
Review methods 7 3 2 2 2 1 0 17
Cost of Regulation 1 2 1 0 1 2 1 8
Others 0 1 0 0 1 2 3 7
Total 124 54 27 50 37 18 11 321
Note:	Other	includes		biodiversity,	biosafety
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approach must be modified to better represent the conditions of farmers who are not entirely 
commercially oriented, whose families constitute the primary source of labor, and who purchase 
and sell on poorly functioning markets. The introduction of risk, through application of stochastic 
budgeting, has constituted an advance. Recall has often been used to measure insecticide use, 
although farmers are often unfamiliar with the names of the insecticides they apply, or mix them, 
or do not remember amounts applied. Some researchers have designed more effective protocols for 
monitoring pesticide use.
Econometric	models	of	production	and	input	use
Most econometric analysis of the impacts of Bt crops have served to test the same hypotheses with 
more advanced statistics. Other methods test the impact of adoption on production efficiency. The quality 
of econometric analysis, in turn, is based in part on the quality of the data. In some cases, the same small 
samples have been used for successive econometric analyses, entailing some test bias. That is, the number 
of independent authors and data sets is narrower than the number of articles published.
Early studies typically estimated yield response or production functions, or insecticide use equations, 
with a dummy variable included as an explanatory variable to test the effect of adoption. A major advance 
was the application of damage abatement models, recognizing that Bt, like insecticides, serve to reduce 
yield loss in the presence of pest pressures, rather than raise yields as does fertilizer.
Other challenges remain. By far the most important consideration is the bias associated with self-
selection of more efficient farmers, or those with greater endowments and access to information and 
resources, into adoption. In the period through 2007, treatment of selection bias was uncommon in 
published studies. Since then, a number of studies have sought to control for selection bias using various 
methods, including Heckman models, instrumental variables, panel fixed effects models and propensity 
score matching. Randomized controlled trials have not yet been published, to our knowledge.
A related challenge has been posed by the fact that the Bt gene has variable expression depending on 
the gene construct and the host cultivar. Comparing Bt crops strictly to their isogenic lines, or controlling 
for host cultivar econometrically is not always feasible with farmer survey data.
A third major challenge is the endogeneity of decision to grow a Bt crop. Unobserved factors can 
affect both this choice, or the decision to use insecticides, and farm yields or other indicators of outcome. 
Presence of endogeneity was rarely tested in early studies, leading to potential bias in estimated impacts. 
Several articles are exemplary in their treatment of both selection bias and endogeneity.
Conclusions
Early published studies of the economic impact of biotech crops on farmers in developing agriculture 
exhibited several common methodological limitations. These were often exacerbated by political 
sensitivities. Many of these limitations have been addressed as research has progressed. However, the 
number of studies published per year appears to have declined in recent years. The number of traits 
studied, and of independent, ex post, farm studies, remains few. Continued scientific progress is necessary 
to overcome methodological limitations and conclusions must be drawn with caution.
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The purpose of this paper is to describe the major ways in which genetically modified (GM) plants 
have improved the welfare of society and which groups in which countries have benefitted and lost from 
this technology. Since other speakers are focusing on benefits to farmers and consumers, this talk will 
focus on the global distribution of benefits to agribusiness. It then discusses how the diffusion of GM 
benefits is shifting agricultural research and the implications of that shift for future benefits.
The first generation of GM plants were herbicide tolerant (HT) or insect resistant (IR) soybeans, corn, cotton, 
and canola. There is now a large body of farm level studies – much of it reported in this conference by Qaim, 
Huffman, Rodríguez, Smale, and Zilberman and others showing that these crops have done the following:
1. HT crops in countries and regions where weeds were already fairly well controlled have reduced the 
time that farmers use to control weeds and have allowed farmers to shift to safer herbicides. Farm 
level studies in most countries show little evidence that HT crops increase yield per unit of land, but 
there is evidence from Argentina that using HT soybeans has allowed an extra crop to be planted per 
year which increased the area of soybean cultivation by 100s of thousands of acres.
2. HT crops in developing countries where weeds are not well controlled through mechanical cultivation, 
herbicides, or hand weeding could see substantial yield gains from HT technology but this has only 
been documented in South Africa so far (Gouse et al. 2010) and Romania (Brookes & Barfoot 2009). 
In countries with few available jobs and low wages HT technology could reduce employment of poor 
labourers or family labour for weeding and increase use of herbicides.
3. IR crops in countries where the insect pests are well controlled have primarily allowed farmers to 
reduce their use of chemical pesticides, but they have also led to limited increases in yield per ha in 
some crops.
4. Adoption of IR crops in countries and regions where insect pests were not well controlled primarily 
increases farmers’ yields but in some cases reduces pesticide use as well.
This same literature shows that the welfare of farmers who adopted these technologies increased 
because the reduction in cost of production led to increased profits, saved on their time so that they 
could earn more money in other jobs, and in some cases improved their health through reducing 
exposure to dangerous pesticides. The total of the increased profits can be summarized as producer 
surplus due to GM plants which has been documented extensively. A few studies have quantified the 
value of time saved (Fernandez-Cornejo et al. 2005) and health of farmers due to reduced pesticide use 
(Hossein et al 2004).
66
A
nn
ex
 3
: P
ap
er
s
Globally most of the benefits have gone to commercial farmers but because the technology is scale 
neutral, small farmers have been able to benefit as much or more per ha than large farmers and millions of 
small farmers have benefitted from the technology. IR cotton production has benefitted 6.5 million small 
cotton farmers in China, 6.3 million small farmers in India, 600,000 in Pakistan, 400,000 in Myanmar, and 
100,000 in Burkina Faso. IR yellow maize benefits 250,000 small farmers in the Philippines and IR and HT 
white maize benefit 1,000s of small farmers in South Africa (ISAAA 2011).
Consumers’ welfare increased because farmers responded to these profit opportunities by 
producing more grain, oilseeds, and cotton which lowered prices. Consumers’ welfare increased 
because they could buy more at lower prices. Some of these “consumers” of agricultural crops are 
agricultural processing industries. For them the lower priced agricultural products reduce their costs 
of production, increasing their profits. Part of this will go into increased profits of the processing 
industries, part will be passed on to the final consumers through lower prices of cooking oil, meat, 
processed food and cotton cloth.
The other increase in societies’ welfare is the increase in profits of the biotech companies through 
technology fees from the sale of genetically modified plants (Moschini and Lapan 2007). The seed 
companies that licensed biotech also got higher profits which could also be considered innovators’ rents 
(Pray and Nagarajan 2010).
Distribution of benefits and losses to different sectors of the economy
Due to strong IPRs and other government policies, biotech firms capture a substantial part of the 
economic surplus from GM plants in wealthy countries. Qaim (2009) summarizes the findings of studies 
in the US.
•	 IR	cotton	-	Farmers	37%,	Consumers	18%,	Biotech	industry	45%
•	 IR	maize	-	Farmers	50%,	Consumer	19%,	Biotech	industry	31%	
•	 HT	soybeans	-	Farmers	20%	Consumers	20%,	Biotech	industry	60%
In developing countries because of government policies such as weak intellectual property rights 
farmers captured most of the benefits rather than the industry. A recent article on the division of benefits 
between the biotech industry and farmers for all major crops based on available micro-level studies 
(Brookes and Barfoot 2009) showed that in developing countries in 2007 industry captured 14% of the 
benefits through technology fees while in developed countries industry captured 33%.
In the initial stages of the use of GM plants the benefits to farmers were concentrated in the US and 
Canada but now these benefits have spread to developing countries in Latin America, Asia and a few 
countries in Africa. The division of benefits between developed and developing countries has shifted. The 
value of farmers’ increased income from GM crops in 2007 in developing countries was $5.8 billion while 
the value of farmers’ income from GM crops in developed countries was $4.6 billion (Brookes & Barfoot 
2010). Farmers’ benefits from insect resistant maize were still primarily in the US, but most of the benefits 
from HT soybeans are obtained by farmers in Argentina and Brazil and the benefits from IR cotton went 
mainly to farmers in China and India. 
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psConsumer benefits are more widely spread than farmer benefits because many countries that do not 
allow production of GM plants do allow consumption of them. Europe, China, and India do not allow 
production of GM soybeans. In 2009 Europe imported primarily for animal feed 23 million tons of soymeal 
and 12.6 million tons of soybeans from South America and the US which is mostly produced by GM 
soybeans. China imports 45 million tons of GM soybean for cooking oil and animal feed and 2.4 million 
tons of oil but does not grow soybeans (FAOSTAT), and India imports 1.1 million tons of soybean oil. In 
Africa Kenya and other countries import white GM maize for direct human consumption from South Africa 
but does not allow production of GM maize. In addition consumers of maize, soybean, canola, and cotton 
in all countries benefitted through lower prices of these crops as is shown in Sexton and Zilberman (2011).
As with any new technology certain companies will have their profits reduced due to the introduction 
of new technology. Many pesticide producers and distributors will lose profits as their sales of insecticides 
are replaced by IR crops and older herbicides will be replaced by glyphosate and glufosinate. Seed 
companies that do not or cannot license GM traits may lose market share to GM varieties.
Farmers who cannot adopt GM technology but face lower prices for their cotton, maize or oilseeds 
because of the productivity increases in other parts of their country or in other countries can also lose 
profits. For example, the Western China cotton region does not have a bollworm problem and so it does 
not get the cost reductions from IR cotton, but it does receive lower prices because of increased production 
in Central and Northern China. Others who could lose are non-GM producers or organic producers who 
lose markets because of mixing or cross-pollination.
Impacts on Science 
Will the shift of the benefits of GM technology to farmers in developing countries lead to more 
research	on	crops	other	than	maize,	cotton,	soybeans,	and	rapeseed?	Will	GM	technology	be	targeted	to	
problems	of	the	tropical	agriculture?	
Brookes and Barfoot (2009) estimate that the biotech industry earned about $1 billion in royalties 
in developing countries and $ 2.2 billion in developed countries in 2007. The numbers in both regions 
have increased since then but grew faster in developing countries in recent years. Fuglie (2009) found that 
global private research by the seed industry, driven in part by the actual and potential profits from sales 
of GM traits, almost doubled in real dollars from 1995 to 2007, while research on pesticides declined by 
about 20%.
The rapid growth of sales of GM products and the technology fees in developing countries has also 
pulled biotech research into the countries where farmers are using GM seeds. The technology fees give 
biotech companies money to invest in local research and the rapid growth in the market for GM holds 
promise of greater profits in the future. In the last ten years Monsanto has invested in major biotech research 
facilities in Brazil, India, and China. DuPont has invested in basic biotechnology labs in China and India. 
In addition there have been major investments in the biotechnology research by multinationals based in 
the developing world such as Advanta (India) and Pannar (South Africa), by national firms particularly in 
India, and governments of China, Brazil and India.
These programs are developing technology for the needs of the developing world – GM white maize in 
South Africa and hundreds of hybrids of Bt cotton to suit local agricultural conditions in India have already 
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been developed by the private sector. DuPont, Bayer Agrosciences and other major biotech companies have 
major rice research programs for Asia which were virtually non-existent 20 years ago. These investments 
suggest that more GM technology for small farmers in Asia will be available in the near future. 
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The early literature on the adoption of biotechnology mainly in the United States found that the high 
yield effects of genetically modified (GM) varieties were modest. Most of their benefits were in terms of 
reduced pesticide costs, reduced exposure to risk, and reduced effort. However, studies that assessed the 
impacts of biofuel in developing countries, in particular, for Bt cotton, show very high yield effects. This 
difference in impact can be explained by the damage-control framework of Lichtenberg and Zilberman. The 
early GM traits were aimed at reducing pest damage. They include the insertion of bacillus thuringiensis 
(Bt) to control insects and to build up resistance to herbicides to reduce weed damage. When GM varieties 
addressed pest problems that were treated before by pesticides, the yield effect was low. But, when they 
treated pests that had not been controlled before, the yield effects were significant. Indeed, a significant body 
of literature confirmed these findings of reduced pesticide use in some countries and increased yield in other 
countries. In addition to the yield effect associated with reduced damage, the adoption of GM increased 
yield because it made the application of complementary inputs, such as fertilizer, more profitable.
Much of the literature contains studies that assess the impacts of GM at specific locations. However, 
Sexton and Zilberman present results that use 20 years of data for more than 100 nations of major field 
crops and assess the yield effect of GM varieties on a per-acre basis for each of the crops. They find that 
crops that adopt GM, such as cotton and corn, have much higher increases in yield than wheat and 
rice for example. Furthermore, among the crops that have adopted GM, the higher yield effects occur 
in developing countries. For example, they estimate that, in developing countries, the yield effect of 
cotton, both through damage reduction and complementary inputs, is greater than 100 percent while, in 
developed countries, it is only 22 percent. In maize, the yield effect per acre in developing countries is 
50 percent and in developed countries, 15 percent. In the case of rapeseed, the yield effect in developed 
countries is about 25 percent. These impacts vary across countries and, in some cases, the adoption of 
GM varieties actually reduced average yield because it enabled the expansion of agricultural land.
Soybeans present an interesting case. While the yield effect in developing countries may reach 30 
percent, the main benefit of GM varieties is increased acreage. Soybean acreage has tripled over the last 30 
years, and GM is responsible for much of it. In particular, Roundup Ready soybeans controlled weeds that 
allowed the double cropping of soybeans with wheat in Argentina and Brazil. The increased soybean output 
in Argentina allowed the growing demand for soybeans in China to be met. Analysis translating some of the 
yield effects to agricultural supply suggests that the introduction of GM varieties reduced the price of corn by 
13 percent to 30 percent and the price of soybeans by 20 percent to 40 percent, depending on the elasticity. 
It also affected the price of wheat because it enabled the growing of other crops on less land. The increase 
in the productivity of cotton also contributed to the increased supply of other crops by developing land from 
cotton and other field crops, such as corn. Actually, the price-deflating effect of GM varieties was of the same 
order of magnitude but in the opposite direction of the price-inflating effect of biofuels.
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If GM traits were adopted in Africa and Europe, then the increase in output of corn would have 
been of the same order of magnitude as the amount of corn diverted to biofuels. The increase in output 
in vegetable oil would have been much larger than the amount of vegetable oil used for biodiesel. If GM 
traits would have been introduced to wheat and rice, globally, they could have reduced substantially 
much of the food-price inflation problems that we face today.
Finally, the adoption of GM tends to reduce greenhouse-gas emissions because of the increased 
productivity that reduced acreage as well as the adoption of low-tillage that reduced emissions. There are 
field experiments that suggest that the productivity effect of GM on special crops is of the same order of 
magnitude as in field crops. The ban on GM in Europe slowed the development of new trade that could 
have both improved the agricultural yield further and increased productivity by improving the quality and 
the digestibility of food and feed.
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The worldwide relevance of genetically modified (GM) plants is growing year by year in agricultural 
production. In 2010 around 150 million hectares were grown with GM commodities in 2009 countries 
(ISAAA, 2011) with GM soybean, maize, cotton and rapeseed amounting for more than 85 % of the global 
GM production area. Despite this situation, the EU and in particular the food industry in Germany has 
developed an almost strict no-GM policy with respect to GM ingredients in foods which have to be labelled 
according to the existing EU regulations. Furthermore, actors operating in a specific value chain are required 
to install an appropriate documentation and traceability system. If food companies intend to introduce food 
products on the EU markets which contain GM ingredients, they have to cope within these regulations.
In this contribution the results of cost analysis done within the Co-extra project are considered in 
order to estimate possible economic impacts of co-existence along food supply chains in EU countries. 
For this purpose a specific modelling approach was used which allows single crop chain consideration 
as well as supply chain comparison of different food products and/or different countries. Taking the 
results of the analysis, it is possible to extrapolate the analysed cost into complete fields of industry (e. 
g. wheat starch industry for food production) or consider processed foods with several affected food 
ingredients (e. g. frozen food industry).
The cost calculations for co-existence in food supply chains measures at each level of the value chain 
follow the principle to aggregate all incurred costs for cultivating and transportation of crops or processing 
of the raw material crops on the different levels and to increase the price of the final product at each level. 
This means that e. g. the commodity price of wheat flour is increased by the costs of co-existence measures 
on the farm level in order to comply with the threshold of 0.9 % for adventitious presence of GM material. 
The resulting price for secured non-GM wheat is automatically the non-GM commodity price in the next 
level of the value chain. This scenario is currently a purely hypothetical one as EU consumers don’t accept 
GM products and the European markets are not disposed for GM food. The aim of this study was to detect 
critical points of the food processing companies and define additional costs that appear when certain GM 
food commodities are unavoidable and the pressure of competition is so high that the food processor has 
to turn to parallel production of labelled GM and non-GM products.
Especially on processing levels of the value chains (elevator, crusher, processor), the composition of 
occurring cost types is strongly oriented on the considered processing strategy (see figure 1). Depending 
on several preconditions (e. g. capacities, size, and location) and parameters (e. g. regulatory framework, 
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co-existence situation, and company’s overall concept) each involved actor has to choose its own strategy, 
whereby economic considerations are surely the crucial factor.
Figure 1. Display of the analysed wheat starch supply chain (left) and possible options to manage co-
existence at processing level (right)
Each of the three possible strategies (figure 1) implies different benefits, critical and weak points and 
extra costs like higher admixture risks and higher efforts in personnel training and monitoring in spatially 
or temporally separated production lines at one company. The total segregation in separated production 
on two sites may cause higher transport distances but lower risk of commingling GM and non-GM 
commodities and processed food products.
On the basis of the case studies conducted, we can conclude that every actor and supply chain level 
will be economically affected by an emerging co-existence situation. As the additional commodity costs 
is the most relevant cost category at the elevator and processor level, the farm level borne co-existence 
costs are of particular importance. In this respect, the most determining factors are the isolation measures 
to ensure the 0.9 % threshold of GM admixture, the threshold determined for “GM-free” seeds, the farm 
structure and the regional penetration level of GM commodities etc., which all finally influence the price 
premium between GM and non-GM commodities at farm level.
According to the results of the analysed food supply chains, significant additional costs are expected 
by organizing co-existence between GM and non-GM products in the value chain from production of farm 
crops up to the processing level of the single supply chains and by maintaining mandatory (or voluntary) 
thresholds and regulations. Depending on factors like crop requirements, farming, storage and elevating 
systems, processing strategies, monitoring managements, etc., the total additional costs of co-existence 
and product segregation systems can rise up to 12.5 % of production turnover for non-GM rapeseed oil in 
Germany (figure 2). In case of non-GM sugar the price loading amounts to 2 % to 5 % and in case of non-
GM wheat starch to 8 % to 13 %. Respecting supply chains in different countries, different cost structures 
can be noticed because of special legal frameworks and company infrastructure. Therefore, variable higher 
prices for non-GM rapeseed oil are determined in Denmark (8.3 % of turnover), Switzerland (5.3 %) or 
Poland (3.6 %).
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turnover
Source:	own	calculations
Interpreting the results of this study, the present food industry’s uncertainty with and lack of 
knowledge in operating GM products has to be considered as in most food industry sectors the question 
of co-existence is strongly disclaimed at the moment. Of course, an implementation and permanent 
running of co-existence and segregation systems in the food supply chains can decrease the additional 
costs due to savings e.g. in the testing requirements of ingredients or routine procedures during the 
documentation process. Otherwise, systems for segregation and maintaining the GMO threshold of 
0.9 % hardly bear any significant additional benefits for producer, retailer or consumer as this would be 
the case in organic, health-related (e. g. anti-allergen) or fair traded production lines. It should not be 
expected that European consumers are not willing to pay extra money for product differentiation in the 
sense of a labeled food product that contains GM materials below the threshold of 0.9 % (Jones et al., 
2009). Thus, food processing companies might not be willing to pay the incurred costs of co-existence 
measures occurring along the line of the supply chains of certain product ingredients. The case studies 
also expose that the qualification of food processors in terms of infrastructure and resources endowment 
to operate both, GM and non-GM commodities in parallel is hardly assured. Especially for companies 
with restricted facilities (SMEs) the conversion to parallel production will be difficult to manage. Only 
few European companies which command already sufficient existing facilities to manage parallel GM 
and non-GM food production might have the opportunity for specialization and supply the market with 
GM and non-GM food products if the demand situation changes. Conversely, it can be expected for the 
coming years that additional branches of the food industry in the EU will be faced with the challenge of 
an increasing risk of GMO-admixture mainly due to the globally growing cultivation area of GM crops. 
This will lead to additional and increasing costs to further realise the “prevention-strategy” which is 
currently adopted by most companies of the food industry in the EU even if very few (or no) GM plants 
are cultivated in the EU.
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Coexistence of conventional, organic and GM crops can be regarded as (1) an economic issue of (2) 
preserving the choices for consumers and farmers among different methods of production by (3) controlling 
agro-ecological dynamics through measures of segregation (4) embedded in a broader regulatory 
framework of (4a) labeling and (4b) approval for GM crops. The economic problem of coexistence, 
therefore, always consists of at least three framing factors: first, consumer and farmer preferences for 
different production methods; second, the agro-ecological dynamics depending on the biology of the 
crops concerned and the agro-ecological environment in which they are released; and, third, the broader 
institutional framework. It should be noted that all these key factors vary internationally, nationally and 
even regionally. Different preferences on the demand and supply sides are fundamental and are suspected 
to affect the institutional environment for GM labeling and approval (e.g. Gruère et al., 2008; Crespi 
and Marette, 2003; Kalaitzandonakes and Bijman, 2003; Bernauer and Meins, 2003)1. Agro-ecological 
dynamics are crop- and location-specific and are extensively addressed in the agronomic literature (e.g. 
Heuberger et al., 2010; Jarosz et al., 2005; Ma et al., 2004).
Agro-biological dynamics – in particular, cross-pollination and other forms of admixture – do not 
by themselves generate any economic problems. The latter emerge purely from the social construction 
of what is considered as GM, conventional or organic and whether they need to be approved or labeled 
in order to be marketed legally (Bender and Westgren, 2001; Beckmann and Wesseler, 2007). In other 
words, the issue is related to the legal definition of goods and the segmentation of markets by labels and 
approval procedures.
Over the past two decades, two distinct approval and labeling regimes have emerged which largely 
distinguish the US and Canada from Europe. At the European level responsibility for risk assessment and 
risk management is divided. Risk assessment based on scientific evidence is prepared by the European 
Food Safety Authority (EFSA), whereas the approval decision is complex and political, involving the 
Commission of the European Commission (EC), the European Council and the European Parliament 
(Wesseler and Kalaitzandonakes, 2011). Differences also exist regarding labeling regimes (Gruère et al., 
1 To be sure, there are many actors who may influence labelling and approval procedures and consumer and farmer preferences, 
e.g. food manufacturers, retailers, NGOs or the biotechnology industry. For the political economy of GM policies, see e.g. Graff et 
al. (2009).
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2008): whereas the U.S. and Canada do not require any GM labeling and allow for voluntary labeling of 
non-GM food and feed, the EU introduced strict, mandatory labeling and traceability of GM food and feed 
(Regulation [EC] No 1830/2003). Whereas under the mandatory labeling and traceability system the GM 
sector has to bear the costs of labeling, documentation and tracing, it is otherwise for the non-GM sector 
(Phillips and Isaac, 1998).
In Europe, a system of labeling has been developed for defining goods on the basis of product 
standards. If a food or feed product contains or consists of a GM organism (GMO) or is produced from or 
contains ingredients produced from GMOs it needs to be labeled. If a product contains less than 0.9% of 
a single GM event due to adventitious or technically unavoidable presence, it does not have to be labeled 
as GM2. This standard applies currently for conventional as well as for organic food and feed, although the 
organic food sector requires even higher standards.
The institutional differences between North America and Europe are important for understanding and 
analyzing the regulation of coexistence. Policies governing coexistence can be differentiated into ex-ante 
regulations and ex-post liability rules. This differentiation is useful, as the economic implications of the 
two also differ (e.g. Kolstad et al., 1990; Posner, 2007; Shavell, 1987).
EU Member States are progressively regulating coexistence at the national level (CEC, 2009). While 
contemporary law and the incentives for GM-farmers to invest in fencing would already solve many 
coexistence problems, the European Commission (CEC) (2003, 2009) has published guidelines for 
coexistence regulations to enable farmers “… to make a practical choice between conventional, organic 
and GM crop production, in compliance with the legal obligations for labelling and/or purity standards.” 
The guidelines include a number of measures member states may choose to achieve coexistence. In 
general, measures include ex-ante regulations and ex-post liability rules and member states have adopted 
them at different levels. Beckmann et al. (2012) provide a list of those regulations and rules and discuss 
them in detail.
The coexistence measures should enable non-GM farmers to deliver their harvest with a possible 
presence of GM material lower than the pre-mentioned labelling threshold (Messean et al, 2006). 
Ex-ante regulations constitute practices that a farmer has to follow if s/he desires to plant GM crops. 
These regulations increase the current regulatory costs, while reducing ex-post liability costs. Following 
Beckmann et al. (2006), ex-ante regulations in the EU can be distinguished with regard to prohibition of 
cultivating GM crops in specific areas, approval procedures, registration, and information duties requested 
from GM farmers, as well as technical segregation measures. This also includes the transaction costs of 
informing the neighbours and/or reaching an agreement with them3. Ex-post liability costs include possible 
damages, due to admixture with GM crops, that GM farmers have to compensate; these depend on existing 
national laws, which are quite diverse within the EU (Koch, 2008). The ex-post liability rules also result 
indirectly in ex-ante precautionary measures, due to the inducing of adaptive behavior by GM farmers, 
such as the planting of windbreaks and negotiations with neighbors about possible damage settlements 
(Beckmann, et al., 2010).
2 The details of the EU regulations on labelling are provided by CEC (2003).
3 In this case the good being exchanged is the right to plant Bt maize and the transaction costs fall under category 1: the costs of 
discovering the right price, and category 2: the costs of negotiating the terms of an exchange, of the transaction costs mentioned 
by Coase as discussed in Fox (2007).
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requirements as reviewed by Demont et al. (2009) in the form of isolation distances and pollen barriers. An 
important factor of distance requirements is the impact on adoption of the technology. First of all, distance 
requirements tend to reduce the adoption rate. A simulation model by Demont et al. (2008) demonstrates 
the effect. Even one non-GM farmer within a given landscape can substantially limit adoption of GM 
crops by other farmers as the study by Groeneveld et al. (2012) shows. Secondly, mandatory distance 
requirements increase the minimum farm size for adoption and hence discriminate against smaller farms 
(Soregaroli and Wesseler, 2005), while via collaboration (Beckmann et al., 2010) and technical measures 
(Ceddia et al., 2009) this effect can be reduced. Consmüller et al. (2009) in a study analysing the adoption 
of Bt maize in Germany find the maize area grown per farm is the single most important factor explaining 
regional and temporal variance in Bt-maize adoption. While distance requirements add extra costs and 
discriminate against smaller farms, Beckmann and Wesseler (2007) and Beckmann and Schleyer (2007) 
argue the regulatory environment will provide incentives for farmers to cooperate to reduce coexistence 
compliance costs. Similarly, Furtan et al. (2007) argue the regulation of GM crops in Canada provides 
incentives for organic farmers to collaborate. If the legal environment allows farmers to cooperate and 
reduce coexistence compliance costs the effect of coexistence regulations on adoption and in particular 
minimum distance requirements and their effect on farm size might be less pronounced. A case study of 
Bt maize farmers from Portugal confirms the possibility to reduce coexistence compliance costs to almost 
zero via cooperation among farmers (Skevas and Wesseler, 2010).
While in general GM and non-GM farmers have been able to coexist without any major problem in 
those countries where GM crops have been approved for commercial cultivation (Czech Republic, Poland, 
Portugal, Romania, Slovakia, Spain), experiences at the EU level show coexistence problems emerge in 
seed and honey production. The problems in seed production in many cases can be addressed via proper 
handling and testing, the European Court of Justice’s decision on honey has the potential to block GM 
crop cultivation within the EU.
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Introduction
Regarding the cultivation of genetically modified (GM) crops, the European Commission recognises 
that ‘European farmers should have a sustainable possibility to choose between conventional, organic 
and GMO production’, underlining that economic damages or losses derived from the introduction 
of genetically modified organisms have to be avoided (European Council, 2006). Specific segregation 
measures during cultivation, harvest, transportation, storage and processing are required to ensure 
coexistence. These segregation measures should be targeted to ensure that non-GM harvests do not 
contain adventitious GM presence beyond the permitted 0.9% established by the EU. Currently, most of 
the European Member States have adopted or are in the process of developing legislation on measures that 
ensure coexistence between GM and non-GM crops. By February 2009, 15 EU countries had adopted 
specific legislation on coexistence (Austria, Belgium, the Czech Republic, Denmark, France, Germany, 
Hungary, Latvia, Lithuania, Luxemburg, the Netherlands, Portugal, Romania, Slovakia and Sweden) 
(European Commission, 2009). Since only Bt maize is approved for cultivation, most of the Member States’ 
current legislation includes specific measures which relate only to GM maize cultivation.
The main objective of this article is to provide an insight into the factors affecting the ex	 ante 
likelihood of adoption of some GM crops, including economic, environmental, technical factors and the 
regulations to ensure coexistence highlighted above. The analysis focuses on two particular GM crops, 
GMHT OSR and GMHT maize, both not yet approved for cultivation within the EU but widely adopted by 
farmers elsewhere. Previous research identified that the producer’s adoption depends on the current and 
perceived future profitability, the convenience of the new technology (i.e. ease of use relative to the current 
technology used), environmental concerns and uncertainty of outcomes (Hillyer, 1999; Breustedt et al., 
2008). Coexistence policy is specific to the EU and may shape GMHT adoption in the EU. Few studies 
have focused on the effect of spatial coexistence measures on GM adoption using simulation techniques 
(Demont et al., 2008 and 2009). However there is a lack of studies on the effect of a wider number of 
policy regulations (registration, segregation measures and insurance covering) on adoption currently under 
debate in the EU. This article aims to help overcome this shortage, through the evaluation of the effect of 
regulations associated with coexistence between current and new technologies, on the adoption of new 
technologies. The incorporation of such measures or regulations in the analysis is crucial for examining 
1 Economic and Social Sciences Division, University of Reading, U.K.
2 Department of Economics. Pablo de Olavide University, Spain
3 Currently at EuropaBio, Brussels.
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the potential level of adoption of GM technology if measures to ensure coexistence between the current 
and the new technology are to be implemented.
The surveys
In order to estimate farmer’s willingness to adopt GMHT OSR and GMHT maize, a survey 
questionnaire was designed including questions on farm characteristics, and a wide list of reasons which 
may encourage/dissuade farmers from adopting GM crops including economic, environmental, technical, 
administrative aspects, and socio-demographic farmers’ characteristics.
A total of 426 farmers were interviewed face-to-face in the Czech Republic, Germany and the United 
Kingdom on their willingness to adopt GMHT OSR during March and July 2007. During the same period 
280 farmers were interviewed in France, Hungary and Spain on their willingness to adopt GMHT maize. 
Therefore, the total number of interviews is greater than the minimum sample size to ensure that all 
countries are adequately represented at EU level for each crop.
Conceptual framework
This paper studies the acceptability and potential adoption of two new crops, GMHT OSR and GMHT 
maize. The willingness to adopt these crops (WTAd) depends on the utility farmers derive from growing GM 
alternatives. In this paper, as it was mentioned above, WTAd and farmers’ utility may be influenced by a 
number of factors related to economic benefits, efficiency and facilitation of weed control or conservation 
tillage. WTAd models were set up in an ordered probit regression framework in which the dependent variable 
is given as a likelihood of farmers adopting GMHT OSR or GMHT maize, on a 5-point scale.
In order to identify those factors that may influence GMHT crops’ adoption, farmers were asked to 
evaluate a number of reasons according to how important they considered them. Within these factors we 
distinguished economic aims, reasons of disbelief, the implementation of coexistence measures and other 
socio-demographic issues.
Estimation results
Table 1 shows the results from the ordered probit model estimated for both GMHT OSR and GMHT 
maize. A likelihood ratio test was carried out to assess the goodness-of-fit of the models. These tests 
indicate that the models had satisfactory explanatory power. 
Most of the estimated coefficients were statistically significant for GMHT OSR. The sign of a parameter 
estimate indicates how the associated explanatory variable is related to the willingness to adopt. Thus, the 
positive signs for the PROS variable in both models support the hypothesis that a farmer’s willingness to 
adopt GMHT OSR and GMHT maize increases as farmers’ own positive aspects such as economic, ease of 
use and environmental benefits become relevant in their decision-making. 
Farmer’s willingness to adopt GMHT OSR/GMHT maize decreases with the degree of importance 
assigned by farmers to negative views towards adoption (CONS), which include both own motivations and 
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GMHT OSR GMHT maize
Explanatory variable Coefficient sign(1)(2) Coefficient sign(1)
Constant + *** + ***
PROS + *** + **
SNORM - -
CONS - ** - ***
COEX - ** - *
SEPARATION - - *
AGE - +
EDUCATION + -
SIZE + +
INCOME +
GE + *
CZ - ***
FR -
SP +
(1)+	means	a	positive	sign	of	the	coefficient	whereas	–	shows	a	negative	sign	of	the	coefficient 
(2)*	statistically	significant	at	the	0.10	level	of	significance,	**at	0.05-level,	***at	0.01-level
farmer’s perception of social pressures on him to not use the new technology. Also, coefficients associated 
with coexistence variables (COEX) show a negative sign in both models. This suggests that farmers for 
whom coexistence measures are crucial in their decision are less likely to adopt GMHT OSR/GMHT maize 
than those for whom such measures are irrelevant. The factor accounting for the individual perception of 
social pressures to adopt GMHT crops (SNORM) is found to be irrelevant in determining the probability of 
adopting GMHT crops.
Coexistence measures were found to hamper the probability to adopt GMHT crops. If separation 
distances of 25m between conventional and GM crops were put in place maize farmers’ would be less 
likely to adopt GMHT maize.
Farm size was not found to be determinant in a farmer’s willingness to adopt GMHT OSR/GMHT 
maize. This result may seem surprising since the impact of farm size on adoption is highest at early 
stages of the diffusion of an innovation, becoming less important as diffusion increases (Fernandez-
Cornejo et al., 2001). However, this result is due to the significant correlation between farm size and 
other variables included in the analysis such as countries (p-value<0.01), which dilutes the effect of 
farm size in explaining adoption. Indeed, the correlation between GMHT OSR/maize adoption and 
farm size is positively significant (p-value<0.05). Among the socio-economic characteristics included, 
age, education and income none was found to be determinant in a farmer’s willingness to adopt 
GMHT OSR/GMHT maize. This does not necessarily mean that socio-economic factors such as age, 
level of education or income have no role in explaining GMHT adoption. They may be influencing 
indirectly the probability of adopting GMHT through other determinants such as PROS and CONS, 
hence the effect dissipates.
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Considering a farm’s location, farmers in Germany were more likely to adopt GMHT OSR than farmers 
in the UK (benchmark country for OSR), being Czech farmers less likely to adopt that farmers in the UK. 
In the case of maize farmers, no difference between countries with regard to likelihood of adopting was 
found.
Conclusions
To conclude we emphasize that the EU coexistence policy is an interesting case worldwide to ensure 
the farmer’s freedom of choice between cultivating GM and non GM crops. This is ensured through the 
implementation of coexistence measures to prevent admixture. By distinguishing between GM and non-GM 
products the EU policy generates a situation in which externalities associated with GM crop production 
(admixture) may occur. This market failure, derived from the way in which the EU interprets the introduction 
of a new technology, gives the public sector a reason to implement coexistence measures to prevent 
admixture (internalize the externality). According to this view the innovators (GMHT growers) are the 
externality producers and the ones who should bear the costs associated with coexistence measures. This 
effectively means that their average costs are increased rendering GM technology relatively less competitive 
than non-GM technologies and GM producers from outside the EU, and obstructing GM adoption.
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Table 1 Top 10 Importers of Soybean Commodities by Tonnage (Avg. 2007/08 – 2011/12)
Soybean Meal Soybeans
1000t % of World 1000t % of World
EU-27 22,057 40% China 49,636 59%
Indonesia 2,689 5% EU-27 12,897 15%
Vietnam 2,464 5% Mexico 3,492 4%
Thailand 2,310 4% Japan 3,286 4%
Japan 2,025 4% Thailand 1,812 2%
Republic of 
Korea
1,740 3% Indonesia 1,571 2%
Philippines 1,729 3% Egypt 1,514 2%
Iran 1,447 3% Turkey 1,303 2%
Mexico 1,436 3%
Republic of 
Korea
1,180 1%
Canada 1,199 2% Iran 987 1%
Source:	Based	on	USDA	PS&D	database
The Global Agricultural Supply Chain: Feasibility, Costs and Opportunities 
for Coexistence
NICHOLAS KALAITZANDONAKES
Economics and Management of Agrobiotechnology Center 
University of Missouri, USA
Kalaitzandonakesn@missouri.edu
Copyright:	©	Nicholas	Kalaitzandonakes,	2011
Since their initial commercialization in the mid-1990s, the introduction and adoption of biotech 
varieties has continued unabated in some key commodities including maize, soybeans, cotton, and 
rapeseed. In 2010, 29 countries grew biotech crops on 148 million hectares (James 2010). The broad 
adoption has been driven by farm-level yield and efficiency gains which have translated into billions of 
dollars of economic benefits every year (e.g. Brooks et al., 2010; Carpenter 2010; Qaim, 2009).
Maize, soybeans, cotton and rapeseed commodities are broadly traded in international markets 
and the bulk of imports and exports of such commodities are generally concentrated among a few key 
countries. For instance, the world share of the top five soybean importers exceeds 80% and the world 
share of the top five soy meal importers is almost 60% (Table 1). The EU the largest importer of soybean 
meal and the second largest importer of soybeans.
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The bulk of these soybean products, but also other biotech commodities, come from a few major 
exporters. For instance, Argentina, the US and Brazil capture 88% of soybean and 85% of soy meal global 
exports (Table 2) and similar high concentrations are observed in the global exports of maize, rapeseed 
and cotton.
Major exporting countries have led the adoption of biotech crops. For instance, except Brazil, 
the levels of biotech maize and soybean adoption ranged 70-99% in all major exporting countries in 
2009 (Table 3). Even in Brazil, biotech soybean and maize adoption has been rising rapidly and looks 
to reach levels similar to those of other major exporters in the next few years. Adoption of biotech 
varieties among top rapeseed and cotton exporters is similarly high. Given these adoption patterns, 
biotech crops represent a substantial share of the maize, soybeans, cotton and rapeseed commodities 
traded in international markets.
Table 2. Top 10 Soybean and Meal Exporters, Avg. 2007/08 -2011/2012. (1000MT)
Soybean Meal Soybeans
1000t % of World 1000t % of World
Argentina 26,647 47% USA 37,079 42%
Brazil 13,314 23% Brazil 30,076 34%
USA 8,445 15% Argentina 10,563 12%
India 4,215 7% Paraguay 4,851 6%
Paraguay 1,201 2% Canada 2,309 3%
Bolivia 1,029 2% Uruguay 1,387 2%
China 826 1% Ukraine 616 1%
EU-27 475 1% China 287 0%
Norway 159 0% S. Africa 141 0%
Canada 143 0% Bolivia 70 0%
Source:	Based	on	USDA	PS&D	database
Table 3. Maize and Soybean Hectareage and Biotech Adoption among primary exporters in 2009
 Maize Soybeans
Country Harvested Hectares %  biotech Harvested Hectares %  biotech
USA 32,169,000 85% 30,907,000 92%
Brazil 12,925,000 36% 23,500,000 71%
Argentina 2,750,000 83% 18,600,000 99%
Canada 1,142,000 84% 1,380,000 72%
Paraguay 600,000    0%* 2,680,000 90%
Uruguay 96,000 82% 863,000 99%
Bolivia 310,000   0% 960,000 78%
*	biotech	maize	has	not	been	approved	in	Paraguay;	however,	USDA	FAS	estimated	that	90%	of	the	2009	hectareage	was	planted	
with	biotech	hybrids	brought	in	from	neighbouring	countries
Sources:	ISAAA,	USDA
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The pervasive adoption and trade of biotech crops by key exporting countries need not be a problem 
in international trade except in cases where (a) there is demand for non-GMO commodities in some 
importing countries; and (b) when GMO varieties approved for cultivation in one or more of the major 
exporting countries remain unapproved in importing countries (a case of asynchronous approvals)1. In such 
cases, efforts are made to separate non-GMO or unapproved varieties from the commodity stream (where 
all varieties produced are commingled) through segregation and coexistence measures. Segregation and 
coexistence must succeed in keeping segregated varieties and commodities from seed to agricultural 
production and all the way through the supply chain while sharing the same land and infrastructure 
(storage, transport, ports, etc). These require reengineering of the standard commodity production and 
supply chain operations.
Because grains are bulky and relatively expensive to transport and store while their final unit value is 
relatively low, commodity supply chains control operational costs and facilitate trade through aggregation. 
Grain from numerous farms and storage facilities are constantly mixed throughout the supply chain 
resulting in perfectly fungible and divisible product streams. This fungibility facilitates the efficient use of 
discrete storage, transport and processing assets and yields significant economies of scale.
In segregated supply chains a primary objective is to ensure the absence of GMOs or unauthorized 
grains from all final products. This implies that GMOs or unauthorized grain must be avoided at each 
and every part of the supply chain. For this purpose, segregated supply chains use both prevention and 
remediation. Prevention of admixtures requires re-engineering of the agricultural production process (e.g. 
through geographic and temporal isolation of production, minimum allowable distances between fields, 
buffers, border rows and other physical barriers that can reduce the incidence of cross-pollination from 
neighbouring crops etc.); as well as of storage processing and distribution processes (e.g. through use of 
meticulous cleaning or use of dedicated equipment and facilities). In addition to prevention, segregated 
supply chains use remediation when admixtures occur despite preventive measures. Through repeated 
testing they seek to identify accidental admixtures thereby isolating unauthorized grain before entering the 
segregated stream or redirecting commingled lots back to the commodity supply chain.
Changes in supply chain operations to prevent admixtures as well as testing and remediation involve 
additional costs, beyond those incurred for commodities. A number of factors can influence their relative 
size but the most significant driver of segregation costs and the overall chance of success of segregated 
systems, however, is the tolerance level set for unwanted GMO material.
Segregation costs increase as tolerances decrease. The rigor with which segregation procedures 
are designed and implemented depends mostly on the allowable “margin of error” which is defined 
by the tolerance levels for unwanted or unauthorized commodities. Segregated supply chains with low 
tolerances imply strict measures designed to prevent even the presence of traces, additional testing 
and greater amounts of product failures (Kalaitzandonakes and Magnier, 2004). Beyond certain levels, 
as tolerances diminish segregation costs increase exponentially (Kalaitzandonakes and Magnier, 2004, 
2006). For instance, Kalaitzandonakes and Magnier 2006 have estimated the incremental costs associated 
1 In some occasions small amounts of biotech crops that have not been authorized for production or trade have been found in 
the food supply chain and, in some cases, have led to trade disruptions (Carter and Smith 2005; Li et al., 2010; Lin et al. 2003; 
Schmitz et al. 2004, 2005). 
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with reducing tolerances from 1% -0.1% in maize seed production to be, on average, 5% - 68% higher 
than those in seed production following standard practices.
Segregation and Zero Tolerance
Under zero or near zero tolerance, the relevant commodity trade between countries could cease 
(Kalaitzandonakes and Kaufman, 2011; Magnier et al., 2009) as perfect segregation of non-GMOs or 
authorized and unauthorized biotech events cannot be consistently achieved. Under zero tolerance there 
are also higher failure risks and costs. Failure risks correspond to the chance that segregated supplies 
considered free of unwanted GMOs test positive at some part of the supply chain. The closer to the final 
product the failure is discovered, the higher the failure costs are likely to be.
When segregated trade is not feasible or is too costly, the bilateral trade between the two countries may 
be suspended (Kalaitzandonakes et al, 2010). The incremental costs associated with the use of segregated 
systems or with the disruption of trade define, in large part, the economic impacts of low tolerances 
and such impacts can be quite variable depending on underlying supply and demand conditions. For 
instance, Kalaitzandonakes et al., 2010 estimated the relative impacts of potential trade disruptions in 
maize and soybean commodities between the EU and one or more of its trading partners due to zero 
tolerance policies for unapproved biotech events. They found that such tolerance policies could cause 
price increases 5%-24% over commodity maize and more than 210% increases over soybean commodity 
prices. Similarly large effects are reported in related studies (e.g. Philippidis, 2010).
References
Brookes, G., Yu, T.H., Tokgoz, S., & A. Elobeid. (2010). The production and price impact of biotech corn, 
canola, and soybean crops. AgBioForum, 13(1), 25-52.
Carpenter, J. E. (2010). Peer-reviewed surveys indicate positive impact of commercialized GM crops. 
Nature Biotechnology 28(4): 319-321.
Carter C., and A. Smith. (2007) “Estimating the Market Effect of a Food Scare: The Case of Genetically 
Modified Starlink Corn,” Review of Economics & Statistics, 89(3).
Kalaitzandonakes N.G., Magnier A. (2004) Biotech labeling standards and compliance costs in seed 
production. Choices 21(2), 1-9
Kalaitzandonakes, N., Miller, D., & Kaufman, J. (2010). Supply chain changes, effects on trade (Chapter 
5). In P. Nowicki et al., Study on the implications of asynchronous GMO approvals for EU imports of 
animal feed products (Final Report for Contract N° 30-CE-0317175/00-74). Brussels, Belgium: Directorate-
General for Agriculture and Rural Development European Commission.
Li, Y., E. Wailes, A. M. McKenzie and M. R. Thomsen (2010) “LL601 Contamination and Its Impact on U.S. 
Rice Prices” J of Agricultural and Applied Economics, 42(1): 31-38.
89
In
te
rn
at
io
na
l w
or
ks
ho
p 
on
 s
oc
io
-e
co
no
m
ic
 im
pa
ct
s 
of
 g
en
et
ic
al
ly
 m
od
ifi
ed
 c
ro
psLin, W., G. Price, and E. Allen (2003). “StarLink: Impacts on the U.S. corn market and world trade,” 
Agribusiness, 19(4 ): 473-488
Magnier, A., S. Konduru and N. Kalaitzandonakes (2009) Market and Welfare Effects of Trade Disruption 
from Unapproved Biotech Crops. Paper presented at the Agricultural & Applied Economics Association’s 
2009 Annual Meeting, Milwaukee, WI, USA, July 26-28, 2009.
Philippidis, G. (2010). “EU import restrictions on genetically modified feeds: impacts on Spanish, EU and 
global livestock sectors,” Spanish Journal of Agricultural Research, 8 (1), 3-17
Qaim, M., (2009) “The Economics of Genetically Modified Crops Annual Review of Resource Economics 
Vol. 1: 665-694
Schmitz,	T.,	A.	Schmitz,	Andrew,	and	C.	Moss,	(2004)	“Did	StarLink	Reduce	Import	Demand	for	Corn?”	
Journal of Agricultural & Food Industrial Organization, 2(2)
Schmitz, T., A. Schmitz, and C. Moss. (2005). “The Economic Impact of Starlink Corn,” Agribusiness, 21(3)

91
In
te
rn
at
io
na
l w
or
ks
ho
p 
on
 s
oc
io
-e
co
no
m
ic
 im
pa
ct
s 
of
 g
en
et
ic
al
ly
 m
od
ifi
ed
 c
ro
psSocio-economic considerations of GM crops in the context of the 
Cartagena Protocol on Biosafety-CBD
JOSÉ FALCK-ZEPEDA
Research Fellow/ Leader Policy Team Program For Biosafety Systems,
Environment and Production Technology Division, International Food Policy Research Institute (IFPRI), 
Washington DC, USA
j.falck-zepeda@cgiar.org
Copyright: ©	José	Falck-Zepeda,	2011
The novelty and lack of familiarity of new applications from genetic engineering in the 1970s and 
1980s induced the scientific and regulatory communities to design and implement assessment procedures 
examining the environmental safety of these technologies. The biosafety protocols were mostly based on 
those used in agriculture and other economic sectors. The 2000 Cartagena Protocol on Biosafety (CPB), 
a supplement to the Convention of Biological Diversity, incorporated many of these principles especially 
in its Annex 3. The main focus of the CPB on environmental safety and transboundary movements was 
later expanded in practice and through different addendums to the CPB to include food/feed safety and 
cultivation decisions for commercialization.
The CPB became operational amongst the countries that signed the agreement in 2003. The CPB has 
been a major factor in triggering the creation of national and, in some cases, regional regulatory systems 
that occasionally extend beyond the fundamental requirements included in the CPB. The evolution of the 
CPB and national/regional measures has had an impact on public and private sector policies, and R&D 
innovation management, especially on those countries who are Parties to the Protocol. Its main objective 
is “to contribute to ensuring an adequate level of protection in the field of the safe transfer, handling 
and use of living modified organisms resulting from modern biotechnology that may have adverse effects 
on the conservation and sustainable use of biological diversity, taking also into account risks to human 
health, and specifically focusing on transboundary movements” (CPB, Article 1, p.3).
Article 26.1 of the CPB (See Box 1) reaffirmed countries’ sovereign rights to implement protective and 
decision measures, subject to their own international obligations. Article 26.1 reiterated the freedom that 
countries had to put in place (or not) any measure to assess the potential socio-economic impact in their 
jurisdiction. Discussions have begun about the potential inclusion of socio-economic considerations into 
biosafety decision making, especially amongst some countries Party to the CPB. Many developing countries 
are seeking guidance in terms of conceptualizing what socio-economic considerations mean in their own 
context, and to design and implement appropriate measures intended to conduct such assessments.
Biosafety regulatory systems may consider safety and efficacy in their assessment of new technologies. 
A safety assessment, be it for environmental or food/feed safety, involves the prevention of introducing a 
harmful technology to the environment or public health. In turn, efficacy relates to preventing the release 
of technologies that do not work as intended or those which may not be addressing important societal 
needs. Most biosafety regulatory systems consider only the safety of a candidate technology under review, 
although they may consider efficacy if this has an impact on safety. These functions are usually considered 
by policy makers when designing biosafety regulatory systems.
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Biosafety regulatory system design considers the trade-offs and the options related to democratic societies’ 
inherent right to know about science, technology and innovation and the freedom to choose or to operate. 
Freedom of choice includes those of consumers to consume, but should also include those of producers to 
produce. Similarly, the freedom to operate should cover those of public and private sector producing goods 
that may benefit society. Finding a mutual point of convergence between these freedoms and rights involves 
negotiations between different societal stakeholders and actors to choose the best outcome.
Regulatory design needs to consider the possibility that a biosafety assessment can reach the 
correct decision or that it can commit errors either by approving an unsafe technology or rejecting a safe 
technology. The possibility of committing Type I or II errors makes the need for a robust biosafety system 
even greater. Regulatory designers need to bear in mind that costly regulatory processes may also be 
costly to reverse. To avoid the latter issues where possible, biosafety and other types of regulatory systems 
have based their assessments on science. Biosafety assessment procedures are a systematic and logical 
approach for the assessment of biosafety issues including environmental and food/feed considerations 
deemed important by society. In fact, most biosafety regulatory systems globally have their science-based 
approach in common. Most of the variations in biosafety implementation occur depending on the degree 
to which policy or political issues are considered in the final decision. Furthermore, most biosafety systems 
consider a set of graduated steps which attempt to improve knowledge about a candidate technology; they 
use familiarity and accumulated knowledge, and learning through new testing, which permits progression 
to the next step, culminating in their deliberate release to the environment as a commercialized product.
SEC and the Cartagena Protocol on Biosafety and laws and regulations
The inclusion of socio-economic considerations into biotechnology and/or biosafety decision 
making has been driven by Article 26.1 of the Cartagena Protocol on Biosafety and/or national laws and 
regulations. These policy instruments respond to society’s need to know about novel technologies that 
may be deployed for use by farmers. As can be seen in Box 1, Article 26.1 of the Cartagena Protocol on 
Biosafety introduces the possibility that when deciding to permit the importation of LMOs or under the 
purview of national laws or regulations countries may consider socio-economic factors in their decision. 
This article reaffirms existing nations’ sovereign rights, although subject to international agreements. 
Furthermore, the scope and potential impact parameters to be included in such an assessment are limited 
to those arising from the potential impact on indigenous and local communities affected by the use or 
introduction of an LMO. Article 26.1 in a sense establishes a voluntary floor in which the competent 
authority is bounded in their assessment procedures. 
Box 1. Article 26 of the Cartagena Protocol on Biosafety
SOCIO-ECONOMIC CONSIDERATIONS
1. The Parties, in reaching a decision on import under this Protocol or under its domestic measures 
implementing the Protocol, may take into account, consistent with their international obligations, 
socio-economic considerations arising from the impact of living modified organisms on the 
conservation and sustainable use of biological diversity, especially with regard to the value of 
biological diversity to indigenous and local communities.
2. The Parties are encouraged to cooperate on research and information exchange on any socio 
economic impacts of living modified organisms, especially on indigenous and local communities.
Source:	Cartagena	Protocol	on	Biosafety	as	part	of	the	Convention	on	Biodiversity
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psMany countries around the world have chosen to go beyond the issues described in Article 26.1 by 
introducing for example social, ethical, philosophical and aesthetical considerations into their decision 
making. Furthermore, countries have chosen many different alternatives in terms of the scope, triggers, 
implementing agencies, time and stage of implementation, and have decided upon decision making rules.
Socio-economic assessments in a biosafety regulatory process
The assessment of socio-economic considerations (SEC) is the result of society’s need to investigate 
the potential impacts of technology adoption to reduce negative outcomes and in many cases satisfy 
intellectual curiosity. Nevertheless, socio-economic assessments conducted under a biosafety regulatory 
process need to clearly differentiate themselves from purely academic and intellectual exercises. This is 
due to the fact that at the end of a regulatory process the decision maker will reach a binding decision 
authorizing or rejecting the technology under review. They may also withdraw an authorization after a 
post-release review. Furthermore, SEC assessments are subject to time limits and to conventional issues 
and limitations that most regulatory processes are likely to face, including whether the assessment is for 
approval or for post-release monitoring purposes.
An SEC assessment done before the technology is released (an ex ante review) will have different 
implications and issues than that used to assess the technology after release (an ex post assessment). 
From a methodological point of view, an ex	ante	assessment will necessarily be based on projections and 
assumptions. The range of methods will be quite limited in comparison to an ex post assessment due to the 
fact that it the assessment is carried out without observing the technology being put into practice. In the 
latter, research limitations include time to complete research, budgets and the complexity of the questions. 
An SEC assessor is usually an expert who uses scientific procedures, especially in an ex ante 
assessment, but who has also to use creativity in addressing the limitations in the analysis. In essence, the 
SEC assessor has to subjectively address the assumptions about the model, parameters and data limitations 
that may be used in the assessment. In some cases, the SEC assessor may have access to primary data can 
be used to define the current status of technology use and impact, society’s welfare and to define some 
of the potential variations in the production or management process due to the LMO intervention. The 
potential range of assessment possibilities are usually contained in a national biosafety framework which 
delineates the biosafety system structure and process. Design decisions need to be carefully thought 
out as they may have profound effects in terms of science, technology and innovation outcomes and 
performance, as well as, the potential outcomes that may affect the different stakeholders in society.
Practical considerations and options for implementation
Biosafety regulatory designers and decision makers have many issues and options to consider when 
designing the biosafety systems’ structure and implementation procedures. Countries need to decide 
whether the inclusion process will be voluntary or mandatory, and what the scope of the assessment will 
be, ranging from a stricter interpretation of Article 26.1 or one that considers broader aspects. The country 
needs to decide when to require the submission of an SEC assessment study, what issues are to be assessed 
and the questions that will need to be answered. Furthermore, the biosafety regulatory system will need to 
specify who will do the assessment (consultants, developers or specialized units within government) and 
what decision making rules and standards will guide the decision making.
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The inclusion of socio-economic considerations will have to follow – and contribute to- those attributes 
that define a functional biosafety system partially based on Jaffe (2005). Attributes include transparency, 
feasibility, fairness, cost and time efficiency, the assessment hurdle proportional to the technology risk, 
support to the CPB objectives and process predictability. Inclusion of SEC will unequivocally increase the 
cost of compliance with biosafety regulations, and in some cases may also increase the time needed to 
complete the assessments. The cost of compliance may not be as relevant in affecting net benefits to society 
as the regulatory delays. In a ceteris paribus exercise Bayer, Norton and Falck-Zepeda (2010) showed that 
regulatory delays as little as three years can negatively affect returns to investments in these technologies. The 
cost of compliance may be relevant though for the public sector and those developing biotechnologies in 
crops and traits of interest for developing countries. R&D organizations may have difficulty paying for an SEC 
assessment on top of the biosafety and R&D necessary to bring this technology to farmers; furthermore they 
may lack the necessary means to address some of the particularities of an LMO assessment.
The SEC assessment process may also generate more, and in some cases improved knowledge about 
the technology and its impact. Thus, competent authorities are left with the task of examining the trade-
offs between gaining more knowledge that can improve decision making thus helping to avoid costly 
mistakes, and the process’ impacts on producer benefits and to innovation and R&D investments (See 
Wesseler and Ansink 2010).
Concluding comment
The assessment of socio-economic considerations and its inclusion in biosafety regulatory decision 
making systems need careful review. It is prudent for countries to carefully review and explain what the 
rationale is behind such an inclusion, even if they have already made the decision through the approval of 
national measures such as laws and regulations. This review needs to consider the feasibility of proposed 
assessments, recognizing that it may not be feasible to assess every socio-economic consideration 
especially in an ex ante framework. The discussion on the inclusion of socio-economic considerations as 
part of biosafety decision making needs to also consider all the costs, benefits and risks of inclusion and 
non-inclusion as is customarily done in a Regulatory Impact Assessment process. Finally the review and 
discussions need to clearly avoid a process without clear decision making rules and standards and other 
attributes that separate a well-defined process from a “black box” full of uncertainties, one which will 
clearly not be a functional regulatory process.
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By the end of the 1990s, Argentina had implemented an export impact assessment stage, which 
became an integral part of the genetically modified (GM) crops’ approval procedure. For several years, 
the authorization for the commercial release of a genetically modified plant organism was granted by the 
Secretary of Agriculture, Livestock and Fisheries based on three independent expert opinions prepared by 
two consultant agencies and a National Directorate of State of the Secretariat of Agriculture, Livestock, 
Fisheries and Food: an environmental risk evaluation, a food and feed safety assessment and an analysis of 
the potential impacts on Argentina’s international trade. Although these three expert opinions constituted 
stages which must be completed in order for a commercialization permit to be granted to a given GMO, 
in all cases they were simply recommendations and, as such, not binding for the Secretary’s final decision. 
The report on the potential impacts on Argentina’s international trade referred to the international 
market of the product concerned and the regulatory status in the main markets, in order to determine 
the consequences which the commercial release of the GM crop, whose authorization has been applied 
for, might have for the international trade of Argentina. It considered the situation of trade competitors, 
potential markets, the relative importance of the crop in the existing trade with the different countries of 
destination, and the share of these imports in their supply.
As from the late 1990s, the so-called “mirror policy” was put in place and, therefore, the final 
decision on GMO assessment was based on a technical analysis and a political decision. The “mirror 
policy” execution generally followed the EU approval patterns, taken as the main benchmark, in terms 
of minimizing impacts on future exports. In the case of soybean events, the importance of soybeans and 
soybean oil sales also required that close attention be paid to approvals granted in India and China, since 
the European Union is a major buyer, specifically of soybean meal for animal feed.
The commercial opinion, unlike other assessments, usually established a “waiting period”, prior to 
the final approval, since the nature of export market analysis may implicitly define the postponement of 
the approval decision. This is so because, when the cause for the risk in trading a GM material disappeared 
since the latter was approved in the country of destination, the opinion changed automatically from 
unfavourable into favourable. The nature of this opinion is different from the others because this is not 
a toxicity or environmental impact problem. Clearly, if it were no one would allow such “mobility” in 
decision making.
The commercial assessment stage thus became the key to executing the “mirror policy”, and only in 
a couple of situations was the word “disruption” heard in connection with such a policy. These situations 
were cases in which Argentina anticipated the decision made by a buyer country, even though the 
commercial report had somehow foreseen the imminent event approval.
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Doing the follow-up on the procedures within the Argentine regulatory system, it can be concluded 
that, in almost every case, there was a favourable technical opinion as to the approval of certain events 
concerning food safety and environmental risk assessment; the final approval being subject to the 
commercial opinion, which became the third stage of the authorization process, and resulted in two 
significant conclusions. The first one is that, in the Argentine system, the speed of event approval was 
greater than in most of importing markets, since a prior technical opinion was issued first, and then 
there was a wait for the commercial approval. The second one is that agility in the regulatory system, 
counteracted by caution in order not to incur a commercial problem, generally delayed the final decision.
In fact, the time spent at the stage of commercial analysis was “virtual” since the required preliminary 
studies for issuing an opinion did not usually take more than 1 or 2 months. However, no final opinion 
was generally issued until it could be verified that any potential trading restriction had been removed.
Considering approval times in Argentina, it can be estimated that there is a period of approximately 
one or two years between the stages of the food safety or environmental impact assessment, as the case 
may be, and the final regulatory approval. Therefore, such a period would be equivalent to the virtual time 
attributable to the commercial analysis.
At present, there are some additional considerations on the scene. When the regulatory system 
became operative in Argentina, events were simple, the number of submissions was small, and the 
regulatory situation in the world was still in its infancy. Within such a context, the introduction of the 
commercial stage was perceived by some actors as an element delaying event approvals.
Nowadays, with some changes in place, the system evolved to a higher institutional degree, and 
grew in some regulatory aspects; but essentially, events became more complex, and they increased in 
number. All this shapes a scenario where the “commercial” approval instance is absolutely embedded in 
the regulatory process.
In the process of approving a new GM material, subject to considering potential conflicts in trade 
matters, the final stage entails the resolution of opposing interests between growers, seed companies, 
exporters, and the government itself. In some circumstances, exporters’ interests prevail because it is a 
priority for exporters not to alter the essential characteristics of their business, which could undoubtedly 
be complicated by the introduction of an unapproved new material in their destination markets.
For several years, Argentina closely followed the approvals granted by the European Union and, in 
recent years, those given by India and China, as reference models for its own approvals. But recently, 
albeit informally, Argentina has been paying attention to progress made by Brazil, as a competitor country 
in many sectors.
Within the GMO regulatory systems, the regulated matter is the outcome of scientific and 
technological processes that are at the forefront of their field. GMO regulatory systems’ requirements and 
procedures do not always include already proven advances in the field of know-how, and faced with the 
latest developments, it is necessary to make periodic and expeditious reviews of effective regulations, and 
without necessarily involving a complete amendment to such rules. Instead, there should be a specific 
review of cases in point. In that sense, during 2011 an in-depth study employing a participatory process to 
assess and propose an update on legal and regulatory aspects was developed, in order to give a renewed 
momentum to the Argentine regulatory system.
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psBeyond regulations and regulated matter, one may consider another aspect of the Argentine system, 
which was based on its position as a net exporting country, namely the internalization of potential trade 
problems. This generally developed into one of the main causes for approval delays, since it was the 
government itself that subordinated the final approval decision to the disappearance of market risks. 
Without discussing the importance of trade information or the necessary caution vis-à-vis potential 
problems, in the sphere of administrative acts, a clear separation of food safety and environmental risk 
evaluations from market-related analysis was recently introduced.
The analysis of impacts on production and commercialization resulting from the introduction into the 
market of a GM crop evolved introducing not only potential losses but also possible gains.
The next step should be to reinforce monitoring in relation to markets and their future evolution, as 
well as market performance vis-à-vis approvals for new events. This will allow the prediction of scenarios, 
and not only a recommendation for caution when faced with a potential problem; i.e. the ability to 
act strategically in the case of a trade policy involving local technology developments. Another role of 
the observation on trade and regulatory aspects consists of seeking enhanced diversification of export 
destinations, by adding promotion policies that may make them attractive for exporters, through specific 
mechanisms such as tax or financing incentives. 
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Traditionally, and still today (though often forgotten), the loss lies where it falls, and therefore remains 
with the victim unless there are compelling reasons to shift it onto somebody else.
The laws of delict offer such reasons, but not in a uniform way if compared across Europe. After all, 
each country has its own distinct tort law system, some even more than one. While there may not be 
radical differences when it comes to fundamentals of liability, the distinct features of each legal system, 
even if seemingly only a matter of detail at first sight, may still lead to different case outcomes.
Already the notion of damage itself is not so uniformly understood after all. One of the prime 
differences between European jurisdictions concerns what is called “pure economic loss”, which is a 
reduction of the victim’s assets without any primary trigger of a more traditional harm. The lost profits 
of a conventional or organic farmer who can no longer sell her crops as non-GM (assuming for the 
time being that there is at least some financial bonus attached thereto) are not a consequence of some 
harm to her field or plants, at least arguably so. Not all countries are prepared, however, to indemnify 
such a pure economic loss in the absence of very specific further conditions. Another problem in this 
context particularly relevant in the GMO context is whether mere fear of future harm is per se already 
compensable, which some jurisdictions confirm and others deny.
Uncertainties of causation are also treated differently throughout Europe, starting already with 
dissimilarities in procedural law. The degree of likelihood to be proven to the judge in theory varies from 
“more likely than not” in some countries to “almost certainty” in others. At least traditionally, surpassing 
this threshold means full compensation to the claimant despite an up to 49% probability that it was not 
the defendant after all that caused her damage. Only few jurisdictions so far consider to split the loss 
according to the respective degrees of likelihood.
The notion of fault is linked to the required standard of care, and the outcome of the case depends 
upon who has to prove a deviation therefrom. Good farming practices as laid down in coexistence 
legislation contribute to identifying such proper conduct. Some countries have introduced liabilities 
irrespective of fault, or at least with a presumption of fault that can hardly be rebutted.
As far as liability for harm to the environment as such is concerned, the so-called Environmental 
Liability Directive primarily foresees administrative law consequences for harm to biodiversity. However, 
some member states have either at the occasion of implementing this Directive or even before introduced 
tort law rules governing harm to the environment, mostly foreseeing strict or at least rather strict rules 
based upon the polluter pays principle and covering also secondary losses to individuals as a consequence 
of harm to the environment.
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The differences mentioned so far mostly concern tort law as a whole and are not peculiar to the 
biotechnology arena. However, there they are overlapped with differing regulatory backgrounds as already 
indicated. Yet another layer that comes into play are the policy objectives behind all these rules, and also 
in this respect no unanimous accord can so far be found in Europe.
Insurance can pool risks not only of individual liability, but also of primary losses sustained by the 
victims themselves, and thereby distribute the burden among all those participating in and contributing 
to the pool. Arguably, insurers can handle claims more efficiently than some complex court procedure 
would. One downside to this tempting loss-spreading mechanism, however, is the lack of risk awareness 
among those concerned. GM farmers, for example, may not see that there is residual risk of loss even 
if they abide by all rules. Also, the differences between and the difficulties of tort laws are obviously 
not resolved by insurance, which merely builds upon these. The most obvious problem at the moment, 
however, is the lack of supply on the market: Insurers still seem to be reluctant to offer products that would 
cater the needs of GM farmers, be it due to lack of data that would allow them to calculate the risk and 
therefore the premia, be it due to uncertainties in the law that remain.
Compensation funds could step in as long as the insurance industry is unwilling and/or unprepared 
to offer solutions. Some countries have already introduced such models, though – again – with quite 
some distinct features each. Such funds could be tailor-made to the peculiar needs of those addressed, 
and claims handling could be rather efficient because one would expect experts to administer such a 
fund. However, states are obviously not wiser than insurance companies when it comes to calculating 
the risk. This is why compensation funds – including those already set up – are threatened by unpredicted 
developments which currently seem to prevent insurers from stepping in. Also, one has to ask why a state 
should set up a more or less complex compensation scheme for such a peculiar risk as the economic 
loss resulting from gene flow as long as there are other – more general – risks that would deserve more 
attention, if only from a statistical point of view.
Undoubtedly hence, there are significant dissimilarities to be found in the laws of the European 
countries, which obviously have an effect on the way potential claims would be handled and resolved. 
The general attitude of a jurisdiction vis-à-vis GM farming clearly leaves a mark on how these countries 
deal with losses thereby caused.
Still, at this point in time it is at least dubious whether harmonization in this field is feasible and/or 
desirable. As long as significant differences between tort laws as a whole remain, it does not seem to make 
sense to impose a specific uniform solution for such a unique problem that does not evidently deserve 
special treatment.
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Liability Cases in North America
Where tolerances for unintended GM content are low and include regulatory penalties, non-adopters 
face liability exposure for costly recalls and the spread of such contamination to the other farms or the food 
chain. Having paid a claim for a rejected shipment or recall of food, the non-GM farmer or food company 
may be left to seek remedies if the causal agent can be isolated and the company responsible sued. These seed 
impurity and unintended commingling issues can lead to significant liability in jurisdictions where applicable 
laws impose strict liability for the mere presence of biotech crop DNA in a non-GM crop or food products.
The US has had two situations in which the courts reported decisions adjudicating legal liability 
arising from an unapproved biotech crop commingling with commercial agricultural crops. StarLink 
was a transgenic corn approved for animal feed and ethanol production, but not approved for human 
food (Uchtmann, 2002). Contaminated corn products, such as taco shells, were then withdrawn from 
sale. Many companies, including grain handlers, farmers, food processors and retailers then successfully 
looked to the developer-patent owner, Adventis CropScience (now Bayer CropScience), for compensation. 
The numerous filings were consolidated into a single class action lawsuit in the United States Federal 
Court for the Northern District of Illinois alleging that crops and grain were unmarketable as food under 
adulteration standards due to the addition of an unapproved substance.
In the legal proceedings that followed, the trial judge ultimately ruled that plaintiffs who could prove 
that unapproved StarLink had physically contaminated their crop or stored grain had viable legal claims 
in negligence, private nuisance and public nuisance. After these rulings, the class action plaintiffs entered 
into a settlement agreement. Adventis agreed to provide $110 million in funding to allow those adversely 
affected by StarLink corn to be remunerated.
In 2006, trace amounts of an unapproved GM event were detected in US rice exports to Europe. 
In what has become known as LL601 rice, the widespread presence of this variety resulted in an 
announcement from the EU on August 20th, 2006, that Europe would not accept further rice shipments 
from the US (Li et al., 2010). The German food producer, Rickmers Reismüehle GMBH (Rickmers), sued 
two Arkansas defendants—the large grower co-operative Riceland Foods and the Producers Rice Mill—
alleging that shipments to the company contained unapproved genetically engineered rice in breach of 
several contracts. Riceland Foods and the Producers Rice Mill turned to the developer of the rice variety, 
Bayer CropScience for an explanation, as well as compensation. As is noted by Kershen (2009), after a 
14-month investigation by the USDA as to how this commingling occurred, no conclusive proof exists. In 
the spring of 2011, the court awarded Riceland Foods $136.8 million.
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Over 1,000 other lawsuits have been launched against Bayer CropScience in this case, as the court 
rejected a class action lawsuit (Redick and Endres, 2009). The authors note that some reports indicate that 
over 6,000 lawsuits have been filed. The lawsuits sought compensation for ruined crops and for depressed 
international markets for America rice imports. In December of 2009, the first of these cases to be settled 
was decided with the first two farmers receiving settlements. One farmer received an award of $1.95 
million, while the second received $53,000.
In the summer of 2011, Bayer offer $750 million to settle all of the producer lawsuits related to the 
LL601 rice case. This settlement is based on one condition, that being that 85% of the total rice acres 
planted between 2006 and 2010, have to participate (Endres and Johnson, 2011). Producers are to be 
compensated on a per acre basis.
Liability Regulation in Europe
Europe has been predisposed towards the integration of the Precautionary Principle into many of their 
regulatory and liability frameworks pertaining to agricultural biotechnology. Much of the rationale for this 
approach is based on previous food safety failures that have been experienced across the continent. As 
a result, Europe’s approach towards a liability framework has differed greatly from the North American 
experience. While the presence of liability and compensation schemes are common across Europe, this 
section will focus its attention on two of the most prominent schemes—that being the liability regimes in 
place in Denmark and Germany.
Denmark
On 9 June 2004, Queen Margrethe II of Denmark gave royal assent to an act entitled The Growing 
etc. of Genetically Modified Crops (Denmark, 2004). With this royal assent, Denmark became the first 
European country to enact legislation regulating the coexistence of conventional, organic and transgenic 
agriculture.
In the regulatory sections of the Act, the Minister of Food, Agriculture and Fisheries is given 
significant discretion to promulgate administrative rules fleshing out the statutory provisions relating 
to the growing, handling, sale and transportation of biotech crops. To ensure that any GM crop 
production is tightly regulated by the State, the Minister may require that any Danish producer wishing 
to grow a GM crop to obtain a license prior to planting (Denmark, 2004). The specifications of the 
licenses may entail that the intending producer, at the producer’s own cost, has to participate in and 
pass an education course on coexistence between GM crops, conventional crops and organic crops. 
The intent of this licensing scheme is to ensure that the Ministry has a known record of all transgenic 
producers within Denmark. The Danish regulatory system does not allow the unlicensed production 
of GM crops. In addition to a production license, the Minister may require any Danish producer 
intending to grow a GM crop to notify the owners and users of neighbouring fields of this intent 
(Denmark, 2004). The transgenic producer may also be required to notify owners of the vehicles, 
machines, equipment and storage the transgenic producer has or will use in growing, transporting 
and storing the crop.
In an attempt to recover part, or all, of the costs the Act stipulates that all producers planting a 
transgenic crop are required to pay 100 Danish kroner per hectare for every year that a transgenic crop is 
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would have to pay to have access to the technology from the seed companies.
In light of the per hectare fee that transgenic farmers must pay to grow transgenic crops and fund the 
compensation scheme, it is not clear if Danish farmers will plant GM crops. The European Commission 
has approved this compensation scheme for a period of five years as a way of successful introducing 
transgenic agriculture to Denmark (European Commission, 2005). However, the fee is functionally a tax 
on producing transgenic crops. From the farmers’ perspective, the tax may not make it worthwhile to plant 
transgenic crops. This tax can be seen as part of the barrier against Danish farmers planting transgenic 
crops as only one farmer had registered to produce such crops by the end of 2007 (New Scientist, 2005).
Taxing GM crops is not a successful way of introduction. Gylling (2010) notes that while over 300 
Danish farmers have taken the training course on how to grow GM crops, there is not a single acre of GM 
crop production occurring at present in Denmark. The conclusion that can be reached is the forcing GM 
crop adopters to fund a liability compensation scheme is such a substantial barrier to the adoption of the 
technology that not a single trained or untrained Danish farmer is willing to bear the burden of this tax and 
consider planting GM crops.
Germany
To conform German law to EU laws (European Commission, 1990), Germany passed an act to 
Regulate Genetic Engineering (GenTG) (Germany, 1993). In 2004, in response to more recent EU laws 
relating to agricultural biotechnology (European Commission, 2001), Germany amended its GenTG by 
adding new provisions regarding legal liability (Germany, 2004).
In the 1993 version of the GenTG, Part V of the law included five sections on Provisions for Liability. 
These five sections were left unchanged by the 2004 amendments and remain a part of the present 
German law on genetic engineering. Section 32(1) Liability imposes civil liability upon operators for the 
death, injury, impairment of health or property damage of other persons resulting from the properties of 
a genetically engineered organism. Section 32(2) adopts joint and several liability whereby in the case of 
multiple users of GM each person is obliged to compensate for the full amount of the damage. Section 
32(7) provides that liability for damage to property extends to impairment of nature or landscape for 
which the party damaged expends funds in restoration of the prior natural or landscaped state.
Section 3(9) Definitions defines “operator” to include those who establish a genetic engineering 
installation, perform genetic engineering operations, release or place on the market genetically modified 
organisms without authorization under the GenTG. When the Section 3(9) definition of operator is taken 
into account, it becomes clear that Section 32 Liability exists only for those involved with transgenic 
organisms through laboratory or confined experiments, field testing or deliberate introduction into the 
environment without authorization. Moreover, the damage for which compensation exists under Section 
32 is direct, physical damage to the life, health or property of another person. When an operator is found 
liable for the direct, physical damage under Section 32, Section 33 places an exposure cap of 160 million 
German marks.
In the fall of 2011, the European Court of Justice ruled on a honey case that contained GM pollen 
that will likely have wide ranging potential liability implications for the future of GM crops in Europe. In 
2005, a dispute arose between an amateur beekeeper, Mr. Bablok and the German State of Bavaria (Court of 
Justice, 2011). The corn variety MON 810 is one of the GM crop varieties that has been grown for research 
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purposes in Germany and in 2005, the protein from this corn variety was detected in Mr. Bablok’s honey. The 
presence of the GM proteins from the GM corn pollen resulted in the honey being unsuitable for marketing 
or consumption. In conjunction with four other amateur beekeepers, Mr. Bablok then brought legal action 
against the State of Bavaria, arguing that the State of Bavaria was responsible for the losses incurred.
The Court observed that even though GM pollen is incapable of replication or genetic material 
transfer it is technically an ingredient and needs to be identified as such. The Court concluded:
… products such as honey and food supplements containing such pollen constitute foodstuffs which 
contain ingredients produced from GMOs within the meaning of the regulation. … As regards the honey, 
the Court observes that pollen is not a foreign substance or an impurity, but rather a normal component 
of honey, with the result that it must indeed be classified as an ‘ingredient’. (Court of Justice, 2011: p. 2)
Conclusions
The potential liability resulting from this decision could be substantial for Europe. The additional 
costs to the honey industry in having to label all kinds of plant pollen in honey will be noticeable, not to 
mention the trade problems that will arise when countries that have adopted GM crops attempt to export 
honey to the EU. The ultimate liability might be that no further GM crop field trials will be allowed in 
Europe as none of these crops are approved for production in Europe and it will be impossible to prevent 
the pollen from these field trials from ending up in honey all over Europe. When this occurs, the honey 
would then contain an unapproved GM event and be banned from the market, as was the case with LL601 
rice. This one ruling may well spell the end of GM crops in Europe, even production of the two approved 
crops. If government research centres are no longer able to conduct field trials as part of the assessment 
process for GM crops, then the future for GM crop production in Europe is very bleak. 
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The year 2011 was the fourteenth year since the first commercial release of a genetically modified 
(GM) crop in South Africa. In 1997/98 insect resistant (Bt) cotton was released for production and South 
Africa (SA) became the fist country in Africa where a GM crop is produced on a commercial level. Bt 
maize was approved for commercial production in the following year and the first plantings of Bt white 
maize in 2001/02 established SA as the first GM subsistence crop producer in the world. Herbicide 
tolerance events for maize, soy beans and cotton as well as stacked (Bt+HT) combinations have since 
been approved for commercial production. In 2010 GM maize covered more than 70 percent of SA’s total 
maize area, HT soy beans covered more than 80 percent of the total soy area and GM cotton covered 
close to 90 percent of the total cotton area. Based on farm-level impacts over the adoption period up to 
2008, it has been estimated that adoption of GM maize, cotton and soy beans directly added more than 
500 million US$ to South African farm income (Brookes and Barfoot, 2010).
Institutional support – policy and regulation
Agriculture is a fundamental sector in the South African economy with a relatively small contribution 
to GDP but with substantial employment and multiplier effects. South Africa has a dualistic agricultural 
sector with commercial (large-scale) farmers producing the bulk of national produce, insuring food security 
in South Africa and to an extent in Southern Africa. The commercial agricultural sector went through 
a process of deregulation and liberalisation in the early 1990s and currently government support to 
commercial agriculture is limited to regulation and the only direct intervention is disaster relief assistance. 
The smallholder sector consists of subsistence farmers, smallholder surplus producers and emerging 
farmers. A large number of these farmers are situated in the former homeland areas where infrastructure 
and agricultural support services are still underdeveloped and lacking. Government interventions focus 
on supporting and developing these previously disadvantaged areas and farmers and to integrate these 
farmers into existing and novel produce value chains.
The South African Committee for Genetic Experimentation (SAGENE) was formed in 1979 by public 
and private scientists to monitor and advise the National Department of Agriculture and industry on the 
responsible development and use of biotechnology and GMOs through the provision of guidelines and 
the approval of research centres and projects. SAGENE gained statutory status in 1992 as national advisory 
committee on modern biotechnology and the approval for the commercial release of Bt cotton and maize 
was done under the guidelines of SAGENE. These guidelines and procedures remained the cornerstone of 
the biosafety framework until South Africa’s GMO Act no 15 of 1997 was approved by Parliament in June 
1997 and entered into force in November 1999 when the regulations were published. Under the Act, the 
108
A
nn
ex
 3
: P
ap
er
s
GMO Registrar forwards submitted applications that comply with the provisions of the Act to the Advisory 
Committee, which replaced SAGENE. Successful applications are recommended to the decision making 
body, the Executive Council, which includes officials of eight key Ministries including the Departments 
of Agriculture, Health, Environment & Tourism, Trade & Industry, Labour, and Science & Technology. The 
GMO Act and resulting regulations have been amended a number of times, mainly to bring it in line with 
international guidelines (Cartagena Protocol) and other national legislation.
The South African Government has identified biotechnology as a strategic industry with potential to 
grow the economy through more efficient industrial processes, innovative products and improved food 
security and health care through development of vaccines, diagnostics and treatments (Cloete et al., 2006) 
as is apparent from the National Biotechnology Strategy (2001) and the draft Research, Development 
and Innovation Strategy to Strengthen the Bioeconomy (2011). By creating a facilitating and enabling 
environment for a scientific and balanced consideration and regulation of agricultural GM technologies, 
the South African government has given farmers the option to utilise the new approved technologies. 
Through the Department of Science and Technology’s Public Understanding of Biotechnology (PUB) 
programme government also make an effort to ensure a clear understanding of the scientific principles, 
related issues and potential of biotechnology and its applications in society through information in the 
media and schools as well as through public debate.
Technology triumph but institutional failure
However, the South African Makhathini Flats experience (Gouse et al., 2005) emphasises 
the cliché that no technology is introduced in a vacuum and more specifically that a production 
technology, GM or otherwise, generally cannot overcome institutional limitations (low prices or failed 
markets). Adoption of Bt cotton by smallholder farmers on the Flats was rapid, increasing to close 
to 90 percent within 5 years. This impressive adoption rate was attributed to the substantial yield 
increases and insecticide savings of early adopters but also to the institutional setup of the cotton 
production system on the Makhathini Flats. In a vertically integrated, contract farming or out-grower 
production system that is common to most African cotton producing countries one, geographically 
demarcated, cotton ginnery or company supply production inputs on credit and farmer support 
through extension services, with the understanding (contractual agreement) that farmers deliver their 
cotton to the specific gin by the end of the season. The input cost and possibly interest and admin fee 
is subtracted and farmers are paid the remainder.
This system worked well on the Makhathini Flats for a couple of years and the ginning company had 
a loan recovery rate of close to 90 percent. However a number of consecutive seasons with floods and 
droughts resulted in a large share of the rain fed cotton farmers not being able to repay production loans. 
This situation was exacerbated by a low international cotton price caused to a large extent by increased 
production in especially India and China.
During the 2001/02 cotton production season a new cotton company erected its gin right next to the 
existing company’s depot on the Flats, and not having incurred any admin or extension service expenses, 
offered farmers a slightly higher price for their seed cotton. Most farmers defaulted on their production 
loans with the first company and the company and the Land Bank of South Africa, who supplied the credit 
facility, lost a significant amount of money. In the next season (2002/03) no credit was made available and 
cotton production on the Flats collapsed. Despite some efforts by the Provincial Government and the new 
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due to low profitability levels linked to the prevailing low cotton price.
Smallholder farmers in SA struggle to control bollworms on cotton due to limited insecticide, labour, 
clean spraying water and equipment. Smallholder farmers on the Flats benefited from the new GM insect 
control technology but due to adverse climatic conditions, institutional failure (ginning company competition) 
and low cotton prices, the welfare gain was short lived. Though cotton production has decreased significantly 
in SA (large and small-scale farmers), the farmers that still produce cotton plant GM cotton and with higher 
world cotton prices projected for the 2011/12 season, cotton planting estimations are up.
GM subsistence crop
Maize is the most important field crop in SA and annually covers an estimated 30 percent of the 
total arable land. Maize serves as staple food for the majority of the South African population and also 
as the main feed grain for livestock. Large-scale commercial farmers and agricultural companies produce 
the bulk of SA’s maize crop while smallholder and subsistence farmers produce less than 5 percent of 
the national maize output. GM maize’s high adoption level (in the presence of various high yielding 
conventional varieties) is indicative of how high commercial farmers value the GM traits (Bt and HT). 
However, adoption of these technologies by smallholder farmers is still minimal.
It is estimated that only about 10 500 of the more than 40 000 smallholders who regularly buy hybrid 
maize from the three major seed companies in SA, planted GM seed in 2007/08. The smallholder GM 
maize area covered about 33 700 hectares. Considering that there are an estimated 240 000 small-scale 
farmers in South Africa and more than 2 million subsistence farmers, it is clear that GM maize adoption 
by smallholders is still minimal. As the majority of these smallholder farmers plant small plots (most less 
than 0.5 ha) on dry land, rainfall is in most cases the determining factor in whether a surplus is produced.
On the production side smallholder grain production is constrained by small plots, land ownership 
issues (communal land), lacking support services (extension, inputs, credit) and limited labour (high levels 
of immigration to urban areas and a high HIV/Aids prevalence). On the marketing side geographical 
separation from large markets, and limited storage and transport infrastructure adds to transaction costs, 
reducing profitability of grain production.
These factors play a role in a smallholders’ input investment decision and on his/her maize production 
motivation. In SA where maize flour is always available in the shops and where government social grants 
ensure at least a minimum income level for the elderly and poor families with children, a failed maize 
crop usually do not mean starvation like in most other African countries. Additionally, government social 
grants have enabled some smallholders to invest in inputs like fertiliser, hybrid maize, GM maize and 
herbicides and grant payout days have created a small but cash market for grain sales to the community.
Smallholder farmers’ motivation for producing maize differ with some hoping to sell grain for profit, 
others only wishing to supply in a couple of months’ household maize flour demand and others only 
planting a couple of rows of maize for consumption as green (fresh) maize. Based on research findings 
(Gouse, forthcoming), it can be expected that smallholders’ GM adoption decision will depend on 
their maize production motivation but also their production limitations. In areas with high stem borer 
infestation, smallholders have adopted Bt maize continuously for a number of seasons and farmers with 
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smaller households and slightly higher off-farm income (less family labour or time to spend on the farm) 
have adopted HT maize. Due to a high level of heterogeneity in the smallholder group, it can be expected 
that GM maize adoption rates will probably not reach the levels seen with commercial farmers.
Conclusion
While the efficacy of Bt and HT GM technologies have been proved in South Africa (large and small-
scale farmers) it is the institutional arrangements that determine adoption, profitability and ultimately a 
sustainable positive welfare impact.
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Figure 1. An explanatory process of GM food acceptance (Costa-Font et al., 2008)
Reviewing Science behind Consumer Attitudes, Willingness-to-Pay
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1. Introduction
The development of genetically modified (GM) food has been a matter of considerable interest and 
worldwide public controversy. However, in order to fully understand the controversy and draft appropriate 
public policy, the demand for these goods needs to be understood as well. No matter how technologically 
superior GM crops may be to the farmer, they will not have an impact if consumers are not willing to 
accept them.
A growing body of literature on consumers’ attitudes and purchasing intentions and behaviour related 
to GM food is available, reviewed by several authors (Lusk et al., 2005; Costa-Font et al., 2008; Smale et 
al., 2009; De Groote, 2011). From this literature, two main findings emerge: (i) consumers in developed 
countries consistently show a preference for non-GM food over GM food, with this preference being 
particularly strong in Europe; and (ii) in developing countries, a lower awareness of GM food and a more 
positive attitude is observed until the point that positive price premiums for GM food are recorded.
Costa-Font et al. (2008) provide an overall picture of the consumer decision process in relation to 
GM food (Figure 1). They conclude that consumer attitudes towards GM food are driven by three main 
dimensions: (i) risks and benefit perceptions associated with GM food; (ii) individual values such as 
environmentalism, conservationism, materialism and equity; and (iii) knowledge and its relation with 
values and trust on the different sources of information.
Smale et al. (2009) further distinguish two main bodies of literature, indicated in Figure 1: (a) surveys 
designed to elicit the attitudes of consumers toward products made with GM crops; and (b) stated and (c) 
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revealed preference methods to estimate the hypothetical and real price premiums consumers are willing 
to pay for products that are free of GM ingredients. In this paper, we focus on the second body of research. 
In particular, we embed the methods that have been used in that literature in a framework which can be 
used to interpret willingness-to-pay (WTP) estimates for GM food across studies.
2. Stated versus revealed preference methods
Lusk et al. (2005) provide a meta-analysis of stated and revealed evidence of GM food preferences 
based on 25 studies and 57 valuations. The evidence confirms the general findings described above 
and further suggests that WTP for GM food is determined by (i) the characteristics of the food being 
valued, (ii) the characteristics of the sample of consumers studied, and (iii) the method for eliciting 
consumers’ valuation. Acceptance of GM ingredients in products increased from meat products to 
oil products and products with tangible benefits such as increased nutrition. By including several 
variables into their meta-analysis related to the method of value elicitation, the authors generate 
interesting information on the method’s influence on WTP. Their sample includes several types of 
conjoint analysis, contingent valuation and experimental auctions. An important variable is whether 
the valuation task was hypothetical or non-hypothetical. For instance, all contingent valuation studies 
included in the analysis were hypothetical and all auctions were non-hypothetical, as were a few of 
the conjoint-choice experiment valuations.
One of the primary reasons experimental auctions have emerged as a useful tool in new product 
development research is the increasing recognition of the drawbacks associated with hypothetical WTP 
and purchase intention questions. There is now a wealth of evidence that people tend to significantly 
overstate the amount they are willing to pay for goods in a hypothetical setting as compared to when real 
purchases are made (see the literature reviews cited by Lusk, 2010). The existence of a so-called positive 
“hypothetical bias” on WTP also surfaces in Lusk et al.’s (2005) meta-analysis.
3. General framework: Balance between control and context
The issues discussed above can be understood when embedded in a larger framework of the balance 
between control and context. Control means the researcher has control over the environment such that 
no unmeasured external force drives choices. That is, confounding of cause and effect is eliminated. What 
separates an experimental auction from other auctions is the attention given to control. Context implies 
that subjects have some contextual cues about why their decision might matter in a bigger world.
Traditional sensory and marketing research methods attempt to estimate ex	ante WTP for new food 
products by constructing hypothetical markets. The growing popularity of explicit experimental methods 
arises in large part from the potential for control, i.e. it enables constructing the proper counterfactual 
(Harrison and List, 2004). Experimental auctions exploit the middle ground between total control and total 
context by creating the missing market (Lusk and Shogren, 2007). In experimental auctions, people bid 
to buy real products using real money in a setting employing rules that provide incentives for people to 
truthfully reveal their value for each product for sale. Whereas responses to conjoint or purchase intention 
questions provide an indication of stated preferences (decision stage b in Figure 1), bids in experimental 
auctions are revealed preferences (stage c) and are interpreted as the maximum amount people are willing 
to pay for the new good (Lusk, 2010).
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values at the point of purchase (Harrison and List, 2004). By moving the auction to more familiar 
territory, such as grocery store or mall, one might gain some context in return for giving up some 
control as the population of interest is directly intercepted (Lusk, 2010). Lusk et al.’s (2005) meta-
analysis suggests that such increase in context substantially reduces WTP for non-GM food. On the 
other hand, increasing the role of the researcher as an intermediary between the experiment and the 
individual substantially boosts WTP which may suggest that the gains in control may be partially 
offset by observation bias and social desirability bias. This bias may further increase if one moves 
from individual to group auctions (Demont et al., in press).
4. Discussion and research implications
The growing body of literature on consumers’ WTP for GM food seems to be unanimous on two 
main findings. The stronger consumer opposition towards GM food in Europe seems to be supported by 
cross-Atlantic studies using the same research method (e.g. experimental auctions, see Lusk et al., 2006). 
In contrast, there is much less single-method cross-country evidence in support of the second hypothesis, 
i.e. that consumers in developing countries support GM food much more than consumers in developed 
countries. Most authors ascribe this outcome in part to government policies, and some to cultural and 
political history (Smale et al., 2009). However, the available evidence does not enable excluding the 
possibility that the differences may have been partly generated by the endogeneity of the research method 
and the context. Two arguments may support this hypothesis.
First, if the research context constrains the researcher to rely on a different research method, WTP 
may be measured systematically differently in developing countries. Lower education levels and higher 
degrees of illiteracy, for instance, may increase the role of the mediator, with the concomitant risk of 
introducing observation bias, and move the valuation study away from the context.
Secondly, experimental methods in food valuation are an emerging research field in developing 
country contexts (De Groote, 2011). Since the publication of Lusk et al.’s (2005) meta-analysis—which 
included only one developing country (China)—the evidence on consumers’ WTP for GM food in 
developing countries has dramatically grown. Smale et al.’s (2009) review identifies 33 of such studies 
of which 12 report WTP estimates for GM food in Asia. Further evidence from Africa is reported by De 
Groote (2011). However, most studies in developing countries rely on hypothetical methods and WTP 
estimates may have been partly inflated due to hypothetical bias.
Both arguments illustrate the crucial role of “reviewing the science behind consumer attitudes” 
in the interpretation of WTP for GM food across studies. Depending on the research question at hand, 
conducting valuation work in a field setting may be beneficial if this is the environment in which 
consumers will actually be making food purchases (Lusk et al., 2005). However, for some research 
questions such as testing the impact of information on WTP, more control is needed. Hence, the 
ultimate challenge for the experimenter will be to find the optimal balance between context and 
control in designing food valuation experiments such that the latter are truly demand-revealing and 
informative to public policy makers.
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In discussions of genetically modified organisms (GMOs), the potential impacts to human health are of 
critical concern. GMOs have the potential to cause both beneficial and adverse health effects in humans. A 
reasonable health concern to consider is that any time a novel gene is successfully introduced into a food 
crop, that crop will produce a novel protein. Proteins, while rarely toxic or carcinogenic, can be allergenic. 
Therefore, care must be taken to introduce genes that would not produce proteins that are known allergens 
or likely to be allergenic in humans. In the United States of America, for example, proteins produced by any 
transgenic crop likely to appear in the market are subjected to a variety of tests to determine their allergenic 
potential: whether the organism from which the transgene is taken causes allergic reactions in humans, 
whether there are homologies in amino acid sequence in the novel protein to known allergens in an allergen 
databank, and the digestibility of the protein in simulated gastric conditions.
However, perhaps of greater importance are the potential health benefits that can accrue from the 
cultivation and consumption of certain GMOs, particularly in less developed countries. Aside from the 
(currently) more theoretical GMOs that would contain essential micronutrients or withstand drought 
conditions, even the GMOs that are most commonly planted worldwide today could provide a variety of 
health benefits. For example, transgenic herbicide-tolerant crops and pest-protected crops could reduce 
the amount of labor needed in the field, which could then be devoted to aquaculture or other pursuits that 
would allow for greater dietary variety. These GM crops are also potentially helpful in communities where 
HIV prevalence is sufficiently high that agricultural workers are limited by their health status in how much 
energy can be devoted to agricultural labor. Additionally, pest-protected crops such as the Bt (Bacillus 
thuringiensis) crops would drastically reduce the amount of topical pesticide required in agricultural fields. 
Planting Bt crops could reduce workers’ risks of excessive exposures to topical pesticides, which can be 
toxic or carcinogenic in humans and harmful as well to wildlife.
Also of great importance is the phenomenon that Bt maize has been shown to have significantly 
lower mycotoxin levels than non-Bt maize isolines. Mycotoxins are secondary metabolites of fungi that 
colonize food crops; these toxins can cause a variety of adverse health effects in humans. The most 
common classes of mycotoxins in maize worldwide include aflatoxins, fumonisins, and deoxynivalenol 
(DON or vomitoxin). Table 1 lists the adverse human and animal health effects associated with each of 
these mycotoxins. In parentheses under the name of each toxin are the fungi that most commonly produce 
the toxins.
The adverse effects of these foodborne mycotoxins in global health is real and measurable. Liu and 
Wu (2010) estimated that 25,200-155,000 liver cancer deaths worldwide are caused by dietary aflatoxin 
each year. Other studies have linked aflatoxin with childhood growth impairment (Gong et al. 2002) and 
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immunosuppression (Jolly et al. 2008). Fumonisin has been implicated in increased risk of neural tube 
defects in babies (Missmer et al. 2006) and esophageal cancer (Marasas 1996). DON has been implicated 
in immune and gastrointestinal dysfunction (Bondy and Pestka 2000).
Bt maize has been shown in a variety of studies across the world to have significantly lower mycotoxin 
levels than non-Bt isolines. The field evidence is reviewed in Wu (2007). The earliest studies on this topic 
were done in Iowa, showing lower levels of fumonisin in multiple Bt maize events (Munkvold et al. 1999). 
The results were then replicated in multiple countries and continents worldwide (Bakan et al. 2002, de 
la Campa et al. 2005). Likewise, DON levels have been shown to be significantly lower in Bt maize than 
non-Bt isolines in different continents (Aulrich et al. 2001, Schaafsma et al. 2002). Aflatoxin reduction in 
Bt maize has been less consistent, in part because until recently, the types of insect pests controlled by Bt 
maize were not usually those implicated in Aspergillus infection. However, recently approved Bt maize 
events may have improved efficacy in reducing aflatoxin contamination (Odvody and Chilcutt 2007).
If Bt maize were planted in the parts of the world where mycotoxin contamination were a serious threat 
to human health, then there could be appreciable health benefits in terms of reducing dietary mycotoxins. 
However, many of the most severe foodborne mycotoxin problems are in Asia and Africa (Liu and Wu 2010), 
where very few nations permit commercialization of Bt maize. Therefore, in order for these health benefits of 
Bt maize to be fully realized, a first step is in regulatory changes that would permit for transgenic crops with 
proven benefits to be allowed for commercialization where they are currently not permitted.
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Table 1. Adverse human and animal health effects associated with three classes of mycotoxins in maize. 
Source: Wu et al. (2011).
Human health effects Animal health effects
Aflatoxins
(Aspergillus flavus, A. parasiticus)
Liver cancer (hepatocellular carcinoma)
Acute aflatoxicosis
Immune suppression
Stunted growth in children
Liver tumors
Immune suppression
Reduced weight gain and productivity
Lower eggshell quality in poultry
Fumonisins
(Fusarium verticillioides,  
F. proliferatum)
Esophageal cancer
Neural tube defects in babies
Equine leukoencephalomalacia 
Porcine pulmonary edema 
Immune suppression
Reduced weight gain and productivity
DON
(Fusarium graminearum,  
F. culmorum)
Gastrointestinal disorders
Immune dysfunction
Gastrointestinal disorders
Immune dysfunction
Reduced weight gain and productivity
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Evaluating the responses of prospective consumers to novel and prospective technologies is always 
difficult, especially when the goods or services are not actually available for them to try. It is even more 
testing when the technology and its products are constantly denigrated as dangerous and worthless with 
opponents claiming as a consequence that “there is no demand”.
Is there ever much of a “demand” for something which does not exist, for which there are no specific 
pictures,	sounds	or	tastes,	or	which	cannot	be	inspected	by	the	potential	purchaser?	It	has	been	said	that	
Sony invented the Walkman, not because members of the public were banging on their doors demanding 
a portable music player, but because the co-chairman of Sony wanted to be able to listen to operas during 
his frequent aeroplane journeys and one of the company’s audio-division engineers had a bright idea. 
Sony created the product – and thereby also created the demand.
The CONSUMERCHOICE project was conceived precisely because of the difficulties of measuring 
shoppers’ potential behaviour. By the time of the project’s conception there had been many polls of 
consumer opinion conducted, it must be stressed, against a raucous background of vigorous antagonism 
on the part of opposing campaigners together with a rich flow of frightening newspaper headlines and 
stories.	Such	polls	 tended	 to	be	based	on	“what	would	you	do	 if?”;	“if there were GM-products in the 
grocery	stores,	would	you	buy	them?”	Such	questions	were	not	infrequently	posed	in	rather	graphic	terms:	
“would	you	eat	Frankenstein	foods?”	or	with	a	picture	of	a	syringe	needle	inserted	into	an	innocent	tomato.	
The responses were no surprise but nor were they reliable evidence of intent or behaviour.
Nevertheless, throughout a decade or more of this type of “market surveys”, crude as they were, a 
rather different picture was emerging here and there from focus groups and from in-depth studies. The 
outcome varied from country to country: my own detailed experience is, specifically, the situation in the 
UK and I cannot easily judge how typical it might be for other Member States. 
It was always clear that the opposition to GM-foods, though loud, was by no means universal. A 
common finding was that a comparatively small proportion of the populace was indeed vigorously 
antipathetic but was often neatly balanced by a roughly similar proportion who proclaimed themselves 
to be rather enthusiastic in the light of their perceived benefits of the new technology. Together, these 
two groups formed about a quarter of the total. The remainder was often divided into another quarter or 
so who were vaguely against GM (for reasons often not clearly defined) but did little or nothing to avoid 
them; the remainder, nearly half the total population, seemed not to care one way or the other.
Opinion polls notwithstanding, there had been little attempt to gauge actual consumer behaviour with 
respect to their purchasing GM-products. There had been various “experiments” to test public reaction. 
One of them was carried out in Germany in April 2004 (and was one of the factors encouraging the 
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development of the CONSUMERCHOICE proposal). In a supermarket, bread from an allegedly GM-wheat 
was mixed with the bulk supply, and the resulting bread given a fake GM label. A 500-gram loaf was 
offered for € 0.29, less than a third of the standard price. Potential customers were observed via a hidden 
camera. At first the reactions were ones of surprise – some people appeared to have little confidence in the 
bread. Indeed, many potential customers regarded the “GM-bread” as unsafe but others were not deterred 
– the low price was effective. Of 30 allegedly GM-loaves on display, 22 were sold on the day of the trial, 
four times the amount of that type of bread sold on other days.
The second trial took place in a snack-bar: normal potato chips (“French fries”) were labelled as 
“GM-chips” and sold at half price. The results confirmed the first test: even though some people, no doubt 
hungry for the chips, had doubts and rejected the “GM”-product, 27 portions were sold actually sold 
compared with only one of the conventional variety. Interesting though those episodes might have been 
– and there have been others in which conventional, GM- and “organic” products have been sold side-by-
side – it is difficult to know to what extent the customers realised that this exercise in Germany was some 
sort of experiment and acted accordingly.
Thus, in December 2003, when the idea of CONSUMERCHOICE first arose in discussion, the 
situation remained unclear, confused and likely to differ in the various Member States of the EU. In the 
usual run of opinion polls we feared that the customers felt they were being asked via a questionnaire or a 
pollster about something which was in some way not normal and not part of their everyday activity. Such 
a perception might well prompt the respondent to think unusually carefully about this question because of 
hidden implications which might be embedded within it. Our objective was therefore to assess the actions 
of shoppers in what was for each individual an entirely familiar shopping environment rather than asking 
questions which would have been bound to alert their attention that something about the whole matter 
was distinctly odd.
There were clearly difficulties in developing such an approach. In those countries in which GM-
products were (and still are) on sale, our hovering around the appropriate shelves in grocery stores (how 
many	such	stores?)	waiting	for	customers	to	buy	(how	many	customers?)	the	products	(how	many	products	
should	be	involved?)	was	an	impossible	experimental	approach	except	on	a	very	small	scale.	Moreover,	
in Member States in which no GM-products were available there was no way in which the behaviour of 
customers could be assessed in the normal environment when presented with a choice of such foods.
We therefore adopted a variety of other methods. As a start, and for all the ten countries in the study, 
we surveyed the public influences on the populace with respect to GM-technology, particularly the roles 
and attitudes of the media and of the political establishment.
In Member States in which GM-products were on sale, we were able to undertake a more meaningful 
study:
1. finding out which products were on sale, how widely they were offered, and whether they remained 
available for a protracted period and hence were actually being purchased; we reasoned that products 
which few people bought would not for long remain on the shelves of competitive food stores;
2. undertaking in some countries a bar code analysis of all the products (including labelled GM-foods) 
actually purchased by consumers who belonged to a panel of shoppers reporting via a bar code 
scanner in their own homes all their purchases to a company analysing the data. Those comprehensive 
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who had made the purchases to questions about whether they would or would not buy GM-foods. 
We	could	 thus	match	answers	given	by	 individual	 shoppers	 to	“what	would	you	do	 if?”	questions	
with what those same individuals actually bought as part of their normal food purchases.
3. for Poland and the UK we were able to conduct polls of residents of those countries who had visited 
Canada or the US (in both of which GM-foods are widespread yet in neither are they labelled), asking 
whether they knew of the prevalence of GM foods in North America, whether they were concerned 
and, if so, what steps they had taken to avoid them.
4. In just one case (in Germany), consumers who had chosen to purchase milk labelled as “GM-free” were 
asked individually after their purchases why they had bought that particular milk rather than some 
other brand not carrying such a label.
5. In almost all the Member States participating in the study we conducted focus group discussions in order 
to explore in some detail the range of attitudes people showed towards the GM question together 
with the arguments they gave in support of their positions.
It was impossible to come to hard and fast deductions applicable to all the circumstances in all the 
countries involved in the two-year study from 2006-2008. But one conclusion was indeed rather clear. 
The project set out to determine whether European consumers bought GM-foods. It is always dangerous 
to give simple answers to complex questions; any answer to this one will certainly not encompass all 
European consumers. Our inquiries have shown much variety in the ten Member States of our study but 
nevertheless, in a broad sense, the answer is:
“Yes – when they have the opportunity”
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Socio-economic assessment of GM crops has been performed most frequently in “1st generation 
crops” (i.e. those with an agronomic trait that benefit farmers) in a limited number of countries. However, 
increasingly attention turns to “2nd generation crops” (i.e. GMOs with a quality trait that offer benefits to 
consumers or crop users in the industry). When considering the need for new methodologies for impact 
assessment of GM crops, an essential step is therefore to look forward to the commercial pipeline of these 
products: While agronomic benefits can be assessed easily using conventional techniques of agricultural 
economics, such new crops may require new methods.
In a recent paper (Stein and Rodríguez-Cerezo, 2010) we showed that currently there are around 
30 commercial GM events that are cultivated worldwide, yet the forecast is that by 2015 there will be 
over 120: for soybeans, currently only 1 GM event is available, but this number is predicted to increase 
to 17 different events; maize events are expected to increase from 9 to 24, rapeseed events from 4 to 8 
and cotton events from 12 to 27. In the case of rice where currently no commercial events are cultivated, 
the prediction is that by 2015 as many as 15 GM events could be grown if the political and regulatory 
environment develops favourably; potatoes also are predicted to move from no current cultivation to 8 
events, and other, minor crops are predicted to grow from 7 events currently marketed to 23 events by 
2015.
Moreover, individual GM events can easily be combined by conventional crossings by plant breeders 
to generate new varieties with multiple desirable traits. Such “stacking” of (authorised) events is already 
common in maize and cotton, but it may be a challenge for methodologies aiming to understand socio-
economic impacts of a particular agronomic or quality trait.
More importantly, though, is that not only new GM crops like rice and potatoes, are foreseen to be 
commercialised soon, but also a limited number of new traits. In addition to currently commercialised 
agronomic traits if insect resistance, herbicide tolerance and virus resistance, the pipeline predicts that by 
2015 also new commercial traits will be available covering crop composition and abiotic stress tolerance 
(mainly optimised oil and starch content, improved nutrient profiles, and drought tolerance).
While drought tolerance is also an agronomic trait whose impact can be measured via higher yields, 
quality traits have no direct benefits for farmers (and may even come with a yield penalty or cause more 
work if the crops have to be segregated). However, crops with quality traits have a higher value for their 
1 Now with the International Food Policy Research Institute in Washington, DC. 
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buyers and, if this is captured through higher prices, the economic assessment of such specialty crops is 
also straightforward as the higher prices farmers receive for their crop can be balanced with any changes 
in yield or differences in input costs.
One exception is for instance where crops with quality traits are developed without a profit motivation 
and for target populations that lack purchasing power to generate a market demand that reflects the 
benefit they derive from consuming these crops. A case in point is e.g. “Golden Rice” – rice that has been 
engineered in the context of a humanitarian project to produce provitamin A in its kernels. Vitamin A 
deficiency imposes a heavy burden on public health in many developing countries with predominantly 
rice-eating populations where the poor cannot afford a more balanced diet containing fruit, vegetables 
and animal products. To carry out socio-economic assessments of such “biofortified” crops, researchers 
adapted methodologies from health economics to quantify the (non-monetary) health benefit that results 
from the consumption of these crops, based on which further economic analyses were possible (Stein et 
al. 2005, Stein et al. 2008).
Another situation where the assessment of new GM crop traits may pose challenges is when the 
cultivation and use of these crops produces externalities that are not captured in the price of these 
crops. For instance, the cultivation of new GM crops could result in a lower impact on the environment 
compared to conventional crops (e.g. because of lower greenhouse gas emissions). To the extent that these 
benefits do not affect the agronomic properties of the crops and do not command a market premium, they 
will not be reflected in conventional economic assessments. From a societal point of view, such benefits 
can be very relevant, though. Therefore the idea of carrying out life-cycle assessments (LCAs) has gained 
increasing popularity over the last years. In such a comprehensive analysis all costs and benefits “from 
cradle to grave” are considered and the impact of product on overall welfare is evaluated.
In conclusion, methodologies used in socio economic impact studies on GM crops need to take into 
account future evolution of the types of crops released (including multiple stacks and 2nd generation, 
consumer oriented crops).
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The socioeconomic impact of GM crops on European agriculture and their inclusion in the 
authorisation process has been the subject of lively debate lately. The basis for this debate can be found 
in the limited experience with GM crops in the EU. This scarcity of data leads to uncertainty during 
assessment and requires the use of assumptions. Hence, ex ante impact assessments of GM crops should 
acknowledge the importance of uncertainty to more accurately represent the reliability of results. The 
invasion of Europe by the alien species Diabrotica virgifera virgifera LeConte or Western corn rootworm 
(WCR) offers an interesting case study to present a possible methodology to cope with two types of 
uncertainty facing the researcher: (i) uncertainty surrounding the technology and (ii) variability in the 
characteristics of farmers.
The first outbreak of WCR in Europe occurred during the early 1990s [1]. The Central European 
outbreak now extends over 11 countries, from Austria to the Ukraine and from Southern Poland to 
Serbia. WCR larvae damage maize by feeding on the root system, with adult beetles feeding on maize 
silks sometimes causing economic damage. Exogenous factors such as precipitation and the timing 
of damage relative to crop phenology determine the extent of yield loss, which leads to tremndous 
variabilty in the relation between population pressure and yield loss [2] and hence the appropriate 
control option. Dillen et al. [3] describe a stochastic bio-economic model to tackle this problem 
and assess the relative and absolute competitiveness of the following crop protection (CP) options 
compared to no control.
1.	 No	CP is applied. The farmer implicitly assumes that the yield loss caused by the pest will be less than 
the cost to apply a CP and so no CP is applied.
2.	 Soil	 insecticides. The efficacy and consistency of soil insecticides depend on a number of factors: 
active ingredient, application timing because of limited persistence in the soil (about 6 weeks), 
leaching, physical and chemical composition of soil, and mechanical and operational aspects (see 
Gerber [4] for a detailed review).
3.	 Seed	treatment. In this case, the active ingredient is placed directly on the seeds via a coating, thereby 
optimizing both spatial and temporal application while reducing management requirements. Although 
these products provide adequate protection under low pest population pressure, they tend to be more 
variable in protection than traditional soil insecticides under high pest population pressure [5-7].
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4. Crop rotation. The univoltine beetle lays its eggs during late summer, mainly in maize fields. Eggs 
overwinter and hatch the next spring. Because WCR larvae cannot differentiate between the roots of 
plant species [8] and have limited mobility, they feed on the roots in their vicinity. However, roots of 
crops other than maize are inadequate food sources for WCR larvae [9], so that rotating maize with a 
non-host crop offers a practical solution to limit pest population growth and control damage.
5. Bt maize. The crop expresses a coleopteran-specific insecticidal toxin in its roots because its genome 
contains genes from the soil bacterium Bacillus	thuringiensis	(Bt). Most farmers adopt Bt varieties as 
substitutes for soil insecticides. Bt maize gives systemic protection to WCR and, because the toxin 
is expressed in the roots, its performance is less likely to be affected by environmental conditions, 
planting time, soil conditions or calibration of machinery [10].
The economic model assumes a counterfactual uninfested yield level and simulates a probability 
density function (PDF) of possible yields under different CP options,	y(CP), calibrated on field trial data 
from the USA [11]:
            (1)
Here ybase is the base (uninfested) yield and d(CP) the percentage of this base yield lost under the 
different CP options. The distribution of final yields feeds a partial budgeting model:
            (2)
Here      is the value of a particular CP options, pmaize the market price for harvested maize and 
k(CP) the cost of the chosen CP option. As farmers have heterogeneous characteristics stemming from the 
differences in soil, climate, managerial capacities, access to markets, labour use, plot size, etc., their yield 
potentials and costs differ. Hence both ybase and k(CP) follow PDFs to capture the heterogeneous outcome 
for farmers for each CP option.
The resulting stochastic bio-economic model uses Monte Carlo simulation to empirically generate the 
PDF representing the value of each CP option compared to no CP. The detailed results for Hungary can 
be found in Dillen et al. [3] and for Austria, Czech Republic, Poland, Romania, Serbia, Slovakia and the 
Ukraine, refer to Dillen et al. [12]. The results show that depending on the country and the type of farmer, 
the average net benefit of Bt maize compared to the next best CP options ranges between €23/ha and 
€58.5/ha in grain maize.
Besides these averages, the stochastic nature of the model allows further analysis of the simulation 
results. We examine the outcome for each individual Monte Carlo iteration to determine the optimal 
CP option for that iteration, given the set of parameters. Based on this analysis, we predict the potential 
adoption rates for the different CP technologies. In this paper we focus on how the deregulation of Bt 
maize would alter the presence of different CP in the agricultural landscape. Figure 1 presents the absolute 
changes in the proportion of the maize area under different CP options after the introduction of Bt maize.
Figure 1 implies that the availability of Bt maize would significantly decrease the area of maize not 
protected against WCR. For instance in Poland, we estimate that 48% of the area planted with maize, 
currently unprotected, would receive some sort of CP if Bt maize were deregulated. Moreover, we notice 
a large decrease in the maize area treated with chemical CP options, especially with soil insecticides 
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(e.g., Austria, Poland, Slovakia). This change is a valuable side effect, as the most commonly used active 
ingredient (tefluthrin) has negative effects on some non-target organisms [13]. Another interesting result is 
that Bt maize does not seem to decrease substantially the area under crop rotation. The largest decrease is 
found in Hungary, where 20% of the area under crop rotation would be converted to Bt maize. Hence, Bt 
maize as such does not shift farmers to more monoculture as is sometimes suggested.
This short paper demonstrates three important points:
•	 Applying a stochastic approach to ex ante impact assessments to represent heterogeneity and 
uncertainty can deepen the insights provided by model results and avoid focusing on a hypothetical 
average farmer that does not exist.
•	 The WCR invasion of Europe is a real economic threat to European maize production.
•	 The deregulation of Bt maize would provide a useful addition to the farmer’s toolbox that has a high 
average value for maize areas infested with WCR and can also decrease dependency on chemical 
insecticides.
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In the last assessment of the pipeline of GM rice projects and prospective products (Stein and 
Rodríguez-Cerezo. 2009 Technical Report EUR 23486 EN), it was anticipated that up to 15 GM traits 
could be commercialized by 2015, and that these would come almost exclusively from Asia and that 
many also would be developed by public national centers. This assessment took into account those events 
or traits in the commercial and regulatory pipeline (5 events, including LLRICE62, in the US only) and 
those proposed to be in the advanced R&D pipeline (14 traits).
Reassessing the progress since then: one of the commercial pipeline events, Bt63, has received a 
biosafety certificate from the Chinese regulatory authority, but has yet to complete the varietal approval 
process (the validity of the biosafety certificate is until Aug, 17, 2014); two other events in China, KMD1 and 
Xa21, are no longer under active development in the country, and the other event, B827, had only a short-
lived release in Iran. Of those in the advanced R&D pipeline, Golden	Rice1 has been replaced with Golden	
Rice2, and many of the biotic and abiotic stress traits listed in the report have not advanced greatly. An 
exception can be found in the multiyear and event selection trials for new lepidopteran resistance materials 
in China and India. As will be discussed below, a number of these events could still be released by 2015.
In both China and India, there has been emerging government scrutiny of the release of GM traits in 
food crops, and the reticence to approve the products may be highlighted by the unfortunate handling 
of the Bt eggplant product in India: unfounded claims of health concerns with the Bt protein - one of the 
world’s most studied proteins and present in millions of hectares of maize and cotton grown annually in 
Brazil, Argentina, South Africa, and North America - has led to a delay in the final release of the product, 
in spite of obtaining biosafety clearance from the then final authority, the Genetic Engineering Approval 
Committee. The situation in India is also complicated by the fact that the new Biotechnology Regulatory 
Act of India and the Seed Law have still not been enacted. However, in neither India nor China, the 
apparent reticence has not slowed the advanced development of GM rice products, with noticeable 
increases in their field testing in recent seasons.
Agricultural biotechnology is a strategic industry for China and for now all GM rice development 
is being driven by mostly public sector institutions, but some of which have licensing agreements with 
prominent seed companies. In a recent review, Chen et al. reported on 17 advanced insect resistant GM 
rice projects, some of which also are combination traits with drought tolerance and herbicide tolerance 
(Chen, Shelton, and Ye, Annu. Rev. Entomol. 2011. 56:81-101 [Suppl]). Some of these traits are being 
developed in hybrid parents and in prominent varieties, suggesting a faster development path than those 
being developed in experimental, non-current varieties. In addition, at least one of these traits was started 
from more a thousand independent transformation events – a prerequisite often for the selection of a 
successfully performing commercial and “regulatory-ready” event.
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In India, late stage regulatory trials of Bt rice have been conducted by Maharashtra Hybrid Seeds 
Company (Mahyco). These efforts are closely followed by multilocation trials of additional Bt rice events 
and other traits, and some of these included event selection trials by BASF, Bayer CropScience, Pioneer Hi-
Bred, and others (source: http://moef.nic.in/divisions/csurv/geac/information.html).
The Golden Rice trait incorporates novel carotenoid biosynthetic genes that are expressed exclusively 
in the rice endosperm and leads to the accumulation of beta carotene in this edible portion of the rice grain; 
beta carotene in the plant-form precursor to vitamin A. A Golden	Rice2 (Paine et al., 2005 Nat Biotechnol. 
23: 482-487) event has been chosen for the project. The project has also secured additional funding from 
the Bill & Melinda Gates Foundation (to complement funding from the Rockefeller Foundation and the US 
Agency for International Development). Helen Keller International has joined the project to determine if 
the product will help alleviate vitamin A deficiency and if yes, to design a program to deliver the product 
to those most in need. It is anticipated that the regulatory dossier could be delivered to the regulators in 
the Philippines by as early as 2013 (www.irri.org/goldenrice).
A number of the leading GM rice traits/products have been examined in ex	ante studies, with 
the most prominent on the economic and other advantages of Bt rice in China. One of these, 
conducted by Jikun HUANG and collaborators, compared the expected performance of Bt rice, in 
multiyear and multilocation field trials, to those of Bt cotton, already a success in China, because 
the Bt rice product was expected to have similar changes in seed cost, yield, labor costs, and 
pesticide reductions. These studies had also modelled the effect of a subsequent potential loss of the 
small rice export market from China to probably sensitive markets (e.g. Japan, Republic of Korea). 
These analyses predicted a net internal gain for rice production from Bt rice, five years following 
market introduction, of a multiple of the billion $ gain for the country from the introduction of Bt 
cotton (Huang, Hu, Rozelle, and Pray, 2005 Science 308: 688-690; ibid, 2008 Econ Development 
and Cultural Change 241- 261). An added aspect of these studies was a self-reported reduction in 
pesticide poisonings by the farm families in the Bt rice trials versus non-participants; these studies 
are being repeated in another large scale trial and will include clinical measurements of pesticide 
exposure (personal communication).
The effect of Golden Rice (and other nutritionally improved GM rice traits) on health consequences 
in a number of countries has studied using an ex	ante Disability Adjusted Life Years (DALYs) approach to 
estimate the reduction in morbidity and mortality as a result of the adoption of these traits (Stein, Sachdev, 
and Qaim, 2006 Nat. Biotechnol. 24: 1200-1201; De Steur et al., 2010, Nat. Biotechnol. 28: 554-556). 
These current studies estimate that the traits would have significant impacts on the reduction of the health 
consequences of vitamin A deficiency and at costs often lower than those of other approaches. For Golden 
Rice, the existing studies were completed before the determination of the bioavailability/bioconversion 
rate of the beta carotene to vitamin A (more than 25% of the beta carotene in Golden Rice is converted 
to vitamin A in adults: Tang et al. 2009. Amer. J Clinical Nutr. 89:1776-83; later studies will report on 
related studies in children) and thus used much more pessimistic estimates of the conversion rate; plans 
are underway to update these ex	ante studies.
In a rather novel valuation exercise, and one that has merited a Harvard Business School Case Study, 
Arcadia Biosciences is collaborating with the Ningxia Hui Autonomous Region (Ningxia) of China to 
establish a carbon credit methodology applicable to rice through the adoption of the GM Nitrogen Use 
Efficient trait developed by the company in the crop (http://hbr.org/product/arcadia-biosciences-seeds-of-
change-abridged/an/711050-PDF-ENG).


